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SUMMARY
The reaction of the E.coli chaperonin GroEL (cpn 60) with the ATP analogue 
2', 3' oxidised ATP (oATP) was studied with a view to identify the important amino 
acid(s) present at the ATP binding site of GroEL. Treatment with the reagent leads to 
loss of the ATPase activity of GroEL in a pseudo-first order fashion; this can be 
prevented by inclusion of ATP in the reaction mixture. Measurements of the 
stoichiometry of the reaction indicate that the loss of activity corresponds to the 
incorporation of about one oATP per subunit of GroEL. From analysis of the 
sequences of modified peptides it is proposed that the reaction probably occurs with 
one or both of the two cysteines Cys 457 and Cys 518, although the instability of the 
adduct(s) makes a definite identification of the site(s) of reaction difficult. The 
involvement of Cys side chains in the reaction with oATP was confirmed by using 
DTNB (5,5'-dithiobis(2-nitrobenzoate)) to estimate thiol groups in both modified and 
unmodified GroEL.
The unfolding of GroEL in solutions in guanidinium chloride (GdnHCl) was 
also studied. From the results of CD, fluorescence and light scattering it is clear that 
major structural transitions in the protein occur over the range 1.0 - 1.5 M-GdnHCl, 
whilst the ATPase activity is lost at lower concentrations (0.75 M). The unfolding of 
the protein appears to be a highly cooperative process. After denaturation in 
concentrations of GdnHCl above 1.0 M, removal of the denaturing agent by dialysis 
results in the very nearly complete regain of secondary structure (as judged by CD) but 
not the regain of correct tertiary structure or quaternary structure, nor ATPase activity. 
The product was shown to be very sensitive to proteolysis by thermolysin, unlike the 
native protein, but did not show enhanced binding of ANS, a characteristic property of 
the ‘molten globule’ state of proteins..
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Chapter 1 Introduction
1.1 Molecular chaperones: general introduction
The first-half of the genetic pathway whereby information from linear genomic 
DNA is transferred into a three-dimensional functional protein has been well 
characterised, but until recently relatively little research has been undertaken to elucidate 
the steps the nascent polypeptide undergoes from emerging from the ribosome to 
folding into its final native structure. The classic work of Anfinsen (1973), on his 
studies on the renaturation of ribonuclease A in vitro, led to the proposal that many 
proteins are able to fold to the native state spontaneously and that the amino acid 
sequence of a protein contains all the relevant information to specify its three- 
dimensional structure. The extrapolation from the results of these types of experiments 
was that a protein in vivo could fold and assemble spontaneously m a process intrinsic 
to its primary structure, independent of other factors. Many in vitro refolding 
experiments, however, are successful only under non-physiological conditions i.e. at 
low temperatures (which attenuates hydrophobic interactions) and low protein 
concentrations (to limit aggregation). The relatively high protein concentrations and 
temperature of the cytosol can subject the growing polypeptide chain to premature inter- 
or intra-polypeptide interactions, often leading to misfolding and aggregation. Thus 
whilst some polypeptides, and especially small globular polypeptides, may fold 
spontaneously in vitro to attain native structure it is becoming increasingly obvious that 
others require the assistance of accessory proteins.
To deal with such problems a group of proteins known as chaperone proteins 
have evolved in order to ensure that polypeptides are able to fold or be transported 
properly. The term 'molecular chaperone' was first used by Laskey et al. (1978) to 
describe the function of nucleoplasmin. Nucleoplasmin binds to histones in order to 
shield their strong positive charge and as such prevents the misassembly of 
nucleosomes from separated histones and DNA. In the absence of nucleoplasmin, at 
physiological ionic strength, self-assembly fails due to the formation of a precipitate
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between the DNA and histone monomers. Although nucleoplasmin is the archetypal 
chaperone protein the definition has been extended in order to comprise a variety of 
sub-classes of chaperone proteins (Table 1.1). It is likely that this list will grow longer 
as other novel chaperone proteins are identified. The major classes are the heat shock 
proteins 60, 70 and 90 which will be discussed later. The chaperone proteins 
discovered to date do not, however, convey any steric information towards the folding 
process. Instead they are believed to have a passive role in that they simply act to 
prevent any off-pathway folding processes such as aggregation. Therefore the 'self- 
assembly' hypothesis of Anfinsen is not violated as the final three-dimensional 
structure is indeed dictated by the primary amino acid sequence. Proteins which fold 
and assemble only in the presence of chaperone proteins may be seen to be undergoing 
a process of 'assisted self-assembly' (Ellis, 1990).
1.2  Protein folding in vivo versus protein folding in vitro
Ideally the studying of protein folding should be performed in vivo, with the 
translation of the mRNA synchronised to the folding of the protein. The opportunity 
exists for refolding to commence on the emergence of the nascent polypeptide from the 
ribosome. Evidence exists that disulphide bonds can be formed co-translationally, this 
has been observed in the folding of rat-serum albumin (Peters and Davidson, 1982) and 
of immunoglobulins (Bergman and Kuehl, 1979). The evidence that short peptides can 
indeed have ordered secondary structure, for example the N-terminal first 45 residues 
of adenylate kinase can still bind MgATP tightly like the native enzyme presumably due 
to having a conformation similar to that in the enzyme (Fry et al., 1985), is consistent 
with the proposal that folding of proteins is initiated on the emergence of the 
polypeptide from the ribosome (Bergman and Kuehl, 1979). However protein folding 
is not entirely co-translational in that protein folding does not cease when translation 
ends, as newly synthesised polypeptides undergo constant adjustments in order to 
attain their final native structure. Such evidence for co-translational folding, however,
2
Table 1.1a Sub-classes of chaperone proteins
Class Members Proposed roles
1. Nucleoclasmin Nucleoplasmin, Protein XLNO-38 Nucleosome assembly.
Protein Ch-N038, Nucleoplasmin S Ribosome assembly & transport
2( s l) Chaperonins Chaperonin-60:
GroEL (E. coli), Hsp 60, mitonin, HuCha 60 Stress protection,
(all mitochondrial), ch-cpn60, rubisco Protein folding,
subunit binding protein (both plastid) Oligomer assembly.
Chaperonin-10: Protein transport,
GroES (E. co li), hsp 10 (mitochondria), DNA replication,
cpn 10 (plastid) mRNA turnover
2('b1 TRiC familv TF55 (archaebacteria), TRiC (mammals)
3. HSP 70 Hsp 68, 72, 73; DnaK; clathrin uncoating Protein folding,
ATPase;BiP; Grp 75, 78, 80; hsc70, Oligomer assembly /
KAR 2; SSC 1; SSD 1; SSA 1-4; disassembly, Protein
SSB 1 transport. Stress protection
4. HSP 90 Hsp 83, 87; Htp G; Grp 94 Masking of hormone receptor
5. Signal recognition particle Protein transport
6. Subtilisin orosequence Subtilisin folding
7. a-lvtic factor orosequence a-ly tic  protease folding
8. Ubiquitinated ribosomal proteins Eukaryotic ribosome assembly
9. Trigger factor Protein transport
10. Sec B protein Protein transport
11. Pap D protein E. coli pilus assembly
12.sHSPs / a-crvstallins Protein folding / Stress protect.
13.Carboxvoeotidase Y prosequence Carboxypeptidase Y folding
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Table 1.1b References for table 1.1a
Class References
1. Nucleoplasmin Laskey et al. (1978), Dingwall and Laskey 
(1990)
2(a) Chaperonins see Hallberg (1990), Ellis (1991), Gething and 
Sambrook (1992), Hendrick and Hard (1993), 
Neupert and Pfanner (1993), section 1.5.6
2(b) TRiC family Trent et al. (1991), Lewis et al. (1992), Yaffe et 
al. (1992), Mummert et al. (1993)
3. HSP 70 see Gething and Sambrook (1992), Hendrick and 
Hard (1993), Neupert and Pfanner (1993),
Zylicz (1993), section 1.5.2
4. HSP 90 Sanchez et al. (1987), Borkovich et al. (1989), 
Picard etal. (1990), Nadeau et al. (1993)
5. Signal recognition particle Georgopoulos (1992)
6. Subtilisin prosequence Zhu et al. (1989), Shinde et al. (1993)
7. a-lytic factor prosequence Silen and Agard (1989), Baker et al. (1992)
8. Ubiquitinated ribosmal proteins Finley et al. (1989)
9. Trigger factor Lecker et al. (1989)
10. Sec B protein Lecker et al. (1989), Georgopoulos (1992)
11. Pap D protein Holmgren and Branden (1989)
12. sHSPs / a-crystallins deJong et al. (1988), Horwitz et al. (1992) 
Jakob et al. (1993), Merck et al. (1993)
13. Carboxypeptidase Y prosequence Winther and Sprensen (1991)
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has led to the proposal that the in vitro method of studying folding, i.e. starting with a 
completely unfolded polypeptide chain via chemical denaturation, is not a good model 
for the studying protein folding (Bergman and Kuehl, 1979; Tsou, 1988), as it is not 
comparable with the in vivo situation.
To characterise the conformational changes a polypeptide undergoes in reaching 
native structure in vitro studies are necessary. The in vivo versus in vitro problem 
described above refers mainly to the kinetics of (re)folding. Protein folding within the 
cell takes of the order of minutes (Tsou, 1988). Refolding in vitro varies in time from 
seconds, monomeric fructose 1, 6, bisphosphate aldolase can regain activity within 10 
seconds after denaturation in guanidinium chloride (Rudolph et al., 1983), to hours and 
is often dependent on the experimental conditions chosen. While the latter time scale is 
incompatible with protein folding in vivo, it is still much more rapid than protein 
folding via a random pathway. Levinthal (1968) has estimated that it would take of the 
order of 1050 years for a polypeptide of 100 amino acids to attain a particular 
conformation by random search. Part of the discrepancy between in vivo and in vitro 
(re)folding may be accounted by the fact that the cell contains additional 'tools’ for 
efficient refolding, such as protein disulphide isomerase and peptidyl prolyl cis-trans 
isomerase which can accelerate the rate of protein folding. These proteins will be 
discussed in a later section. Despite any discrepancies between the time-scale of 
(re)folding, in vitro conformations, biological activity and relative molecular mass of a 
refolded protein are the same as would be found within the cell (Jaenicke, 1987). This 
would suggest that the in vitro method of studying protein folding, by denaturation 
with a strong denaturant followed by its removal to initiate the refolding process, is 
indeed a valid way of providing valuable information about the refolding process.
The efficiency of folding in vitro is very variable. While small monomeric 
proteins, especially those which lack disulphide bridges, can refold in vitro at rates 
comparable with the in vivo system some more complex proteins are unable to regain
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activity at all after denaturation. This has been noted especially for large multimeric 
proteins such as the hexameric glutamate dehydrognase (West and Price, 1988) and 
ribulose 1, 6, bisphosphate carboxylase (Rubisco)(Goloubinoff et al., 1989). The 
efficiency of folding in vivo has been estimated to be greater than 95% of all newly 
synthesised polypeptides eventually attaining their correct three dimensional structure 
(Gething and Sambrook, 1992). However misassembly and misfolding clearly occur in 
the cell (and in vitro ) under unbalanced physiological conditions (Pelham, 1986) and 
the cell must have a mechanism to compensate for this.
1 .3  The protein folding problem
The isomerisation of proteins from the unfolded state to the native conformation 
involves the transient formation of folding intermediates. A general folding pathway for 
monomeric proteins may be described in simple terms by the equation
fast slav
where U, I and N represent the unfolded, intermediate and native states, respectively^ 
The initial fast steps in protein folding involve the rapid formation of secondary 
structure, which occur on the millisecond time scale, and the formation of a 'molten 
globule’ type structure, as denoted by I in the above equation (Ptitsyn et al., 1990; 
Christensen and Pain, 1991). The 'molten globule’ is believed to be a general 
intermediate in protein folding, and is characterised by having a compact yet mobile 
structure that lacks the close packing of the secondary structure elements of the native 
protein and due to the fluidity of the structure the amino acid side chains are more 
accessible to solvent molecules than in the folded protein. The 'molten globule' form 
exists in rapid equilibrium with the unfolded state. The rate determining step in protein
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folding is, however, the slower, cooperative formation of specific tertiary structure 
associated with the native structure. It is the merging of pre-existing units from the 
semi-ordered 'molten globule' to the final adjustments in tertiary structure which are the 
limiting rate for a protein to attain native structure. These slow protein folding steps 
may involve disulphide-bond arrangements, isomerisation of X-Pro peptide bonds or 
domain pairing in the case of multi-domain proteins. In the case of the first two 
examples the rate-determining step in protein folding can be accelerated by the enzymes 
protein disulphide isomerase and peptidyl prolyl cis-trans isomerase, respectively 
(section 1.4). The folding of multimeric proteins is more complex and has been the 
subject of a number of reviews (see Price, 1992) and for reasons of brevity will not be 
discussed in this section .
Incorrect interactions can often take place during protein (re)folding leading to 
the formation of inactive aggregates due to incorrect inter- or intra-polypeptide 
interactions. This has been observed both in vitro (see section 1.5) and in vivo, in the 
case of formation of inclusion bodies during protein over-expression (Lee and Olins, 
1992; Edgerton et al., 1993) or during stress conditions within the cell (Pelham, 1986; 
Nguyen et al., 1989). The 'molten globule' states of proteins are less soluble than the 
native protein, presumably due to having a greater number of hydrophobic residues 
exposed and as such have a penchant for aggregation. The kinetic partitioning of the I 
state between the N state and the aggregated state (lagg) is therefore of great significance 
for the efficient folding of proteins.
U I N
1
In vitro one can control some of the factors which lead to aggregation. The 
simplest ways to suppress aggregation during in vitro refolding are by reducing the 
concentration of the protein, in order to reduce the amount of potential intra-molecular 
interactions, or by reducing the temperature of the refolding reaction, which suppresses 
hydrophobic interactions. In the complex cellular milieu such approaches are obviously 
not feasible and in order to resolve this dilemma the cell has apparently evolved 
molecular chaperones in order to modulate in vivo folding reactions (section 1.5).
1 .4  Catalysis of protein folding
In vitro (and thus presumably in vivo) the rate determining steps of protein 
folding involving the isomerisation of covalent bonds can be catalysed by the enzymes 
described below. These enzymes, protein disulphide isomerase and peptidyl prolyl cis- 
trans isomerase, do not determine the folding pathway but act simply so as to 
accelerate the slow rate-determining steps of protein folding.
1.4 .1  Protein disulphide isomerase
Protein disulphide isomerase (PDI) is an abundant protein found within the 
lumen of the endoplasmic reticulum (E.R.), which catalyses the thiol : disulphide 
interchange reactions leading to protein disulphide bond formation, isomerisation or 
reduction (depending on the polypeptide substrate and the imposed redox potential). 
The level of secretory protein synthesis in the E.R. of different cell types correlates 
with the abundance of PDI (Freedman, 1989). In vitro PDI can accelerate the formation 
of native interchain disulphide bonds in both type I and type II procollagen (Koivu and 
Myllyla, 1987) whilst co-translational studies have shown that the formation of 
disulphide bonds in y-gliadin, in dog pancreatic microsomes, is dependent on the 
presence of PDI (Bulleid and Freedman, 1988). In vivo crosslinking studies have also
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demonstrated that there is a specific association between newly synthesised 
immunoglobulin chains and the enzyme (Roth and Pierce, 1987).
The mammalian enzyme is a homodimer with identical subunits of Mr 57,000 
each containing duplications of domains which show a strong homology to thioredoxin 
(Edman et al., 1985). The active site of PDI, like thioredoxin, contains a pair of 
conserved vicinal cysteine residues in the sequence WCGHCK which participate in the 
thiol : disulphide exchange reactions. PDI has also been shown to be highly 
homologous to a number of other proteins suggesting that it may have multiple roles 
concerned with protein modification and assembly within the E.R.. The enzyme is 
identical to the P-subunit of prolyl-4-hydroxylase (Pihlajaniemi et al., 1987), an 
enzyme which causes extensive modification of proline residues in nascent collagen 
molecules, although it is unknown, as yet, whether the active site cysteine residues 
involved in 'thiol shuffling' are also involved in the hydroxylation reaction. In addition, 
PDI is also a component of the microsomal triglyceride transfer protein complex which 
facilitates the incorporation of triglycerides into nascent very low density lipoproteins 
within the E.R.(Wetterau et al., 1990). PDI has been shown to be related, on a 
sequence level, to a number of other proteins within the cell including a glycosylation 
site binding protein and thyroid hormone binding protein (Freedman, 1989).
Intriguingly PDI has also been proposed to be a chaperone protein, albeit one 
which also contains PDI activity, due to its multifunctionality and its general non­
specificity towards substrate polypeptides (Wang and Tsou, 1993). The P-subunit of 
prolyl-4-hydroxylase (i.e. PDI) is essential for the correct folding and assembly of the 
OC2P2 functional complex of prolyl-4-hydroxylase, as it prevents the misfolding and 
aggregation of the a-subunit (John et al., 1993). This may be considered a chaperone- 
like function although, unlike other known chaperone proteins, the P-subunit is also 
part of the final functional complex. Consistent with the proposal that PDI may also 
have chaperone-like activity the isomerase activity of PDI can be inhibited by the
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alkylation of the conserved vicinal cysteine residues but the modified enzyme can still 
bind to peptides (Noiva et al., 1991). The enzyme can apparently bind peptides without 
having any obvious sequence specificity ; this is similar to chaperone proteins which 
also show no obvious sequence specificity (discussed later). The four thioredoxin-like 
domains of mammalian PDI account for only approximately 40% of the entire 
polypeptide (Edman et al., 1985). The thioredoxin-like domains may be responsible for 
the isomerase activity, whist the remainder of the chain may be responsible for non­
specific peptide binding, that is the chaperone-like activity. Analogously, the peptide 
binding region of PDI has recently been located near the C-terminus, distinct from the 
PDI active site (Noiva et al., 1993). Interestingly a recent paper has provided more 
direct evidence of this putative chaperone-like role of PDI. PDI is able to bind to a 
variety of denatured polypeptides and, along with other proposed E.R. chaperone 
proteins including BiP (a known E.R. chaperone protein), is released only in the 
presence of ATP (Nigam et al., 1994). It remains for this interesting proposal to be 
confirmed.
1.4 .2  Peptidyl prolyl cis-trans isomerase
Peptidyl prolyl cis-trans isomerase (PPIase) catalyses one of the rate-limiting 
steps in in vitro protein refolding, namely the slow cis-trans isomerisation of proline 
peptide bonds. The efficiency of catalysis by PPIase is variable and dependent on the 
target protein. The slow steps of refolding can be accelerated rapidly in the case of 
immunoglobulin light chains (Lang et al., 1987) and ribonuclease T1 (Fischer et al., 
1989) whilst more moderate catalysis is observed with porcine ribonuclease (Lang et 
al., 1987) and type in  collagen (Bachinger, 1987). In other cases such as in the 
refolding of bovine ribonuclease A, no acceleration in the slow step of refolding is 
observed in the presence of PPIase, although the functionally distinct protein disulphide 
isomerase can catalyse more efficient refolding (Lang and Schmid, 1988). The 
isomerisation of Pro-peptide bonds is a relatively late step in protein (re)folding. Lang
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et al. (1987) have proposed that the variability in catalysis of prolyl isomerisations may 
be due to the fact that in some cases the Xaa-Pro bond is simply inaccessible due to the 
protein having reached some degree of 'nativeness'
Proteins with PPIase activity are highly abundant and widely distributed and 
found in all tissues and organisms from bacteria to mammals. In addition, two 
structurally unrelated classes of PPIases exist, characterised by their inhibitor and 
substrate specificities. The first class of PPIase is identical to cyclophilin, a protein 
known to bind to the immunosuppressive drug cyclosporin A, (Takahashi et al., 1989; 
Fischer et al., 1989) whilst the other class of PPIase bind the structurally distinct 
immunosuppressant FK506 (Siekierka et al., 1989; Harding et al., 1989). Whilst the 
role of PPIase in immunosuppression warrants close attention the main in vivo role of 
PPIases is, however, believed to be in the catalysis in the rate of cis-trans isomerisation 
of Xaa-Pro peptide bonds during protein folding although, as yet, only circumstantial 
evidence for this in vivo role exists. Mutant flies with a defect in the ninA gene, which 
codes for a homologue of cyclophilin-PPIase, show a 10 fold reduction in the levels of 
rhodopsin although the mRNA is produced normally. The ninA gene product may 
therefore be necessary for the folding and stability of rhodopsin (Shieh et al., 1989; 
Schneuwly et al., 1989). In addition the in vivo folding of the triple helix of type I 
collagen in chick fibroblasts is delayed in the presence of cyclosporin A (Bachinger and 
Compton, 1991). More direct evidence is required to fully implicate PPIase as a catalyst 
in cellular protein folding. It has also been recently proposed that PPIase may, as has 
been suggested for PDI, also have a chaperone-like activity, for example in preventing 
the aggregation of carbonic anhydrase (Freskgard et al., 1992).
1.5  Molecular chaperone proteins
Molecular chaperones have been defined as 'a family of unrelated classes of 
protein that mediate the correct assembly of other polypeptides but are not themselves
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components of the final functional structure1 (Ellis and van der Vies, 1991). The term 
mediate was deliberately chosen because the exact mechanism of chaperone mediated 
protein folding is still not yet fully understood. Chaperone proteins discovered to date 
do not act as catalysts of protein (re)folding, the recent proposals that PDI and PPIase 
may have chaperone-like activity (section 1.4) notwithstanding, but rather act to prevent 
off-pathway processes such as aggregation (section 1.3). The various chaperone 
proteins (table 1.1) are structurally homologous with each other, within each class, but 
not between classes. The major chaperone proteins, with particular emphasis on 
GroEL, will be discussed in this section.
1.5.1 The Nucleoplasmins
Nucleoplasmin is an acidic soluble nuclear protein which is the most abundant 
protein in amphibian oocytes, constituting between 7 and 10% of the actual nuclear 
protein in Xenopus oocytes (Mills et al., 1980). The chaperoning function of 
nucleoplasmin was first described by Laskey et al. (1978) who implicated the protein in 
the formation of nucleosome cores from separated histones and DNA in Xenopus 
oocyte extracts. At physiological ionic strength nucleosome cores are unable to form, in 
the absence of nucleoplasmin, due to the formation of a precipitate between the basic 
histones and acidic DNA. In the presence of a molar excess of nucleoplasmin the strong 
positive charge of the histones is shielded by the binding of the chaperone, and thus 
initial non-specific DNA-histone interactions are prevented allowing the formation of 
the most energetically stable conformation, the nucleosome. Nucleoplasmin assisted 
nucleosome assembly is believed to be Mg-ATP independent (Laskey et al., 1978), 
which distinguishes it from other known chaperone proteins such as the Hsp 70 and 
chaperonin 60 class. Under non-physiological conditions nucleosomes can also be 
reconstituted from separated DNA and histones, in the absence of nucleoplasmin, by 
prolonged dialysis from high salt concentrations (2 M-NaCl) to lower salt
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concentrations (Felsenfeld, 1978), indicating that the steric information for nucleosome 
assembly resides in the histones and not in nucleoplasmin.
Since the discovery of nucleoplasmin several homologues have been 
discovered, including the nucleolar protein XLNO-38 which may mediate the assembly 
of ribosomes. This suggests that a family of nucleoplasmin-like proteins exists, the 
members of which carry out various chaperoning functions within the cell (Dingwall 
and Laskey, 1990).
1.5.2 The Hsp70 family
1.5.2.1 General background
The heat shock 70 class (Hsp 70) class of molecular chaperones is an abundant 
family of stress proteins which are found throughout eukaryotic cells. In yeast 
members include the cytosolic proteins Ssal-4p, endoplasmic reticulum Kar2p and the 
mitochondrial protein Ssclp; homologues in mammals identified to date include the 
cytosolic Hsc73 protein and BiP (or Grp78) which is found in the endoplasmic 
reticulum. Members of this family have also been identified in plastids, namely ct- 
Hsp70. These proteins have been conserved throughout evolution, indeed the Hsp70 
homologue in E. coli, DnaK, shows approximately 50% sequence identity at the amino 
acid level to Hsp70 of eukaryotes (Bardwell and Craig, 1984). These proteins were 
initially discovered as stress proteins which were induced during the exposure of the 
cell to heat or other forms of stress. Under such conditions polypeptides can become 
partially denatured, exposing hydrophobic regions, and thus are prone to aggregation. 
This led to the proposal that Hsp70 can interact with such proteins in order to limit any 
such aggregation and, perhaps, promote disaggregation (Pelham, 1986). However, not 
all members of the Hsp70 proteins are heat-shock inducible, some are constitutively 
expressed and thus it has become clear that these proteins also have essential functions
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in the normal cell, particularly in de novo protein folding. These proteins have been 
shown both in vitro and in vivo to bind and stabilise unfolded forms of polypeptides in 
order to facilitate membrane translocation and / or their subsequent proper folding and 
assembly (for recent reviews see Craig and Goss, 1991; Gething and Sambrook, 1992; 
Hendrick and Hartl, 1993).
1.5.2.2 Conserved structure of the Hsp70 class
The Hsp70 proteins bind ATP and have a weak ATPase activity which has been 
implicated in their function. Comparison of the amino acid sequences of known Hsp70 
proteins show that the N-terminal two-thirds (-450 a.a.'s) are more highly conserved 
than the C-terminal region. Protease treatment of bovine clathrin uncoating ATPase 
(Hsc70) has identified an amino terminal 44-kDa resistant fragment that retains ATPase 
activity which is uncoupled from clathrin binding (Chappell et al., 1987). The structure 
of this domain has been determined by X-ray diffraction to a resolution of 2.2 A 
(Flaherty et al., 1990), revealing two domains of similar fold on either side of a large 
cleft with an ATP binding site at the bottom of the cleft. Despite the differences in 
function and amino acid sequence of the proteins the three-dimensional arrangement of 
the 44-kDa fragment of Hsc70 is similar to that of both rabbit skeletal muscle actin 
(Flaherty et al., 1991) and the nucleotide binding site of yeast hexokinase (Flaherty et 
al.9 1990). The ATP binding motif of these type of proteins - proposed to have evolved 
from a common ancestral origin (Bork et al., 1992) - is, however, distinct from other 
ATP binding proteins such as rec A protein and adenylate kinase which contain a type A 
phosphate binding motif as described by Walker et al. (1982). This latter type of 
nucleotide-binding protein themselves have been proposed to have a common ancestral 
core (Milner-White et al., 1991) and, may, have evolved independently from the ATP 
binding protein class of which Hsc70 is a member.
14
The variable C-terminal region of the Hsp70 proteins is responsible for 
polypeptide binding (Chappell et al., 1987) and has been identified as an 18-kDa region 
of Hsc70 protein located immediately after the 44-kDa ATPase domain (Wang etal., 
1993). The three-dimensional structure of the peptide binding domain is not known and 
several investigators have attempted to define this region, particularly in view of the 
rather catholic nature these chaperone proteins have towards 'substrate' polypeptides. 
This region of the protein has, however, been predicted to resemble the (X1OC2 
superdomain (i.e. the peptide binding site) of the human MHC class 1 antigen HLA 
based on a consensus secondary structure deduced from the amino acid sequences of 
33 Hsp70 proteins (Rippmann et al., 1991). Data would seem to indicate that Hsp70 
chaperone proteins interact with short stretches of (mainly) hydrophobic amino acids 
(Flynn et al., 1991; Richarme and Kohiyama, 1993; Blond-Elgundi et al., 1993a; 
Gragerov et al., 1994) which exist in an extended conformation (Landry et al., 1992; 
Blond-Elgundi et al., 1993a). Taking advantage of the fact that binding of some, but 
not all, short synthetic peptides stimulates Hsp70 ATPase activity, Flynn et al. (1991) 
synthesised a series of peptides of random amino acid sequence of known chain length 
in order to study binding to BiP, the mammalian endoplasmic reticulum Hsp70. These 
authors found that the peptide binding site of BiP is filled by a stretch of 7 residues, 
which are enriched in aliphatic amino acids, particularly in positions 3-6. Taking this a 
step further Blond-Elgundi et al. (1993a) used a bacteriophage display system to search 
many peptide sequences which could be recognised by BiP. This led to the discovery 
of a heptapeptide motif which has been implicated in recognition by BiP, namely Hy- 
(W/X)-Hy-X-Hy -X-Hy, where Hy is a large hydrophobic amino acid (most frequently 
Trp, Leu or Phe), W is Trp and X is any amino acid. The (poly)peptide binding site 
would therefore be seen to contain 4 pockets that can accommodate the large side chains 
of these hydrophobic and aromatic amino acids. Interestingly this type of arrangement 
is similar to that described for the binding of peptides to major histocompatability 
antigens (see Brown et al., 1993). The E. coli Hsp70 homologue DnaK also 
preferentially interacts with short stretches of hydrophobic sequences (Richarme and
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Kohiyama, 1993; Gragerov et al., 1994) although, as yet, no general consensus 
sequence has been identified. Such extended hydrophobic stretches are likely to be 
exposed only during the early stages of polypeptide synthesis and / or folding, 
presumably being buried in the native protein. Such hydrophobic peptides may be 
targets for Hsp70 chaperone proteins which could thus prevent off-pathway 
interactions occurring in vivo between the exposed hydrophobic regions which would 
otherwise limit translocation and /  or correct folding. The fact that Hsp70 proteins 
recognise such target motifs in an extended form (Landry et al., 1992) which contain 
little or no stable secondary structure, such as reduced carboxymethylated a -  
lactalbumin (Langer et al., 1992a), distinguishes them from the chaperonin 60 (Hsp60) 
class of chaperone proteins which seem to recognise secondary structure elements. This 
is likely to account for the differing roles of the Hsp70 and the chaperonin 60 class 
within the cell and will be discussed in a later section (section 1.6).
1.5.2.3 General mechanism for Hsp70 chaperone mediated action
Hsp70 proteins, certainly in the case of the E. R. protein BiP, are believed to 
exist in a oligomeric form which can be mobilised into an active monomeric form on the 
binding of substrate polypeptides (Blond-Elguindi et al., 1993b). They interact with 
unfolded segments of the polypeptide chain - i.e. a nascent polypeptide emerging from 
the ribosome, or after membrane translocation through the lipid bilayer or with 
sequences exposed by partial denaturation after cellular stress. The interaction is via 
their C-terminal region. The binding of the chain prevents any (further) premature inter- 
or intra-polypeptide interactions from occurring which may lead to aggregation or non­
productive folding. The binding of Hsp70 proteins to both protein and peptide 
substrates is weakened in the presence of hydrolysable ATP (Flynn et al., 1989; 
Palleros et al., 1991; Liberek et al., 1991b; Landry et al., 1992; Langer et al., 1992a). 
Nucleotide binding to the N -terminus causes a conformational change in the Hsp70 
protein, as judged by protease susceptibility (Liberek et al., 1991b), which is
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presumably transmitted to the C-terminal domain, whereupon the polypeptide is 
released. The released polypeptide may then fold into its native state, as a monomer or 
oligomer, or interact with other members of the chaperone machinery (Section 1.6) 
before attaining native structure. In vivo, however, the Hsp70 chaperones are believed 
to interact with other proteins which help to regulate the chaperones ATPase activity 
and thus polypeptide release (section 1.5.2.4).
1.5.2.4 Regulation of Hsp70 function
The mechanism of Hsp70 mediated action is not quite as straightforward as 
described above, due to the discovery of a number of accessory proteins which regulate 
the (ATPase) activity of these chaperone proteins. The E. coli Hsp70 homologue 
DnaK is regulated by the 41-kDa chaperone DnaJ and the 20-kDa GrpE, a 
constitutively expressed stress protein. The dna K gene was initially identified along 
with dna J and grp E as E. coli genes required for the growth of bacteriophage X 
(Friedman et al., 1984) and all three gene products have since been implicated as being 
important for normal cellular function.
Although a molar excess of DnaK on its own, in the presence of ATP, can 
prevent the thermal inactivation of RNA polymerase in vitro and reactivate it (Skowyra 
et al., 1990), the presence of the other regulatory components is required, in other 
cases, to potentiate the effect of DnaK-mediated folding (Langer et al., 1992a; Schroder 
et al., 1993). In vivo and in vitro all three components of the DnaK, DnaJ and GrpE 
chaperone system, plus ATP, are required for the efficient repair of thermally 
inactivated luciferase (Schroder et al., 1993). DnaJ itself is a chaperone protein, it can 
suppress the aggregation of luciferase, prior to the addition of DnaK and GrpE, and is 
known to bind to unfolded polypeptides such as| rhodanese (Langer et al., 1992a). In 
addition DnaJ recognises and binds nascent ribosome-bound polypeptides as short as 
55 amino acids (Hendrick et al., 1993). The role of DnaJ in vivo is believed to be to
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protect the nascent polypeptide from aggregation then target the unfolded polypeptide to 
DnaK. This leads to the formation of a ternary complex between DnaJ, DnaK and 
polypeptide of which DnaK, stabilised in its ADP-bound state (via ATP hydrolysis on 
DnaJ / polypeptide binding), has a high affinity for 'substrate' polypeptides (Palleros 
et al., 1993). The ATPase activity of DnaK is regulated by both DnaJ and GrpE, 
whereby DnaJ directly stimulates ATP hydrolysis and GrpE acts as a nucleotide 
exchange factor (Liberek et al., 1991a). Release of the polypeptide from DnaK is via an 
ATP induced conformational change in this chaperone. This is mediated by GrpE 
which, via its nucleotide exchange activity, stimulates the release of ADP followed by 
the binding of ATP. It is believed that it is the binding of ATP, rather than its 
hydrolysis, which is required for polypeptide release (Palleros et al.> 1993). The ATP 
bound form of DnaK has a lower affinity for 'substrate' polypeptides and as such the 
'chaperone complex' dissociates allowing release of the polypeptide to fold 
productively or be withdrawn by binding to another chaperone member (section 1.6). 
The polypeptide may, however, have to undergo several cycles of binding and release 
to DnaK, tightly regulated by DnaJ and GrpE, before reaching a state whereby it is 
committed to folding.
Several homologues of these regulatory proteins have also been found 
throughout eukaryotic cells. In yeast, DnaJ homologues include the cytosolic protein 
Ydjlp, the mitochondrial protein Scjlp and Sec63p, located in the endoplasmic 
reticulum. These proteins share several conserved features with DnaJ such as a 
cysteine-rich motif of unknown function and a putative domain, the 'J-region', which 
may mediate interactions with Hsp70s (Silver and Way, 1993). The mechanism of 
action described for the DnaK system is, therefore, also likely to be universal in the 
eukaryotic system..
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1 .5 .3  The Hsp90 family
Like Hsp70s, members of the Hsp90 class of chaperones are highly conserved 
in bacteria, yeasts and mammals with approximately 40% identity between the various 
eukaryotic Hsp90s and the E. coli homologue HtpG (Bardwell and Craig, 1988). 
Hsp90s are highly abundant proteins, localised predominantly in the cytoplasm. In S. 
cerevisiae two homologues exist, Hsc82 - a constitutively expressed protein - and 
Hsp82, which has a low basal level of expression and which can be induced 10 to 15 
fold on heat-shock (Borkovich et al., 1989). Inactivation of both of these genes is lethal 
at any temperature, although cells can survive single mutations at temperatures up to 
37.5°C.
The vertebrate Hsp90 proteins are found associated with a variety of proteins 
including cellular protein kinases and steroid hormone receptors (Gething and 
Sambrook, 1992) where the common role of the Hsp90 proteins, in these cases, seems 
to be in stabilising the target protein in an inactive or unassembled state. Hsp90-bound 
steroid receptors retain a high affinity for the steroid hormone but are unable to bind 
DNA and therefore unable to activate transcription. The displacement of Hsp90 from 
the receptor occurs on steroid-binding which then enables the steroid receptor to bind 
DNA and activate transcription (Sanchez et al.y 1987). This is not simply a case of 
steric hindrance by the Hsp90 protein. Glucocorticoid and estrogen receptors are unable 
to activate transcription in S. cerevisiae strains depleted in Hsp90 (Picard et al.y 1990) 
whilst in vitro studies have demonstrated that Hsp90 binding to glucocorticoid 
receptors is a prerequisite in order to maintain the hormone binding conformation of the 
receptor and, in turn, induce DNA-binding (Bresnick et al.y 1989). The role of the
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Hsp90 protein is, therefore, to interact with aporeceptors in order to convert them into 
an activatable conformation, whereby the hormone binding domain is established, and 
to inactivate any other functional domains which is reversed upon steroid binding (and 
Hsp90 release) (Picard et al.y 1990).
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Further evidence of the chaperoning properties of Hsp90 comes from studies on 
chemically denatured proteins. Bovine pancreatic Hsp90, in a manner analogous to the 
E. coli chaperonin GroEL, suppresses the aggregation of citrate synthase and increases 
the yield of reactivation of both citrate synthase and the Fab fragment of a monoclonal 
antibody (Wiech et al., 1992). The binding to the target polypeptide is at a 
stoichiometry of 1 Hsp90 dimer per 1 or 2 molecules of unfolded polypeptide. In these 
cases there was no requirement for nucleoside triphosphates and it is therefore difficult 
to evaluate the significance for this role in vivo , in the absence of controlled binding 
and release. However it should be noted that the the Fab fragment can also be released 
from the GroEL chaperone protein in the absence of ATP (Schmidt and Buchner, 1992) 
which may reflect the weak binding of this protein. Recently members of the Hsp90 
class have been shown to have an ATPase activity, which is more potent than that of 
the Hsp70 chaperones, and undergo conformational changes upon ATP binding 
(Nadeau et al., 1993). This may suggest that these proteins have a similar mechanism 
of action as the Hsp60 and Hsp70 proteins whereby the ATPase activity is regulated in 
vivo by accessory proteins. Such proteins, if they exist, have not been identified 
although Hsp90 have been shown to be associated with Hsp70 and both classes of 
peptidyl prolyl cis-trans isomerases (Nadeau et al., 1993). It remains to be seen 
whether these proteins interact together to refold proteins in the heat-shock response.
1.5.4 The sHSP family
Small heat shock proteins (sHSP) are a ubiquitous and conserved group of 
heat-shock inducible proteins with a molecular mass of 15-30 kDa which exist in high 
molecular weight complexes within the cell. The sHSPs are homologous to a-crystallin 
(a predominant eye lens protein which is also present in other tissues) at both the amino 
acid sequence level (deJong et al., 1988) and on a structural level (Merck et al., 1993). 
The a-crystallins and the sHsps also share functional chaperone-like properties in
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preventing misfolding of a variety of thermally and chemically denatured proteins. The 
a-crystallins suppress the thermally induced aggregation of a variety of proteins 
including the other major eye lens structural proteins p-crystallin and y-crystallin and 
can assist the refolding of chemically denatured y-crystallin (Horwitz, 1992). a- 
crystallin and sHsps have comparable functions in influencing the folding of other 
(non-eye lens specific) proteins under heat-shock conditions (Jakob et a l ., 1993; Merck 
et al.y 1993). Interestingly the reactivation of both citrate synthase and a-glucosidase in 
the presence of sHsps or a-crystallin seem to be independent of ATP (Jakob et al.y 
1993), similar to that described for the Hsp90 class (above). The mechanism of 
chaperoning-action of both sHsps and Hsp90 remains to be elucidated. It remains to be 
seen whether the sHSP (and possibly the Hsp90) class(es) have specialised functions 
within the cell, independent from the other chaperone proteins, or whether they act in 
concert with regulatory proteins in vivo .
1.5 .5  Co-translational chaperones
The assembly of a number of polypeptides, which are synthesised as 
precursors, require the presence of their N-terminal pro-sequences in order to attain 
native structure. The correct (re)folding of subtilisin (Zhu et al.y 1989), a-lytic protease 
(Silen and Agard, 1989) and carboxypeptidase Y (Winther and Sorensen, 1991) is 
dependent on the presence of the respective pro-sequences in order to attain their final 
functional structures. These extra sequences assist the correct assembly of their target 
polypeptides before being cleaved. These pro-sequences have been termed 'co- 
translational chaperones' (Ellis and van der Vies, 1991) because they are covalently 
attached to the molecules whose assembly they mediate, thus having the advantage of 
interacting with their ligand from (potentially) the onset of translation without having to 
seek out their target in the complex cellular milieu. It should be noted that the co- 
translational chaperones are not strictly speaking a family of chaperones, i.e. no 
sequence homology exists between them, but rather they are grouped together because
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of their similar functions. The mechanism by which co-translational chaperones assist 
polypeptide folding is, as yet, unknown. In the case of chemically denatured a-lytic 
protease, addition of the pro-sequence is required to overcome a kinetic block in the 
folding pathway to allow a catalytically inactive but folding competent state (resembling 
a 'molten globule') to attain native structure (Baker et al., 1992). This is more in the 
manner of a folding catalyst rather than a conventional chaperone protein. No similar 
intermediates are present during the refolding of subtilisin. Shinde et al. (1993) have 
proposed that the pro-sequence of subtilisin is actually required from the onset to 
induce a folding competent state of the protein, characterised by the presence of residual 
secondary structure, and assist in formation of final native structure. This latter 
suggestion is more in line with the conventional definition of molecular chaperones and 
is possibly nearer what happens in vivo .
It should be noted that the proteins described above do not require the assistance 
of other chaperone proteins in order to fold correctly and as such differ from those 
proteins whose pro-sequences are insufficient to guide them to their final native 
structure in the absence of other chaperones.
1.5.6 The Hsp60 family:- the chaperonins
1.5.6.1 General history
The Escherichia coli protein cpn60 (GroEL) and its homologues in 
mitochondria (Hsp60) and chloroplasts (mbisco subunit binding protein or ch-cpn60) 
belong to a class of evolutionary related stress proteins which are members of the sub­
class of chaperone proteins known as chaperonins (Hemmingsen et al., 1988). GroEL 
is a heat shock protein which can be increased from about 1% to 10% of the total 
soluble cytoplasmic protein following cellular stress (Hemmingsen et al., 1988) but is
t .
essential for cellular growth at all temperatures (Fayet et al., 1989). The groE gene,
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encoding GroEL and its partner chaperonin GroES, was initially discovered because 
mutations in it prevented the growth of several bacteriophages. This block is at the 
level of assembly of the bacteriophage where GroEL is required for the assembly of 
bacteriophage X and T4 head structures and T5 tail structure (Georgopoulos et al., 
1972; Georgopoulos et al., 1973; Zweig and Cummings, 1973). Rubisco subunit 
binding protein was discovered several years later associated with newly translated 
large subunits of rubisco in the stroma of P. sativum chloroplasts but absent in the 
mature protein (Barraclough and Ellis, 1980), whilst Hsp60 in mitochondria was first 
identified in Tetrahymena thermophilia as a GroEL related stress protein during heat 
shock conditions (McMullen and Hallberg, 1987). These early studies indicated a role 
for the chaperonin proteins in the assembly of other proteins and it now seems clear that 
this is a general function for these proteins within the cell. Highly-related Hsp60 
homologues have not been detected in the eukaryotic cytosol or the endoplasmic 
reticulum. Proteins with weak Hsp60 homology have, however, been identified in the 
cytosol of thermophilic archaebacteria, plants and mammals which appear to possess 
chaperonin-like functions (Trent et al., 1991; Lewis et al., 1992; Yaffe et al., 1992; 
Mummert et al., 1993). These proteins may be regarded as a sub-class of chaperonins, 
namely the TRiC family, which are postulated to carry out GroEL-like functions within 
the eukaryotic cytoplasm.
1.5.6.2 The gro E gene products
GroEL is an oligomeric protein consisting of 14 identical subunits, with a 
subunit Mr of 57, 259 as deduced from its amino acid sequence (Hemmingsen et al., 
1988). Electron microscope analysis of negatively stained oligomeric GroEL indicates 
that the complex has an overall cylindrical shape containing a central cavity; the height 
and diameter of the cylinder are approximately 160 nm by 130 nm, respectively, and 
the subunits are arranged in two heptameric rings stacked on top of each other 
(Hendrix, 1979; Hohn et al., 1979; Ishii et al., 1992; Langer et al., 1992b). Each
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subunit contains two domains of approximately equal size which appear as a double- 
ring in electron microscope side views. The electron dense central channel, which 
traverses the protein, is approximately 6 nm in diameter and has been proposed to be 
the site for polypeptide binding (Langer et al., 1992b; Braig et al., 1993). GroEL also 
possesses a weak ATPase activity (kcat « 0.06 sec"1 per subunit) (Hendrix, 1979) 
which is dependent on the presence of Mg2+ and K+ ions for maximal activity (Viitanen 
et al., 1990). Nothing is known to date about the tertiary organisation of the GroEL 
polypeptide.
The gro E operon also encodes another heat-shock inducible protein known as 
GroES. GroES has a subunit Mr of 10, 368 (Hemmingsen et al., 1988) and exists in a 
homo-oligomeric form composed of seven identical subunits arranged in a ring-like 
structure, 8 nm in diameter with a 2 nm electron dense central channel (Chandrasekhar 
et al., 1986). GroES and its homologues in mitochondria (HsplO) and plastids 
(cpnlO), which are thought to have a similar structural arrangement, have also been 
defined as (co-)chaperonins (Hemmingsen et al., 1988).
Genetic and biochemical evidence exists that the GroEL and GroES proteins 
functionally interact, which helps explain why mutations in either the gro ES gene or 
gro EL gene often results in a similar phenotype. The genetic evidence consists of the 
isolation of missense mutations in the gro EL gene which compensates for the 
temperature sensitive phenotype of certain gro ES mutations in an allele specific manner 
(Tilly and Georgopoulos, 1982). Biochemical evidence has shown that the uncoupled 
ATPase activity of GroEL is effectively inhibited by the binding of GroES to GroEL, 
an event that itself requires the presence of ATP or ADP (Chandrasekhar et al., 1986; 
Viitanen et al., 1990; Gray and Fersht, 1991; Bochkareva et al., 1992). Such a stable 
GroEL-GroES complex can be isolated by sedimentation or gel filtration 
(Chandrasekhar et al., 1986; Viitanen et al., 1990; Bochkareva et al., 1992) and is 
believed to be the basis of GroE function in vivo.
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1.5.6.3 GroE homologues in higher organisms
The GroEL homologues identified in bacteria, fungi and plants all have the 
characteristic double-toroid tetradecameric structure observed in GroEL. The 
chloroplast homologue (ch-cpn60) is unusual, however, in that it is composed of two 
types of subunit of relative Mr 61,000 and 60,000, known respectively as the a  and (3 
subunits (Hemmingsen et al., 1988). The two subunit types are highly divergent, with 
the a  subunit showing a high sequence homology to GroEL, for example the wheat 
plastid a  subunit of ch-cpn60 shows 46% identity to GroEL (Hemmingsen et al., 
1988). The two subunit types are present in equal amounts in the tetradecamer, but their 
structural arrangement within the chaperonin complex is unknown. A mammalian 
homologue of GroEL has recently been identified in bovine mitochondria (Viitanen et 
al., 1992b). In contrast to previously characterised chaperonin 60 molecules this 
protein functions as a single heptameric toroid. The mammalian mitochondrial Hsp60 is 
virtually identical to GroEL in face views when examined by electron microscopy but 
the side view of GroEL is about twice as long, carrying the characteristic four striations 
running parallel to the long-axis compared to two such striations in bovine 
mitochondrial Hsp60 (Viitanen et al., 1992b). It is unknown whether these mammalian 
chaperonin 60s generally function as a single-ring unlike the bacterial and plant 
chaperonin 60s which function as double rings.
Co-chaperonin, or E. coli GroES, homologues in higher organisms have been 
identified only relatively recently. These proteins, which are believed to interact 
functionally with their larger partner chaperonin proteins in a manner analogous to the 
GroE system, have been identified using a GroEL-dependent Rhodospirillum rubrum 
rubisco reconstitution assay. They are found to be present in mammalian mitochondria 
(Lubben et al., 1990; Hartman et al., 1992), yeast mitochondria (Rospert et al., 1993) 
and higher plant chloroplasts (Bertsch et a l, 1992). The stress-inducible rat liver
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mitochondrial HsplO shares approximately 40% sequence homology with GroES and 
has a subunit Mr of 10, 813 (Hartman et al., 1992). The oligomeric arrangement of this 
protein, judging from gel filtration experiments, is likely to be hexameric or heptameric, 
like GroES (Hartman et al., 1992). The yeast mitochondrial HsplO protein has an 
approximate Mr of 9, 000, from SDS-PAGE, although nothing is known about its 
oligomeric arrangement (Rospert et al., 1993). Unexpectedly this protein is unable to 
inhibit the ATPase activity of its partner chaperonin, yeast mitochondrial Hsp60, 
although it can form a stable, isolatable complex with it in the presence of ATP. This, 
therefore, may be a property unique to the GroE system. The GroES equivalent in 
higher plant chloroplasts, ch-cpnlO, is apparently a 'double' chaperonin having a 
subunit size of approximately 24-kD which is twice the size of other reported 
chaperonin-10s (Bertsch et al., 1992). This protein has apparently arisen through either 
gene duplication or through the fusion of two distinct chaperonin-10 genes. Both the 
N- and C-terminal halves of the mature protein exhibit high homology to GroES and 
the two halves show 40% identity (70% if conservative changes are taken into account) 
to each other (Bertsch et al., 1992). The quaternary structure of this protein is not 
known with any certainty. Thus both the ch-cpn60 and ch-cpn-10 proteins are unique 
in their structural arrangement These proteins may have evolved to perform specialised 
functions, perhaps related to the assembly of higher plant rubisco. As it is unknown 
whether multiple isoforms of ch-cpn60 exist one cannot rule out the possibility of a 
more conventional ch-cpnlO homologue.
1.5.6.4 Studies on GroE mediated (re)folding
The chaperonin proteins play an important role in stress protection under 
unbalanced physiological conditions, however it has become apparent that these 
proteins also have a more general role within the cell, namely in assisting the folding 
and / or assembly of a variety of proteins during the normal functioning of the cell The 
first evidence that chaperonin proteins were involved in a general role in protein folding
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and / or assembly in vivo came from studies on a yeast strain (mif-4) which harboured 
a temperature sensitive mutation in the Hsp60 gene encoding the mitochondrial 
chaperonin Hsp60. Although protein synthesis and translocation into the mitochondrial 
matrix is unaffected in this strain at non-permissive temperatures polypeptides imported 
into the mitochondria, including Hsp60 itself, are unable to assemble into their native 
catalytically active structures (Cheng et al., 1989; Cheng et al., 1990). This is indicative 
of the importance of these proteins.
Chaperonins do not only interact with and promote the folding of polypeptides 
that have first crossed membranes, as studies on the GroE proteins have demonstrated. 
Overexpression of GroEL and its co-chaperonin GroES in vivo results in the enhanced 
expression of a number of foreign proteins in E. coli which would otherwise misfold 
or aggregate (Carrillo et al., 1992; Lee and Olins, 1992; Wynn et al., 1992; Edgerton et 
al., 1993). This is consistent with the proposed role for the GroE proteins in protein 
biogenesis. Newly synthesised E. coli proteins are known to undergo aggregation in 
cells lacking a heat shock response (Gragerov et al., 1992) but a more global role for 
the products of the gro E gene in polypeptide folding has recently been reported. 
Horwich et al. (1993), in line with the mif -4 mutants described above, introduced a 
temperature sensitive lethal mutation into the gro E gene and demonstrated that a 
defined group of cytoplasmic proteins, including citrate synthase, ketoglutarate 
dehydrogenase and polynucleotide phosphatase, are synthesised but fail to attain a 
native conformation when the cells are shifted to a non-permissive temperature. These 
authors estimated that approximately 30% of the soluble protein species are affected 
through GroEL deficiency; this is in rough agreement with the observations of Viitanen 
et al. (1992a) who estimate that approximately 50% of soluble protein species of E. coli 
are bound by GroEL upon dilution from chaotrope in vitro.
Much of the information regarding the mechanism of how GroEL functions in 
assisting protein folding and /  or assembly have come mainly through in vitro studies
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using purified chaperonins and chemically denatured purified ’substrate' proteins. 
GroEL has been shown to interact with a number of unrelated polypeptides in vitro and 
mediate the refolding into their final functional structure. Polypeptides bind to GroEL in 
an ATP independent process and generally form a stable complex with the chaperonin. 
Polypeptides can be released from the chaperonin in a folding-competent state in vitro 
in one of two ways. Release may be triggered by the presence of ATP alone or by the 
presence of GroES and ATP. In the former case GroEL has been shown to interact 
with and assist the refolding of a number of polypeptides including lactate 
dehydrogenase (Badcoe et al., 1991; Jackson et al., 1993), phytochrome photoreceptor 
(Grimm et al., 1993), bamase (Gray and Fersht, 1993), enolase (Kubo et al., 1993), 
glutamine synthase (Fisher, 1992), dihydrofolate reductase (Viitanen et al., 1991; 
Martin et al., 1992), tryptophanase (Mizobata et al., 1992), the Fab fragment of a 
monoclonal antibody (Schmidt and Buchner, 1992), a-glucosidase (Holl-Neugebauer 
et al., 1991) and pre-p-lactaminase (Laminet et al., 1990). It should be noted that 
whilst ATP is sufficient for the successful release and reactivation of these proteins, the 
presence of GroES potentiates the effect in most of these examples.
The proteins which have an essential requirement for both ATP and GroES for 
efficient GroEL mediated folding include|rhodanese (Mendoza et al., 1991; Mendoza et 
al., 1992; Martin et al., 1991; Bochkareva et al., 1992; Tsalkova et al., 1993), 
ornithine transcarbamylase (Zheng et al., 1993) rubisco (Goloubinoff et al., 1989; 
Viitanen et al., 1990; Baneyx and Gatenby, 1992; van der Vies et al., 1992; Viitanen et 
al., 1992a), citrate synthase (Buchner et al., 1991), malate dehydrogenase (Hartman et 
al.t 1993a; Miller et al., 1993) and 6-hydroxy-D-nicotine oxidase (Brandsch et al., 
1992). The two best studied examples are rhodanese and rubisco. In each case the
I
GroEL bound polypeptide can be released in the presence of ATP alone but fail to attain 
native conformation due to aggregation of the released polypeptides (Martin et a/., 1991; 
Baneyx and Gatenby, 1992; Viitanen et al., 1992a). In the presence of GroES and 
ATP, 85-90% of bound Rhodospirillum rubrum rubisco is released from GroEL
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leading to the formation of both the active rubisco dimer and a smaller amount of 
inactive, but folded, monomer (Baneyx and Gatenby, 1992; Viitanen et al., 1992a). In 
contrast, in the presence of ATP alone 50-75% of bound rubisco is released from 
GroEL but most of the material is unable to fold into either the monomeric or dimeric 
form (Baneyx and Gatenby, 1992; Viitanen et al., 1992a). Similar results have been 
observed with the ATP induced release of jrhodanese from GroEL, i.e. |rhodanese‘< 
released in the presence of ATP, but in the absence of GroES, is unable to attain native 
structure and undergoes aggregation (Martin et al., 1991). The polypeptide is therefore 
released from GroEL in a different conformational state depending on whether ATP or 
ATP and GroES was responsible for release. In the presence of GroES, the bound 
polypeptide is able to progress to a state whereby it is not susceptible to aggregation on 
release and is committed to folding, indicating that the co-chaperonin plays a regulatory 
role in co-ordinating the timely release of polypeptides from GroEL.
1.5.6.5 GroEL as a catalyst
GroEL is undoubtedly a catatyst, albeit a sluggish one, with respect to the K+ 
dependent hydrolysis of ATP to ADP and Pi. However the question of whether GroEL 
is a catalyst with respect to protein folding remains to be fully resolved. In most of the 
examples investigated the presence of the GroE proteins and ATP increases the yield of 
active protein upon refolding (often by suppressing aggregation). However in many of 
these cases little or no enhancement in the actual rate of (re)folding is observed {e.g. 
Laminet et al., 1990; Buchner et al., 1991; Badcoe et al., 1991; Holl-Neugebauer et al., 
1991; Schmidt and Buchner, 1992; Gray and Fersht, 1993; Kubo et al., 1993; Miller et 
al., 1993; Jackson et al., 1993). In the case of dihydrofolate reductase the rate of 
refolding in the presence of GroEL and ATP is actually slower than that observed for 
refolding in the absence of chaperonins. The presence of GroES slightly increases the 
refolding rate, although it is still slower than spontaneous refolding (Martin et al., 
1991; Viitanen et al., 1991). In contrast only two cases have been reported to date
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whereby the rate of refolding is accelerated in the presence of the chaperonin system, 
namely the refolding of rubisco (Viitanen et a/.,1990) and ornithine transcarbamylase 
(Zheng et al., 1993). The rate of spontaneous rubisco refolding at 15°C is increased 
approximately 10 fold in the presence of the GroE proteins and ATP (Viitanen et 
al.,1990). It is difficult to interpret the results of such experiments with respect to what 
occurs in vivo , since the success of rubisco refolding in vitro (and that of other 
proteins) depends on the experimental conditions chosen, regarding ionic strength and 
temperature. The majority of the evidence available to date would, however, suggest 
that GroEL does not act as a catalyst of protein refolding (i.e. to enhance the rate of 
refolding) but rather acts to prevent off-pathway interactions which may inhibit correct 
folding.
1.5.6.6 Recognition of target polypeptides by GroEL
GroEL interacts with a variety of polypeptides which are unrelated with regards 
to sequence, structure and function and assists in their (re)folding to native 
conformation (see section 1.5.6.4). With two exceptions, pre-p-lactaminase (Laminet 
et al., 1990) and dihydrofolate reductase (Viitanen et al., 1991), GroEL does not 
interact with polypeptides once they have attained native structure but rather only 
interacts with their non-native forms. Thus the structural motif(s) recognised by GroEL 
must be present only during the early stages of protein (re)folding and be no longer 
present or inaccessible in the native protein. Indeed in the case of pre-P-lactaminase 
(Laminet et al., 1990) and dihydrofolate reductase (Viitanen et al., 1991) these proteins 
are known to exist in a slow equilibrium with a number of conformational states, at 
least one of which may interact with GroEL.
Studies by Martin et al. (1991) have indicated that both rhodanese and 
dihydrofolate reductase are bound to GroEL in a similar conformation. These proteins, 
when bound to GroEL, are more susceptible to proteolysis (compared to the native
protein), show enhanced binding of the hydrophobic probe ANS, and show 
fluorescence properties intermediate between that of the fully unfolded state and the 
native state. Thus GroEL stabilises [ rhodanese: and dihydrofolate reductase in a 
conformation lacking the ordered tertiary structure characteristic of an early folding 
intermediate, the ’molten globule' (see section 1.3). Indeed some partial folding may 
also occur whilst the polypeptide is associated with GroEL (Martin et al., 1991). 
Although Badcoe et al. (1991) have proposed that GroEL does not interact with the 
'molten globule' form of lactate dehydrogenase, but rather an earlier folding 
intermediate, many other polypeptides are believed to interact with GroEL in such a 
conformation. Independent studies on GroEL-bound rhodanese (Mendoza etal., 1992) 
have confirmed the proposal of Martin et al. (1991) whilst the fluorescence spectra of 
GroEL-bound a-glucosidase is suggestive of a 'molten globule' type structure (H511- 
Neugebauer et al., 1991). Evidence also exists that GroEL interacts with a compact 
intermediate form of rubisco (van der Vies et al., 1992) whilst an intermediate of the 
a-subunit of luciferase, which lacks stable tertiary structure (as judged by N.M.R.) 
but contains a high degree of secondary structure, is recognised by GroEL (Flynn et 
al., 1993).
The 'molten globule’ folding intermediate contains a high proportion of exposed 
hydrophobic residues compared to the native protein and as such may have a propensity 
to aggregate in the absence of chaperonins. Thus it is conceivable that GroEL may, in 
part, recognise and target hydrophobic residues as its site of interaction. The answer to 
this question will come from high resolution techniques such as N.M.R. studies but to 
date only limited such studies have been undertaken. A peptide corresponding to the N-
terminal 13 amino acids of rhodanese binds to GroEL in an a-helical conformation
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(Landry and Gierasch, 1991). These authors have proposed that GroEL interacts with 
peptides that have the potential to adopt amphipathic a-helixes, perhaps by interacting 
with a hydrophobic face. Interestingly another synthetic peptide, vsv-C, binds to 
GroEL in a a-helical form but binds to DnaK (the E. coli Hsp70 homologue) in a
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more extended form (Landry et al., 1992). This is likely to reflect the fact that 
chaperonins are involved further downstream in the folding pathway than the Hsp70s. 
However, GroEL does not just bind to (poly)peptides which have the potential to adopt 
a-helixes. Schmidt and Buchner (1992) have shown that GroEL can functionally 
interact with an Fab fragment of a monoclonal antibody which is an all p-protein. 
Therefore, as yet, no 'typical' consensus sequence has been observed for GroEL 
binding as has been observed for members of the Hsp70 class (Blond-Elgundi et al., 
1993a; section 1.5.2.2.). It is likely that polypeptide interactions with GroEL will 
depend mainly on the nature of the folding intermediate rather than a specific element of 
secondary structure.
1.5.6.7 The stoichiometry of binding and the site of recognition
The stoichiometry of binding of unfolded polypeptides to GroEL has been 
examined mainly by measuring the amount of GroEL required to prevent aggregation or 
spontaneous refolding of polypeptides on dilution from denaturant (Laminet et al., 
1990; Badcoe et al., 1991; Martin et al., 1991; Mendoza et al., 1991; Bochkareva et al.,
1992). The results of such studies have indicated that one or at most two molecules can 
be bound per GroEL tetradecamer. Direct examination of gold-labelled dihydrofolate 
reductase molecules bound to GroEL suggest that two molecules (but occasionally 
three) bind to GroEL (Braig et al., 1993).
The stoichiometry of one or two molecules binding per GroEL oligomer may 
suggest that binding occurs at the centre of the GroEL complex. Indeed scanning 
transmission electron microscopy studies have demonstrated that unfolded 
dihydrofolate reductase tagged with gold clusters binds within the central cavity of 
GroEL (Braig et al., 1993). In support of this, negative stain electron microscopy 
images of both I rhodanese and alcohol oxidase bound-GroEL show a stain excluding 
mass in the central portion of GroEL which is not present in the absence of 'substrate'
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polypeptides (Langer et al., 1992b). Thus it seems as though 'substrate' polypeptides 
do indeed bind within the central cavity of GroEL. This cavity can accomodate 
polypeptides up to approximately 90-kD (Braig et al., 1993) and conveys several 
advantages, namely (a) folding intermediates can bind at multiple sites of the 
surrounding monomeric subunits and upon GroES /  ATP mediated release be rebound 
by the surrounding monomers (or by the adjacent ring) if a native-like conformation is 
not initially achieved, (b) by physically removing the polypeptide from the complex 
cellular environment its chances of aggregating is greatly reduced and (c) with the 
polypeptide binding sites of GroEL positioned within a cavity, homotypic interactions 
between GroEL rings themselves would be minimised. The location of the polypeptide 
along the long-axis of GroEL is not fully understood, however it is interesting to note 
that a functional Hsp60 chaperonin has been isolated from mammalian mitochondria 
which, unlike other characterised chaperonin-60 molecules, exists as a single 
heptameric toroid (Viitanen et al., 1992b) (see section 1.5.6.3 above).
1.5.6.8 GroEL - GroES interactions
In vitro studies have indicated that whilst some proteins can refold efficiently in 
the absence of GroES, for others the presence of GroES is absolutely essential to attain 
native conformation (see section 1.5.6.4). This may, in part, reflect the relative binding 
affinities of GroEL for different polypeptides and /  or indicate that slower folding 
polypeptide intermediates require additional interactions with GroEL, in a GroES and 
ATP-assisted process, before being released in a folding-competent state. It should also 
be noted that GroEL does not assist in the refolding of all polypeptides within the cell 
(Horwich et al., 1993). Such in vitro experiments, however, do not rule out a role for 
GroES in vivo and in many cases where GroES was not essential for efficient release 
and refolding it did potentiate the effect (Laminet et al., 1990; Holl-Neugebauer et al., 
1991; Viitanen et al., 1991; Fisher, 1992; Martin etal., 1992; Schmidt and Buchner,
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1992; Gray and Fersht, 1993). Thus in vivo GroEL and GroES are likely to function 
together.
The stoichiometry of (ATP /  ADP dependent) GroES binding to GroEL is one 
GroES heptamer per GroEL tetradecamer. Several lines of evidence have determined 
this, for example maximum inhibition of the uncoupled GroEL ATPase activity by 
GroES occurs at a 1 : 1 stoichiometry (Chandrasekhar et al., 1986) whilst the in vitro 
refolding of polypeptides occur optimally when the chaperonins are present together in 
such a ratio (Goloubinoff et al.> 1989; Martin et al., 1991; Langer et al., 1992b; Miller 
et al., 1993). Electron microscopy image analysis has directly demonstrated such 
GroEL - GroES interactions both in vitro (Saibil et al., 1991; Langer et al., 1992b) and 
in vivo (Ishii et al., 1992). A single GroES ring binds asymmetrically to one end of the 
GroEL cylinder producing a 'bullet-like' appearance (Saibil et al., 1991; Ishii et al., 
1992; Langer et al., 1992b). The binding of the co-chaperonin to GroEL induces a 
conformational change in both the GroES adjacent end and the opposite end of the 
GroEL cylinder (Langer et al., 1992b). This apparently prohibits the binding of a 
second GroES oligomer. Interestingly, GroES can interact initially with either end of 
the GroEL cylinder (Langer et al., 1992b), which may suggest that the GroEL rings are 
arranged in an A-B-B-A formation along the long-axis (compared to an A-B-A-B 
formation). The nature of the GroEL-GroES interaction remains unclear. Landry et al. 
(1993) have postulated that native GroES contains a highly flexible and accessible 
polypeptide loop, spanning amino acid residues 17-32 in the GroES sequence, which is 
important for binding to GroEL at a GroES specific site. This site be may located near 
the C-terminus of GroEL since GroES binding prevents proteolytic cleavage of the C- 
terminal 16 residues of GroEL (Langer et al., 1992b). Further characterisation will be 
required, however, to identify the molecular details of such an interaction.
1
GroEL can also functionally interact with the GroES homologues identified to 
date from higher organisms. GroEL can form stable, isolatable complexes in the
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presence of ATP with bovine mitochondrial HsplO (Lubben et al., 1990), cpnlO from 
pea chloroplast (Bertsch et al., 1992) and yeast mitochondrial HsplO (Rospert et al.,
1993). In each case, these heterologous chaperonin complexes are able to assist in the 
refolding of denatured Rhodospirillum rubrum rubisco in a manner analogous to the 
GroE complex. Refolding of ornithine transcarbamylase by a heterologous GroEL / rat 
mitochondrial HsplO system has also been reported (Hartman et al., 1992). This is 
likely to reflect a considerable conservation of interactive surfaces on GroEL and the 
diverse chaperonin-10s. Interestingly, although the cpnlO of higher plant chloroplasts 
is partially functional with yeast mitochondrial Hsp60 (Rospert et al., 1993), GroES 
can functionally interact with neither yeast mitochondrial Hsp60 (Rospert et al., 1993) 
nor with bovine mitochondrial Hsp60 (Viitanen et al., 1992b), either to form a stable 
heterologous chaperonin complex or to promote rubisco refolding. No interactions 
between GroES or plastid cpn60 has been reported either. The complete primary 
sequence of rat mitochondrial chaperonin-10 (HsplO) has recently revealed that, unlike 
GroES, the amino terminal of the polypeptide is acetylated (Hartman et al., 1993b). It 
is feasible, therefore, that Na-acetylation of rat HsplO (and therefore of other 
chaperonin-10s) is required for a functional interaction with its mammalian Hsp60 
counterpart.
In summary it is likely that GroEL and GroES functionally interact in vivo, 
certainly under normal cellular conditions. The role of the GroES protein is to co­
ordinate the ATP dependent release of bound segments of the ‘substrate1 polypeptide 
and prevent premature release which may lead to aggregation. Under heat -shock 
conditions, i.e. at high temperatures, some GroEL can become reversibly 
phosphorylated which allows ATP-dependent release of substrate polypeptides to occur 
in the absence of GroES (Sherman and Goldberg, 1992). This form of GroEL may be 
more efficient, than the major GroEL species, in promoting the repair of (heat) 
damaged polypeptides
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1.5.6.9 The ATP binding site of GroEL
The GroEL oligomer contains 14 ATP-binding sites and binding and hydrolysis 
of the nucleotide is a highly co-operative process which is enhanced by the presence of 
GroES (Gray and Fersht, 1991; Bochkareva et al., 1992; Jackson et al., 1993). GroES 
is believed to act to couple the hydrolysis of ATP with the release of the polypeptide in 
a folding competent state (Viitanen.er al., 1990). The molecular mechanism of this 
tightly coupled interaction is not yet fully understood. On a simplistic level 
polypeptides, at least in vitro, can be released from GroEL simply through the binding 
of ATP. ATP hydrolysis is not required to alter the conformational structure of GroEL 
to reduce its affinity for 'substrate' proteins. GroEL undergoes similar conformational 
change in the presence of ATP, ADP or non-hydrolysable ATP analogues (Baneyx and 
Gatenby, 1992) and many polypeptides which interact with GroEL can be released in 
the presence of non-hydrolysable ATP analogues or ADP (table 1.2) and fold into their 
native state. The refolding yield is generally lower than in the presence of ATP and 
reflects the fact that the ATP 'substitutes' bind more weakly to the ATP-binding site 
(Baneyx and Gatenby, 1992; Jackson et al., 1993). Interestingly almost all of these 
proteins do not have essential requirements for GroES to assist protein refolding in 
vitro. The exception is ornithine transcarbamylase which normally requires GroES and 
ATP for efficient refolding. This protein can be released from GroEL in the presence of 
ATPyS and GroES but the released polypeptide is not competent for assembly (Zheng 
et al., 1993). It appears that in those cases where an absolute requirement for GroES 
exists, there is also an absolute requirement for hydrolysis of ATP. Indeed the energy 
requirement of GroEL-GroES assisted] rhodanese refolding in vitro is relatively high. 
About 130 molecules of ATP are hydrolysed per molecule of | rhodanese folded, 
indicating that the reaction cycle undergoes multiple rounds of ATP hydrolysis per 
GroEL tetradecamer (Martin et al., 1991). During such a folding process the 
polypeptide substrate and the regulatory protein GroES undergo cycles of binding and
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Table 1.2
Polypeptides which can be released from GroEL in the absence of ATP 
hydrolysis
Protein Releasing agent(s) Reference
bamase AMP-PNP, ADP Gray and Fersht (1993)
dihydrofolate reductase AMP-PNP, ATPyS Viitanen et al. (1991)
enolase ADP, CTP, UTP Kubo etal (1993)
Fab fragment AMP-PNP, ATPyS Schmidt & Buchner (1991
glutamine synthase AMP-PNP, ATPyS Fisher et al. (1992)
lactate dehydrogenase AMP-PNP Badcoe et al. (1991)
ornithine transcarbamylase AMP-PNP Zheng et a/.(1993)
phytochrome photoreceptor ATPyS Grimm etal (1993)
tryptophanase AMP-PNP, ATPyS, ADP Mizobata et al. (1992)
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release to GroEL until polypeptide folding is complete (Martin et al., 1991; Martin et 
al., 1993a).
A general model for the chaperonin-mediated folding pathway can be proposed 
(see Fig. 1.1). This model is based on the existence of both 'high' and 'low' affinity 
states of GroEL for either polypeptide binding or GroES binding which are mutually 
exclusive. In the absence of substrate polypeptides the ATPase activity of GroEL is 
effectively inhibited by the binding of GroES (Chandrasekhar et al., 1986; Viitanen et 
al., 1990; Gray and Fersht, 1991; Bochkareva et al., 1992), which presumably 
prevents wasteful energy release. This complex is probably the preferred state under 
physiological conditions and GroEL is stabilised by GroES in a form with a high 
affinity for ADP (Jackson et al., 1993; Martin et al., 1993a). Addition of unfolded 
polypeptide to such a complex is known to result in a stimulation of the GroEL ATPase 
activity (Martin et al., 1991; Jackson et al., 1993). The 'substrate' polypeptide 
presumably binds to the free cavity opposite the bound GroES molecule. The binding 
of the unfolded polypeptide into the central cavity of GroEL reduces its affinity for 
ADP and as a consequence both ADP and the co-chaperonin are released (Martin et al., 
1993a). This in turn makes the seven subunits in the interacting GroEL toroid 
accessible for ATP binding. The binding of ATP lowers the affinity of GroEL for 
bound polypeptides and weakly bound substrate proteins may be released (either 
completely or partially) at this point. Tightly bound polypeptides, however, require the 
(GroES-assisted) hydrolysis of ATP for productive release. GroES reassociates with 
the ATP-bound GroEL complex, binding to the opposite ring, prior to ATP hydrolysis 
(Martin et al., 1993a). GroEL then undergoes rapidly consecutive rounds of ATP 
hydrolysis, in both rings, causing release of the polypeptide which is then free to 
undergo folding in the central cavity. Proteins which have folded or have attained a 
folding-competent state during this single cycle are free for release. This also applies to 
the folded subunits of oligomeric proteins before their assembly. Proteins which have
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Fig. 1.1 Model for the GroEL-GroES assisted folding of polypeptides
See text for main details and references. (1) The GroEL-GroES complex is favoured 
under physiological conditions. The GroES associated ring of GroEL is stabilised in a 
high affinity ADP-binding state (denoted ADP in bold), the other ring has a lower 
affinity for ADP. (2) Upon binding of the unfolded polypeptide (U), ADP and 
consequently GroES dissociate. (3) ATP binds, weakening the interaction between the 
polypeptide and GroEL, and allows GroES to rebind. (Proteins with a low affinity for 
GroEL may be released at this stage). (4) ATP hydrolysis releases the bound 
polypeptide into central cavity, allowing it to fold. Proteins attaining (near) native 
structure after this single cycle are released (i.e. N). (5) Generation of the ADP state 
increases the binding affinity of GroEL for GroES. Polypeptides which are still 
(partially) unfolded rebind and the reaction cycle continues (from step 2) until a folding 
competent state is reached. Between steps (5) and (2) the GroEL protein is rotated 
180°C, with the substrate polypeptide remaining bound in the same ring. This model 
was adapted from Martin et al. (1993a).
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only partially folded and / or have exposed recognition elements may then rebind to the 
ADP-stabilised GroEL - GroES complex and undergo further cycles of release and 
folding until a (near) native conformation is released. It is unknown whether the folding 
polypeptide can shuttle between the two rings of the chaperonin during folding and it 
remains for the molecular details of this reaction cycle to be characterised further.
1 .6  Sequential action of the chaperone Hsp70 and Hsp60 proteins
The discussion of the various classes of chaperone proteins separately may give 
the misleading impression that such proteins play specialised but independent roles 
within the cell. However, the Hsp70 and Hsp60 chaperones have distinct but 
complementary roles with respect to polypeptide folding. The Hsp70s act as monomers 
or dimers within the cell and their main role during protein folding seems to be in 
shielding exposed hydrophobic surfaces of nascent polypeptides during translation (or 
during translocation) until at least a complete protein domain is available for productive 
folding (section 1.5.2). The Hsp60s, on the other hand, act as large oligomeric double­
ring complexes which sequester completely synthesised but unfolded polypeptides 
from the complex cellular milieu and not only prevent aggregation but help promote 
folding into the native conformation (section 1.5.6). These distinct classes of chaperone 
proteins act sequentially in the folding pathway. Polypeptides entering the 
mitochondrial matrix, in a loosely folded conformation resembling the nascent chain 
emerging from the ribosome, interact initially with matrix-located Hsp70 proteins 
(Kang et al., 1990; Scherer et al., 1990) prior to transfer to mitochondrial Hsp60 
which, at least in some cases, is responsible for subsequent folding to attain native 
structure (Cheng et al., 1989; Ostermann et al., 1989; Cheng et al., 1990). The basis 
for this differential recognition is the distinct structural features recognised by both the 
Hsp70 and Hsp60 proteins. The Hsp70 proteins recognise polypeptides in an extended 
form which have little or no secondary structure (section 1 .5.2.2), whilst members of
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the Hsp60 class recognise early folding intermediates of polypeptides resembling 
'molten globules' (section 1.5.6 .6 ).
The transfer of polypeptides from Hsp70 to Hsp60 proteins is not a feature 
unique to mitochondria. Indeed transfer has been demonstrated in vitro between the 
respective E. coli cytoplasmic homologues (Langer et al., 1992a). The E. coli Hsp70 
homologue DnaK in conjunction with its partner chaperone DnaJ stabilises |rhodanese 
in an unfolded conformation and transfer to GroEL, for subsequent folding, is 
mediated by the 'coupling-factor' GrpE and ATP (Langer et al., 1992a). It remains to 
be established whether this pathway occurs in vivo since both DnaK and DnaJ, unlike 
the GroE proteins, are dispensable for E. coli at normal growth temperatures (Bukau 
and Walker, 1989; Sell et al., 1991), although it is possible that the GroE system can 
function alone or that a second pair of DnaK / DnaJ related proteins exist which may be 
able to function generally, albeit with a low(er) efficiency. Recent evidence has, 
however, suggested that DnaK and GroEL have complementary effects in preventing 
polypeptide aggregation within the cell (Gragerov et al., 1992). It should also be noted 
that not all polypeptides fold by such a sequential chaperone pathway, consistent with 
the observation that some E. coli cytosolic proteins can fold in the absence of GroEL 
(Horwich et al., 1993). Some polypeptides may be free to fold and attain a native 
conformation simply on release from the Hsp70 chaperone. Indeed reactivation of 
thermally denatured firefly luciferase requires a functional DnaK system {i.e. DnaK / 
DnaJ / GrpE /  ATP) but not the GroE chaperonins (Schroder et al., 1993). This 
sequential model for the folding pathway of (some) polypeptides remains to be 
confirmed in vivo and demonstrated in cell-free translation systems in vitro. Its 
relevance to polypeptide folding in the eukaryotic cytosol remains unclear as, to date, 
no GrpE homologues or potential co-operating factors for the chaperonin 60-like TRiC 
family of proteins have been identified. It remains a task for future work to characterise 
this interesting pathway further.
1.7  Aims of the project
The main aims of the PhD project were to study two unanswered but 
fundamental questions about the function of the GroEL protein, and were as follows;
(1) To identify the important amino acid residue(s) involved in the ATP 
binding site, in order to gain some information towards understanding 
the tertiary arrangement of the chaperone protein.
(2) To study the unfolding and the refolding of GroEL in order to gain 
some insight into how the GroEL protein, itself, attains native structure.
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Chapter 2 Materials and Methods
2.1  Materials and reagents
2 .1 .1  Chemicals and biochemicals
Ampicillin, 8 -anilino-l naphthalene sulphonate (ANS), benzamidine, 
bromophenol blue, Coomassie brilliant blue, 5, 5'-dithiobis (2-nitrobenzoate), 5' p 
fluorosulphonyl benzoyladenosine, 4-(iodoacetamido)salicylic acid, sodium 
borohydride (N aB H ^ N ^ N ’^ '-tetram ethylethylene diamine (TEMED), 
triethanolamine and triton X-100 were obtained from Sigma Chemical Co., Poole, 
Dorset, U.K.
Bactotryptone, yeast extract and Bactoagar (agar) were obtained from Difco, 
Detroit, Michigan, U.S.A.
ATP, DTT, NADH, phenylmethanesulphonyl fluoride (PMSF) and 
phosphoeflo/ pyruvate were obtained from Boehringer Mannheim, Lewes, Sussex, 
U.K.
2-Mercaptoethanol and sodium periodate were obtained from BDH Chemicals, 
Poole, Dorset, U.K.
Guanidinium chloride (GdnHCl) of ultrapure grade was obtained from BRL, 
Gibco Ltd., Paisley, Scotland, U.K.
Acrylamide, N, N1 methylenebisacrylamide, SDS and trichloroacetic acid were 
obtained from FS A Laboratory Supplies, Loughborough, Leicestershire,U.K.
2',3'-dialdehyde ATP (oATP) was prepared by periodate oxidation of ATP 
following the procedure of Easterbrook-Smith et al. (1976). Purity was judged by thin
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* Thin layer chromatography was performed on polyethyleneimine sheets using 0.8M- 
NH4 HCO3 as the developing solution and u.v. light to detect the position of the 
nucleotide. The relative Rf values were 0.52 and 0.05 for ATP and oATP, respectively.
I *
layer chromatography, as described, and the resulting product was divided into aliquots 
and stored at - 70 °C.
HPLC grade trifluoroacetic acid (TFA) and acetonitrile were obtained from 
Rathbum Chemicals Ltd., Walkerbum, Scotland, U.K.
[2',5’,8-3H] ATP was obtained from Amersham International Pic., Amersham, 
Buckinghamshire, U.K.
Polyvinyl difluoride (PVDF) membranes (Immobilin-P transfer membranes, as 
described by Matsudaira, 1987) were obtained from Millipore, Bedford, 
Massachusetts, U.S.A.
All other chemicals were of analytical grade and were obtained from one of the 
following suppliers: Aldrich Chemical Co. Ltd., Poole, Dorset, U.K.; BDH 
Chemicals; FSA Laboratory Supplies; Koch-Light Ltd., Colnbrook, 
Buckinghamshire, U.K.
2 .1 .2  Enzymes and proteins
Bovine serum albumin (BS A), pyruvate kinase / lactate dehydrogenase enzyme 
suspension, thermolysin (protease type X) and a molecular weight standard marker kit 
were obtained from Sigma Chemical Co.
Proteinase K was obtained from Boehringer Mannheim.
Trypsin was obtained from Koch-Light Ltd.
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Chymotrypsin was obtained from Worthington Biochemical Corp., Freehold, 
New Jersey, U.S.A.
2 .1 .3  Chromatography media
Sephacryl S-200, Sephadex G-10 and Sephadex G-25 were obtained from 
Pharmacia, Milton Keynes, Buckinghamshire, U.K.. DEAE-cellulose (DE52) was 
obtained from Whatman Biochemicals, Maidstone, Kent, U.K.
2 .1 .4  Pre-packed media
Pre-packed Mono Q, alkyl-superose and superose 6  columns were obtained 
from Pharmacia and utilised on a Pharmacia FPLC System. pBondapak C l8 reverse 
phase column was obtained from Waters Chromatography, Watford, Hertfordshire, 
U.K.and attached to a Beckman System Gold HPLC apparatus (Beckman Instruments 
Inc., High Wycombe, Buckinghamshire, U.K.).
2 .1 .5  Bacterial strains
The bacterial strain used during this study was E.coli DH1 carrying either the 
plasmid
(a) pND5, an 8.1kb Eco R1 E.coli chromosomal fragment carrying the gro ESL 
operon (Jenkins et al., 1986), or (b) pGT3270, containing the gro E genes on a 2.1kb 
Eco Rl-Hind ID DNA fragment (McLennan et al., 1993) (Fig. 2.1). These strains 
were gifted by Dr. N.F. McLennan, ICMB, University of Edinburgh, Scotland, U.K.
Bacterial stocks were stored at -70°C as a frozen stock, prepared by mixing 5ml 
of overnight L-Broth (LB) culture with an equal amount of sterile glycerol. Short term 
storage was on a suitable sealed L-agar plate at 4°C.
I :
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EcoRI 0.00
ptac
laclq
groE
pGT3270
7.50 Kb
BamHI 1.95
rrnB Hindlll 2.20
ampR
oriV 4.45
Plasmid name: pGT3270
Plasmid size: 7.50 kb
Constructed by: NF McLennan
Construction date: unknown
Comments/References: Fig. 2.1 Plasmid pGT3270
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2 .2  General laboratory methods
2.2 .1  pH measurement
pH measurements were carried out using a Corning 220 pH meter (Ciba 
Coming Diagnostics Ltd., Sudbury, Suffolk, U.K.), calibrated at room temperature.
2.2 .2  Protein estimation
Protein concentrations were determined by the method of Bradford (1976), with 
BSA as standard.
2.2 .3  Lyophilization
Protein and peptide solutions were collected either into Reacti Vials (Pierce 
Chemical Co., Rockford, Illinois, U.S.A.), polypropylene tubes (Eppendorf) or 25- 
1 0 0 ml acid washed round-bottom flasks and the contents frozen by immersing the 
vessels in a dry-ice/ethanol mixture before lyophilization on a FTS Systems (Stone 
Ridge, New York, U.S.A.) Flexi-Dry freeze dryer.
2 .3  SDS-polyacrylamide gel electrophoresis
Electrophoresis in the presence of SDS was performed by the method of 
Laemmli (1970), with a 3% stacking gel and a 12% or 15% separating gel. The ratio of 
acrylamide : bisacrylamide in all PAGE experiments was 30 : 0.8 and polymerisation 
was induced by the addition of 0.03% (v/v) TEMED and 0.05% (w/v) ammonium 
persulphate. After electrophoresis gels were stained for protein by the Coomassie 
method (Section 2.3.1)
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PhastGels (Pharmacia) and SDS buffer strips, utilizing the Pharmacia Phast- 
System, were routinely employed for SDS-PAGE during GroEL purification.
2.3 .1  Staining for protein
After electrophoresis, protein on the gels was visualised by staining with 
Coomassie blue for at least 1 hour at 40°C. The Coomassie reagent was 0.1% (w/w) 
Coomassie brilliant blue G250 in 50% (v/v) methanol, 10% (v/v) glacial acetic acid; 
destaining was carried out at 40°C in 10% (v/v) methanol, 10% glacial acetic acid until 
the background was fully destained and bands clearly visible.
2 .4  Enzyme assays
Enzyme assays were performed at 20°C for unfolding /  refolding experiments 
and at 25° C for chemical modification , in a total volume of 1ml, using a 
Gilford/Unicam model 252 uv/vis spectrophotometer.| All ATPase assays were performed 
|at least twice. Results were found to be highly reproducible between separate experiments.
2.4 .1  GroEL ATPase assays
(a) GroEL ATPase coupled continuous assay
The ATPase activity of GroEL was measured spectrophotometrically by 
coupling the hydrolysis of ATP to the oxidation of NADH by the coupling enzymes 
pyruvate kinase and lactate dehydrogenase. Unless otherwise stated assays 
were performed in 50 mM-triethanolamine buffer pH 8.0 (with KOH) containing 10 
mM-magnesium acetate. Concentrations of substrates and coupling enzymes in the 
buffer described were; 0.5 mM-ATP, 1.0 mM-phosphoe/zo/ pyruvate, 0.15 mM- 
NADH, 25 pg/ml-pyruvate kinase and 8.3 fig/ml-lactate dehydrogenase. The oxidation
of NADH was monitored at 340 nm (E^onm = 6.22 x 103 Mr1 cm-1) Price e ta l  (1993).
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(b) GroEL ATPase "coupled quench” assay
The effect of GdnHCl on the ATPase activity was studied by a coupled quench 
assay procedure of the type described by Johnson and Price (1988). 0.2 ml aliquots of 
the reaction mixture, containing GroEL in the presence of increasing concentrations of 
GdnHCl (Section 2.8.2) and 250|iM-ATP, were added to 0.8 ml samples of the assay 
cocktail described above (Section 2.4.1 (a)). The rapid decline in A340 corresponded to 
the concentration of ADP formed during the ATPase reaction. By taking aliquots at 20 
min intervals, the rate of the ATPase reaction was calculated. Control experiments of 
the type described by Johnson and Price (1988) were undertaken to confirm the validity 
of the method.
2 .5  Growth of E.coli DHl/pGT3270 and E.coli DHl/pND5
2.5 .1  Growth media
The 'rich' media used for E.coli growth in these studies was:
Medium Composition (per litre)
L-broth (LB) 10 g bactotryptone
5 g yeast extract 
lOgNaCl
(+ 5 ml 20% (w/v) glucose)
L-agar as LB, +15 g agar
All media was sterilised by autoclaving at 15 psi.
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2 .5 .2  Selection supplements
Ampicillin (Amp) was added to the 'rich' media at a final concentration of 50 
pg/ml, to select and identify the recombinant organisms. A stock solution of 25 mg/ml 
was filter sterilised and stored at -20°C. Hot L-agar was cooled to 55°C before 
ampicillin was added. L-Amp plates were stable for at least 4 weeks when stored at 
4°C.
2.5 .3  Cell growth
All cell growth was performed at 37°C, with continuous shaking.
E.coli DHl/pGT3270 or E.coli DHl/pND5 from a glycerol stock, was 
streaked out on an L-agar plate containing 50 |Xg/ml ampicillin and incubated overnight. 
10 ml LB/amp was then inoculated with a single colony of E.coli and grown 
overnight. 2.5ml of this culture was then added to each of two 150 ml culture flasks of 
LB/amp. These cultures were grown overnight and 25 ml used to inoculate each of 8 x 
500 ml LB/amp media, in 2 1 conical flasks. Incubation continued until the cell 
suspension had reached saturation (ODgoo of approximately 5) before harvesting the 
cells by centrifugation (4,500 g for 15 minutes using a M.S.E. Mistral 6 L centrifuge). 
Cells which were not used immediately were stored at -20°C. A typical 41 culture gave 
24 g wet weight of cells.
2.5.4  Cell breakage
Cell pellets were resuspended in 2 volumes of ice-cold extraction buffer (50 
mM-trisHCl pH 8.0,5 mM-2-mercaptoethanol, 1 mM-PMSF, 1 mM-benzamidine) and 
broken by 2 passages through an automatic French pressure cell at 98 MPa (14 300 psi
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internal pressure). The cell was pre-cooled on ice before use (cat. no. 4-3398A, 
American Instruments Company, Silver Spring, Maryland, U.S.A.).
2 .6  GroEL purification
GroEL was purified from either E.coli DHl/pGT3270 or E.coli DHl/pND5 
using a procedure modified from that described previously (Hendrix, 1979; 
Chandrasekhar et al., 1986). The protocol is fully detailed in section 3.2.
2.6 .1  Storage of purified GroEL
Purified GroEL was dialysed for 24 hours against 100 volumes of 50 mM- 
trisHCl pH7.5 containing 50% (v/v) glycerol and stored at -20°C.
2 .7  Determination of GroEL concentration
The characterisation and quantification of GroEL was performed 
spectrophotometrically using a value of 0.285 for the specific absorption coefficient 
(litre.g-1.cnr1) at 280 nm (Price et al., 1991).
2 .8  Unfolding and refolding of GroEL
2.8.1 Concentration of Guanidinium chloride r \
The concentrations of GdnHCl solutions were checked by refractive index 
measurements in accordance with the data given by Nozaki (1972) and Pace (1986).
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2 .8 .2  Unfolding of GroEL
The unfolding of GroEL was studied in a buffer of 50 mM-potassium 
phosphate pH 7.5, 20 mM-potassium acetate, 5 mM-magnesium acetate, 0.1 mM- 
dithiothreitol. Solutions of GroEL (final concentration 50 (ig/ml) were incubated in the 
presence of varying concentrations of GdnHCl for 15 minutes at 20°C before any 
measurements of CD, fluorescence, light scattering or ATPase activity were taken. 
There was no further significant change on incubation for a further 45 minutes.
2.8.3 Attempted refolding of GroEL
In order to initiate the refolding process the denaturing agent was removed by 
dialysis at 20°C against two changes of 200 volumes of the buffer described above 
over a period of 6  hours. Measurements of refractive index confirmed that after dialysis 
the residual GdnHCl concentration was less than 0.01 M.
2.9  Characterisation of GdnHCl treated GroEL
Changes in GroEL secondary, tertiary and quaternary structure, after 
denaturation in the presence of GdnHCl for 15 minutes at 20°C, were determined by 
circular dichroism (CD), fluorescence and light scattering, respectively. The effect on 
ATPase activity, ANS binding and proteinase susceptibility was also studied. Parallel 
experiments after the removal of the denaturant by dialysis were also carried out. All 
experiments were carried out in the buffer described in section 2 .8 .2 .
2.9.1 CD analysis
CD spectra were recorded at 20°C on a JASCO J-600 spectropolarimeter. 
Unless otherwise stated spectra were recorded in a pathlength of 1 mm. Determination
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of the secondary structure content was undertaken using the CONTIN procedure at 0.2- 
nm intervals over the range 240-190 nm (Provencher and Glockner, 1981). All spectra 
were recorded by Sharon Kelly, Department of Biological and Molecular Sciences, 
University of Stirling.
2.9 .2  Fluorescence studies
Changes in the fluorescence of GroEL were recorded at 20°C on a Perkin Elmer 
LS50 spectrofluorimeter with excitation at 280 nm or 290 nm.| Slit width setting was 8.0.
2.9 .3  Light scattering measurements
Changes in Mr of GroEL were determined by light scattering using a Perkin
Elmer LS50 spectrofluorimeter. The wavelength used was 360 nm, and the experiment
carried out at 20°C. The data was analysed by the method of Parr and Hammes (1975),
by using the values for refractive index increments quoted by Tashiro et al. (1982).| Slit 
|width setting was 2.5.
2.9 .4  GroEL ATPase activity
The effect of GdnHCl on the ATPase activity of GroEL was measured by a 
coupled quench assay as described in section 2.4.1.
2.9 .5  ANS fluorescence
Denatured and "refolded" GroEL were incubated in the presence of a 20 fold 
molar excess of ANS for 5 minutes at 20°C. The fluorescence of ANS in the presence 
and absence of protein was measured using excitation and emission wavelengths of 380 
nm and 470 nm, respectively, using a Perkin Elmer LS50 spectrofluorimeter. Emission
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spectra were corrected for background fluorescence due to ANS in the absence of 
GroEL. Slit width setting was 5.0.
2.9 .6  Proteinase susceptibility
The susceptibility of GroEL to thermolysin was studied by incubating GroEL 
(50 pg/ml) with thermolysin (2-100% (w/w)) at 20°C for 10 minutes. The proteinase 
was then inactivated by the addition of EDTA to a final concentration of 2 mM, and 
samples analysed by SDS-PAGE.
2.10 Molecular weight determinations
SDS-PAGE was used to estimate the subunit Mr of the purified protein and 
proteinase treated GroEL. Unless otherwise stated, a low molecular weight (LMW) 
calibration kit (Sigma) was used to produce standard curves of Rf against log Mr. The 
standard molecular weight proteins were as given below:
Protein Subunit Mr
Bovine serum albumin 66,000
Egg white ovalbumin 45,000
Rabbit muscle glyceraldehyde-3-phosphate dehydrogenase 36,000 
Bovine erythrocyte carbonic anhydrase 29,000
Bovine pancreas trypsinogen 24,000
Soybean trypsin inhibitor 20,100
Bovine milk a-lactalbumin 14,200
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2.11 Chemical modification and inactivation of GroEL ATPase activity
2.11.1 4-(iodoacetamido)salicylic acid treatment
GroEL (0.3mg/ml) was incubated in the presence of 0.5 - 2.0 mM-4- 
(iodoacetamido)salicylic acid in a buffer of 50 mM-triethanolamine pH 8.0 containing 
10 mM-magnesium acetate, at both 4°C and 25°C. The final volume of the reaction 
mixture was 1 ml and at time intervals 50 |il aliquots were withdrawn and assayed for 
ATPase activity according to the procedure described in section 2.4.1.(a).
2.11.2 5'-p-fIuorosuIfonylbenzoyladenosine treatment
5'-p-fluorosulfonylbenzoyladenosine (5'pFSBA) was freshly prepared as a 10 
mM stock in ethanol. GroEL (0.3 mg/ml) was incubated in the presence of 0.5 - 1.0 
mM-5'pFSBA under the conditions described in section 2.11.1 and assayed for 
ATPase activity at various time intervals. Control experiments of GroEL in the presence 
of 5 -10 % ethanol (v/v) were undertaken and assayed for ATPase activity.
2.11.3 Determination of oATP concentration
oATP was synthesised according to the procedure of Easterbrook-Smith et al. 
(1976) and the concentration determined using an extinction coefficient of 14,900 M- 
lcm l at 258nm. oATP was preincubated at 25°C for 12 hours before use.
2.11.4 oATP inactivation reaction
Inactivation was carried out by incubating GroEL (0.15 - 0.3 mg/ml) with 
various concentrations of oATP in 50 mM-triethanolamine pH 8.0 containing 10 mM-
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magnesium acetate at 25°C. 50 |il aliquot samples were removed from the 1 ml reaction 
mixture at various time intervals and assayed for ATPase activity (section 2.4.1).
2.11.5 Protection by substrate against oATP inactivation
Protection experiments were carried out by including increasing concentrations 
of ATP in the reaction mixture described in section 2.11.4.
2.11.6 Borohydride reduction of oATP treated GroEL
The reaction of oATP with GroEL was quenched by the addition of a 10 fold 
molar excess of sodium borohydride over oATP. Sodium borohyride was freshly 
prepared as a 100 mM stock solution in distilled water containing 10 mM-NaOH and 
protected from light.
2.11.7 Stoichiometry of incorporation of oATP
The stoichiometry of incorporation of oATP into GroEL was studied using [3H] 
oATP. After inactivation and sodium borohydride treatment (sections 2.11.4 and 
2.11.6) the protein was precipitated, in the presence of 4 mg BSA, by the addition of 
10% trichloroacetic acid (TCA) and the pellet washed exhaustively in 10% TCA to 
remove unbound [3H] oATP. The pellet was then solubilised in 100 p.1 lM-NaOH
before measuring incorporated radioactivity using a Wallac 1409 Liquid Scintillation
• \
Counter (Pharmacia).
The stoichiometry of incorporation of oATP into GroEL was also studied in the 
presence of ATP (5 mM, final concentration), as described above.
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2 .12  Limited proteolysis of GroEL
GroEL (0.2 mg/ml) in a buffer of 50 mM-triethanolamine pH 8.0 containing 10 
mM-magnesium acetate was digested in the presence of 2% (w/w) thermolysin at 37°C. 
At various time intervals aliquots were withdrawn and the reaction stopped by the 
addition of 2 mM-EDTA. Samples were then assayed for ATPase activity as described 
(section 2.4.1) and digestion monitored by analysis on 12% SDS-PAGE gels (section 
2.3).
Proteolysis was also carried out in the presence of 2% (w/w) trypsin, under the 
conditions described above. Aliquots were withdrawn at given times and the reaction 
stopped by the addition of 4% (w/w) soybean trypsin inhibitor. Samples were assayed 
for ATPase activity and digestion monitored by SDS-PAGE (12% gels).
Limited proteolysis of GroEL by chymotrypsin (2% w/w) was carried out 
under the conditions described above. Reactions were stopped by boiling at 100°C for 
5 minutes and the time course of digestion monitored by SDS-PAGE (12% gels).
2.13 Peptide isolation and sequencing
2.13.1 Acid-washed glassware
Glassware for protein chemistry was boiled for 1 hour in 6  N-HC1 or 6  N- 
HNO3 then left at room temperature overnight. It was then rinsed exhaustively in 
distilled water and dried in a hot oven. Glass Reacti Vials (Pierce) were used for 
purified peptide collection and freeze drying.
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2.13.2 Preparation of oATP modified GroEL
oATP modified GroEL in the presence and absence of substrate (ATP, 5 mM 
final concentration) were prepared by reacting 5 mg of GroEL with 1 mM oATP in a 
buffer of 50 mM-triethanolamine pH 8.0 containing lOmM-magnesium acetate at 25°C. 
After 6  hours incubation more than 95% of the ATPase activity was lost from the 
sample incubated in the absence of substrate, whereas the protected sample retained 
70% of its activity.
Both reaction mixtures were quenched by the addition of sodium borohydride 
and subjected to gel filtration on Sephadex G-25 (30 cm x 1.6 cm column), equilibrated 
in 0.5% ammonium bicarbonate, to remove excess reagent. The flow rate was 40 
ml/hour and GroEL was detected spectrophotometrically by absorbance at 280nm. 
Samples were then digested with protease as described in section 2.13.3.
2.13.3 Digestion of oATP modified GroEL
oATP modified GroEL, in the presence and absence of substrate, in 0.5% 
ammonium bicarbonate, was digested with thermolysin, trypsin or chymotrypsin 
(protease : GroEL, 3% w/w) at 37°C for 24 hours. Digestion was carried out in a 
round bottomed acid-washed flask containing a small magnet (acid-washed) for 
continuous stirring. After 24 hours samples were immediately frozen in dry-ice/ethanol 
and then freeze dried.
2.13.4 Reverse phase HPLC of peptides
Fractionation of peptides was carried out using a Cl 8  fiBondapak reverse phase 
column (Waters) equilibriated in 0.15% trifluoroacetic acid in water (pH 2) and 
developed with a linear gradient of a mixture (70:30, v/v) of acetonitrile and 0.1%
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trifluoroacetic acid. The flow rate was 1 ml/min and eluting peptides were monitored 
spectrophotometrically at 214nm and 260nm to detect peptide bonds and oATP 
modified peptides, respectively. Isolated peptide fractions were collected manually, 
freeze-dried and rechromatographed using a shallower linear acetonitrile gradient. 
Modified peptides were again collected manually, freeze dried and stored at -20°C.
2.13.5 Modified peptide sequence analysis
The modified GroEL peptide was sequenced on an Applied Biosystems 477A 
pulsed liquid phase sequencer with on line detection of amino acid thiohydantoins by a 
model 120A analyser. The instrument was operated by Dr. B. Dunbar at the SERC 
Protein Sequencing Facility, University of Aberdeen.
2.13.6 Mass spectroscopy of the modified peptide
The GroEL modified peptide was analysed on a VG BioTech Platform single 
quadropole mass spectrometer in the electrospray ionisation mode. An aliquot of the 
sample was diluted 1:1 with acetonitrile and was injected into a mobile phase of 1:1 
acetonitrile:water flowing at 5(0.1 /  min via a 10pl loop. The mass spectrometer was 
scanned over the range 300-1800 in 10 seconds and the data was acquired in multi­
channel analysis mode. Spectra were acquired in both positive and negative ion mode 
and the mass spectrometer was calibrated from a separate introduction of a mixture of 
polyethylene glycols. The instrument was operated by Dr. H. Major, VG BioTech, 
Macclesfield,Cheshire, U.K.
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2.14 Characterisation of proteinase K-treated GroEL
2.14.1 Limited proteolysis with proteinase K
GroEL (0.1 mg/ml) in 50 mM-triethanolamine pH 8.0 containing 10 mM- 
magnesium acetate was digested in the presence of proteinase K (2% w/w) at 25°C. At 
time intervals aliquots were removed and the reaction stopped by the addition of 2 mM- 
PMSF for 5 minutes. Digestion was follwed on 12% SDS-PAGE gels and samples 
were assayed for ATPase activity.
GroEL incubated in the presence of 1-mM oATP or 5mM-ATP was also 
subjected to proteinase K digestion, as described above.
2.14.2 Electroblotting of proteinase K-treated GroEL
GroEL was digested and run on SDS-PAGE as described in section 2.14.1. 
Proteins were then transferred onto polyvinyl difluoride (PVDF) membranes using a 
modification of the method of Matsudaira (1987), described below.
The blotting was carried out in lOmM CAPS buffer pH 11.0 (titrated with 2 M 
NaOH), which contains no free amino groups to interfere with the sequencing.
The PVDF membrane was pre-treated by soaking in 100% AnalaR methanol for 
a few seconds, then 50% methanol/water before transferring to electroblotting buffer 
(10 mM CAPS pH 11.0).
The gel was removed from the electrophoresis apparatus and soaked in 2 x 250 
ml of electroblotting buffer, along with 2 pieces of Whatman 3MM filter paper cut to 
gel size with a 2  x 2  cm overlap.
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The PVDF membrane was placed over the gel then sandwiched between the two 
pieces of filter paper and ensuring that no air was trapped, placed in the electroblotting 
apparatus. Electroblotting was carried out at 50V at room temperature for 90 minutes.
The PVDF membrane was then rinsed with deionised water for 5 minutes, then 
dipped into 100% methanol for a few seconds prior to staining (section 2.14.3).
2.14.3 Staining and destaining of PVDF membranes
PVDF membranes were stained for 2 minutes in 0.1% (w/v) Coomassie Blue 
R-250 in 50% (v/v) methanol and destained with several changes of 50% (v/v) 
methanol / 10% (v/v) acetic acid. Membranes were then rinsed with several changes of 
deionised water and allowed to air dry before storing at - 20°C.
2.14.4 N-terminal sequence analysis
Protein blotted onto PVDF membranes were sequenced by Dr B. Dunbar, 
University of Aberdeen, as described in section 2.13.5.
2.14.5 Stoichiometry of oATP incorporation into proteinase K-treated 
GroEL
GroEL (0.2 mg/ml) was digested by proteinase K (2% w/w) as described in 
section 2.14.1, for 1 hour before stopping the reaction by the addition of 2 mM-PMSF. 
The samples were then incubated in the presence of 0.6 mM-[3H] oATP, in the 
presence or absence of 5 mM-ATP, at 25°C for 6  hours before treatment with sodium 
borohydride and precipitation of the protein as described in section 2.11.7. 
Incorporation of radioactivity was measured using a Wallac 1409 Liquid Scintillation 
Counter (Pharmacia).
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2.15 Titration of thiol groups with DTNB
GroEL (0.2mg/ml) was reacted with 250 |iM-5,5'-dithiobis(2-nitrobenzoate) 
(DTNB) in 50 mM-sodium phosphate buffer pH8.0 at 25°C in a final volume of 1ml. 
The reaction was initiated by addition of 0.1% SDS. The absorption at 412nm was 
measured against a blank lacking GroEL on a Gilford/Unicam model 252 uv/vis 
spectrophotometer. The formation of TNB was calculated using a molar extinction 
coefficient of 13 600 M-1cm_1 (Ellman, 1959).
Free titratable GroEL thiol groups in the presence of 1 mM-oATP, with or 
without 5 mM-ATP, in the buffer described above were also measured, according to 
the method described.
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Chapter 3 Purification of GroEL
3 .1  Introduction
This chapter describes the purification of GroEL from the E.coli strain DH1 
carrying either the plasmid pGT3270 or pND5. The purification was monitored by 
SDS-PAGE since the ATPase activity of GroEL is too weak and non specific to 
monitor. The purification was modified from that described previously (Hendrix, 1979; 
Chandrasekhar et al., 1986) in order to achieve the high degree of purity required for 
both the chemical modification (chapter 4) and unfolding/refolding experiments (chapter 
5).
Purification of GroEL to a high degree of homogeneity can be complicated by 
the presence of bound 'substrate' polypeptides associated with GroEL, which can vary 
with preparations (Hayer-Hartl and Hard, 1993). The method described in this chapter 
utilizes a hydrophobic interaction chromatography step, not previously reported, in 
order to yield electrophoretically homogenous GroEL.
3 .2  GroEL purification.
Unless otherwise stated all manipulations following cell breakage were 
performed at 4°C.
Step 1: Extraction and centrifugation
A 20g batch (wet weight) of E.coli cells were broken as described in section 
2.5.4. Following cell breakage DNAse was added to a final concentration of 1 mM and 
the lysate stirred slowly on ice for 30 minutes. The extract was then centrifuged for 45 
minutes at 25,000 g using a Beckman J2-HS centrifuge with a JA-20 fixed angle rotor. 
GroEL was purified from the resulting cell-free extract.
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Step 2: 'Negative' chromatography on DEAE-cellulose
The crude extract was pumped at 60 ml/h through a column (7.5 cm x 5 cm) of 
DE52 pre-equilibrated with 50 mM-trisHCl pH 7.5 containing 0.1 M-(NH4)2S0 4 t 1 
mM-EDTA, 10% glycerol, 5 mM-2-mercaptoethanol, 0.05% triton X-100. The column 
was washed with equilibration buffer and the run through (brown colour), typically 
150 ml, collected.
Step 3: Salt fractionation with (NH4)2S0 4
The run through from the DE52 column was brought to 50% saturation by 
addition of solid (NH4)2S0 4  (314 g /1). After stirring for 30 minutes, the precipitated 
proteins were collected by centrifugation at 25,000 g for 30 minutes using a Beckman 
J2-HS centrifuge with a JA-20 fixed angle rotor.
Step 4: Sephacryl S-200 gel permeation chromatography
Precipitated protein was resuspended in 4 ml S-200 buffer (50 mM-trisHCl pH 
8.0 containing 5 mM-EDTA, 10% glycerol, 5 mM-2-mercaptoethanol, 1 M-KC1,0.5% 
triton X-100) and loaded onto a Sephacryl S-200 column (120 cm x 3 cm) equilibrated 
in the same buffer. The flow rate was 10 ml/h and GroEL containing fractions, eluting 
in the void volume of the column, were identified by 12% PhastGel SDS-PAGE as 
shown in Fig. 3.1. GroEL-containing fractions were pooled together and dialysed 
overnight versus 100 volumes of 20 mM-trisHCl pH 7.5 containing 5 mM-EDTA.
Step 5: Chromatography on Mono Q
The GroEL containing-pool was applied to a Mono Q HR 5/5 anion exchange 
column equilibrated in 20 mM-trisHCl pH 7.5 containing 5 mM-EDTA. The column
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was eluted with a 25 ml 0-1 M linear NaCl gradient in the buffer described above; the 
GroEL protein eluted at 0.45 M-NaCl as shown in Fig. 3.2. The flow rate was 1 
ml/min and 0.5 ml fractions were collected. Fractions containing GroEL (identified by 
PhastGel SDS-PAGE) were pooled and dialysed against 100 volumes of 50 mM- 
potassium phosphate buffer pH 7.0 containing 1.5 M-(NH4)2SC>4 .
Step 6: Chromatography on Alkyl-Superose
The partially pure GroEL (85-90% pure) was then loaded onto an Alkyl- 
Superose HR 5/5 hydrophobic interaction chromatography column, equilibrated in 50 
mM-potassium phosphate pH 7.0, 1.5 M-(NH4>2S0 4 . GroEL was eluted with a linear 
1.5-0 M-(NH4)2S 0 4 gradient in a volume of 20 mis. GroEL was eluted at 
approximately 0.6 M-(NH4)2S0 4  (Fig. 3.3). The flow rate was 0.5 ml/min and 0.5 ml 
fractions were collected. GroEL was normally judged to be greater than 95% pure on 
SDS-PAGE, although occasionally a further purification step was required (step 7).
Step 7: Superose 6 chromatography
As a final purification step the pooled GroEL-containing fractions were dialysed 
against 50 mM-trisHCl pH 7.5 containing ImM-EDTA and 0.2 M-NaCl and 
concentrated by ultrafiltration using Amicon Centriprep 30 cells. 0.5 ml samples were 
applied to a Superose 6 HR 10/30 column and eluted with the same buffer. The flow 
rate was 0.5 ml/min and 0.5 ml fractions were collected. The elution profile of GroEL 
is shown in Fig. 3.4.
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F igure  3.1 SDS-PAGE analysis of GroEL eluting at Sephacryl S-200 
void volume
Fractions eluting near the void volume of the S-200 column were analysed under 
denaturing conditions on a 12.5% Phast Gel as described in section 2.3 and stained for 
protein using Coomassie blue as described in section 2.3.1.
Lane 1: markers; BSA, ovalbumin, GAPDH, carbonic anhydrase, trypsinogen, trypsin 
inhibitor, a-lactalbumin.
Lanes 2-8: material eluting near the S-200 void volume. The position of GroEL is 
indicated by the arrowhead.
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Figure 3.2 Chromatography on Mono Q
GroEL-containing pool from Sephacryl S-200 chromatography was loaded onto a 
Mono Q column and eluted with an increasing salt gradient (indicated by the dashed 
line ) as described in section 3.2. The protein elution profile was measured by 
absorbance at 280 nm (A280X ^  position of GroEL elution indicated by the
a rrow h ead .
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Figure 3.3 Chromatography on Alkyl-Superose
GroEL from chromatography on Mono Q was loaded onto an Alkyl-Superose column 
and eluted with a decreasing salt gradient (indicated by the dashed line ) as described in 
section 3.2. The protein elution profile was measured by absorbance at 280 nm (A280X 
with the position of GroEL elution indicated by the arrowhead.
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Figure 3.4 Chromatography on Superose 6
GroEL from chromatography on Alkyl-Superose was loaded onto a Superose 6 column 
as described in Section 3.2. The protein elution profile was measured by absorbance at
280nm (A2go)-
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Figure 3.5 SDS-PAGE analysis of purified GroEL
Samples from each step of the purification were analysed on a 12% denaturing gel as 
described in section 2.3 and stained for protein using Coomassie blue as described in 
section 2.3.1.
Lanes 1 and 8: markers; BSA, ovalbumin, GAPDH, carbonic anhydrase, trypsinogen
(section 2.10)
Lanes 2-7: crude extract, (NH4)2S04 cut, DE52 pool, Sephacryl S-200 pool, Mono Q 
pool and Alkyl-Superose pool respectively.
7 1
100
■ ar-1
® ----------------- -ivPM
X C
Im
£
■v e
|
10 -
i
------>- t" t - i------—r
0 . 0  0 . 2  0 . 4  0 . 6  0 . 8  1 . 0
Rf
Fig. 3.6 Molecular mass of GroEL
Purified GroEL was subjected to SDS-PAGE (12%) as described in section 2.3. The 
Rf values of standard proteins (section 2.10) were calculated and plotted against the log 
Mr. The R f of the purified GroEL is shown (0). The standard marker proteins are ; a = 
BSA (66,000 Mr), b = ovalbumin (45,000 Mr), c = GAPDH (36,000 Mr), d = carbonic 
anhydrase (29,000 Mr), e = trypsinogen (24,000 Mr), f = trypsin inhibitor (20,100 Mr) 
and g = a-lactalbumin (14,200 Mr).
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3 .3  Purity of GroEL
Only one band was visible on SDS-PAGE (12%) after staining with Coomassie 
blue (Fig. 3.5, lane 7) after purification, as described above. GroEL was judged to be 
over 95% homogenous by laser densitometric analysis on a 12% SDS-PAGE gel.
3 .4  Molecular weight determination of GroEL
The subunit Mr of GroEL was 57,400, as determined by SDS-PAGE (12%) 
using Sigma low molecular weight markers (Fig. 3.5). This value is in close agreement 
with the subunit Mr of 57, 259 as derived from the amino acid sequence of GroEL 
(Hemmingsen et al., 1988).
3 .5  Purification yield of GroEL
A typical yield of pure GroEL from 20g (wet weight) of E.coli 
DHl/pGT3270 was in the order of 15 - 20 mg per preparation. The strain carrying 
plasmid pND5, which contains surplus genes over plasmid pGT3270, was found to be 
less efficient for purification, with the plasmid seemingly regressing.
Purified GroEL was stable for at least 2 months when stored at - 20°C in 
50% glycerol (section 2.6.1).
3.6  Discussion
A highly homogenous preparation of GroEL could be obtained using the 
purification protocol described above. Most published protocols are modifications of 
the methods of Hendrix (1979) and Chandrasekhar et al. (1986) and as such the final 
purification step is generally the anion exchange chromatography step (e.g. Buchner et
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al., 1991; Fisher, 1992). Purification of GroEL from E.coli DH1 (with either plasmid 
pND5 or pGT3270) required additional chromatography step(s) involving hydrophobic 
interaction chromatography and / or gel filtration.
After the Mono Q step GroEL was still not pure as judged by SDS-PAGE 
(Fig. 3.5, lane 6 ) with several contaminating proteins still present. This is not all that 
surprising when considering that the role of GroEL in vivo is to interact with many 
different polypeptides to assist in their assembly into native structure. Thus at least 
some of these contaminants may be actually associated with the GroEL protein itself 
and thus difficult to dissociate (Hayer-Hartl and Hard, 1993). It should also be noted 
that different E.coli strains as well as plasmids were used in this work compared to the 
published methods mentioned above.
The use of the Alkyl-Superose column was generally sufficient for the final 
purification step (Fig. 3.5, lane 7). GroEL was able to bind to Alkyl-Superose 
presumably via exposed hydrophobic patches on the surface of the protein. This is 
consistent with reports that the hydrophobic probes ANS (Mendoza et al.,1992; chapter 
5) and bisANS (Mendoza et al., 1991) showed enhanced fluorescence when interacting 
with GroEL. Release of GroEL from the column was achieved by a decreasing salt 
gradient to yield electrophoretically homogenous protein. Thus the use of hydrophobic 
interaction chromatography can be useful for final purification of GroEL, possibly by 
removing associated polypeptides from GroEL which themselves are binding through 
hydrophobic interactions. The purified GroEL was used for the experiments outlined in 
chapters 4 and 5.
Chapter 4 Affinity labelling the GroEL ATPase active site
4.1 Introduction
The 3-dimensional arrangement of the polypeptide chain in GroEL has, as yet, 
still to be elucidated and as such the amino acid residues of GroEL involved in ATP 
binding and hydrolysis have not yet been identified; this chapter deals with the 
investigation of such residues.
Many ATP binding proteins posses sequence motifs such as the type A motif 
(Walker et al., 1982), often abbreviated to -G-(X)4 -G-K-T/S-. Although some 
members of the chaperonin 60 class show the presence of a putative ’extended' type A 
motif containing an extra two amino acids between the first and second glycine residues 
of the consensus sequence (Tsugeki et al., 1992), the reported cDNA derived amino 
acid sequence of GroEL (Hemmingsen et al., 1988) does not contain any such 
sequence. In order to define amino acid residues involved in ATP binding an affinity 
labelling approach was undertaken.
4 .2  Affinity labelling with oATP
4 .2 .1  Background
Although chemical modification using group specific reagents has proved to be 
a useful tool in identifying amino acid residues involved at the active site of proteins, a 
potentially more powerful technique in defining such residues is by affinity labelling of 
the active site. This method can avoid some of the non-specific labelling often observed 
with group specific reagents. Specifically designing reagents, with structural similarity 
to the natural substrate, which contain reactive functional groups has been widely used 
in investigating purine nucleotide sites in proteins (Colman, 1983; Easterbrook-Smith et 
al., 1976; Roy and Colman, 1980).
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One such reagent is 2', 3' dialdehyde ATP (oATP) which has been successfully 
used to specifically label a number of ATP binding proteins (Easterbrook-Smith et al., 
1976; King and Carlsson, 1981; Kumar et al.,1979). oATP is structurally similar to the 
natural nucleotide, containing the purine ring and the correct number of phosphate 
groups; however the ribose ring has been perturbed by periodate oxidation of the 2 ',3 '- 
cis -diol to yield the corresponding dialdehyde (Fig. 4.1). The general mechanism of 
reaction is proposed to be the formation of a Schiff base by the nucleophilic attack of 
one of the dialdehyde groups by the a-amino group of lysine, although additional non- 
Schiff base forming reactions have been reported. The results of treating GroEL with 
oATP are reported in this chapter. Other potential active site reagents used are also 
described.
4 .2 .2  Criteria for a potential affinity label
The following criteria should be fulfilled when designating a compound as an 
affinity label;
(a) Kinetic evidence for the initial formation of a reversible enzyme-inhibitor complex 
prior to irreversible inactivation should be demonstrated.
(b) The extent of modification by the affinity label should be more limited than that 
produced by a structurally unrelated reagent with the same reactive group.
(c) The presence of the natural substrate that binds to the same site should decrease the 
rate of inactivation by the affinity label.
o o
I I
NH
N
N
P  O  CH
H/ || II \o o
Fig. 4.1 2', 3' dialdehyde ATP (oATP)
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4 .2 .3  Kinetics of oATP inactivation of GroEL ATPase activity
Incubation of GroEL with oATP at 25°C in 50 mM-TEA, 10 mM-magnesium 
acetate, pH 8.0 resulted in a loss of ATPase activity. In control experiments, in the 
absence of oATP, no loss in activity was observed. The fraction of activity remaining 
was calculated as the percentage of activity remaining (A/Ao, where A is the activity at 
each time and Ao is the initial rate of activity, i.e. at time 0) at a given time (t). The plot 
of the logarithm of A/Ao against t at various concentrations of oATP shows pseudo 
first-order kinetics (Fig. 4.2 A). The rate of inactivation is dependent on oATP 
concentration. Table 4.1 shows the half life period (t i/2)of inactivation determined at 
various oATP concentrations, calculated from the pseudo first order plot. Inactivation 
was unaffected whether or not the reaction was quenched by sodium borohydride.
Table 4.1
Half-life (t 1/2 ) and first order rate constant (k0 bS) for the inactivation 
of GroEL ATPase activity at different oATP concentrations
[oATP] mM t 1 /2  (min) k 0bs / min
0 . 1 0 158 0.0044
0.25 63.5 0 .0109
0.50 38 .0 0 .0182
1 . 0 0 2 2 . 2 0.0312
2.50 14.0 0.0495
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The half-life period (ti/2) for the inactivation process is the time after which the 
activity has decreased to half of its original activity, i.e. A = A q/2. The half life period 
may be expressed as
ti/ 2 = In 2/kobs = 2.303 log 2/kobs = 0.693/kobs
From this relationship the pseudo first-order rate constant for inactivation, kobs 
= 0.693/ti/2, was calculated.
The relationship betw.een kobs and desired constants (i.e. Kj) may be described 
by the equation (Kitz and Wilson, 1962)
kobs = k2 /  [(Ki /  [I]) + 1] [equation (1)]
This describes the observed rate constant and is derived from Michaelis-Menten type 
derivations of the following system
kl k2
E + 1 E - 1----------► EX
k-1
where E represents the free enzyme, I, the inhibiting reagent, E - I the reversible 
enzyme inhibitor complex and EX, the inactivated enzyme. Kj is the concentration of I 
giving the half-maximum inactivation rate, i.e. Ki = (k_i + k2)/ki.
A double reciprocal plot of kobs versus oATP concentration (Kitz and Wilson, 
1962) (Fig 4.2B) showed saturation kinetics with the pseudo first-order rate constants 
proportional to the concentration of oATP. This is indicative of the formation of 
a reversible GroEL-oATP complex prior to irreversible inactivation, one of the criteria 
for an affinity label. In accordance with equation (1) the apparent Ki determined from
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Fig 4.2 Kinetics of inactivation of GroEL ATPase with oATP
A. Pseudo first-order plots for inactivation
GroEL (~ 3.5 |iM per subunit) was incubated with increasing concentrations of oATP 
in 50 mM-TEA, 10 mM-magnesium acetate, pH 8.0 at 25°C. At time intervals aliquots 
were removed and assayed for ATPase activity as described in section 2.4.1 (a). The 
concentrations of oATP used were , 0.0 mM (o), 0.1 mM (■), 0.25 mM (0), 0.5 mM 
(A), 1.0 mM (•) and 2.5 mM (o).
B . Determination of Kj and k2
Pseudo first-order rate constants (kobs) calculated in part A were proportional to oATP 
concentration in this double reciprocal plot. The second order rate constant for the 
inactivation of GroEL ATPase activity by oATP, as denoted by the slope of the curve 
(Ki /k2), is 46 M_1 min _1.
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Fig. 4.2B was 2.11 mM, with the maximum rate of inactivation (k2 ) at saturating 
concentrations of oATP was 0.1 min*1.
4 .2 .4  Substrate protection against oATP inactivation
Substrate protection of an enzyme is one of the criteria for an affinity label. 
Protection of substrate against inactivation strengthens the argument that inactivation is 
likely to be due to a reaction at or near the active site (Colman, 1983).
The ATPase activity of GroEL could be protected against inactivation by the 
prior inclusion of ATP (Fig. 4.3A). The data from the pseudo first-order plot indicates 
that the half-life of inactivation increases with ATP concentration (table 4.2). Increased 
protection against 1 mM-oATP inactivation was observed with increasing ATP 
concentrations, with up to 70% of the original activity remaining in the presence of 5 
mM-ATP (Fig. 4.3B). Therefore it appears as though oATP is interacting with critical 
amino acids at or near the ATP binding site.
Table 4.2
Effect of substrate concentration on oATP inactivation of GroEL ATPase 
activity
[ATP] mM 11/2 (min) kobs/min
0.0 22 .0 0 .0315
1.0 48 .5 0 .0143
5.0 91 .0 0.0076
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Fig.4.3 Substrate protection against oATP inactivation of GroEL 
ATPase activity
A. Pseudo first-order plots for inactivation
GroEL (~ 3.5 pM per subunit) was incubated in the presence of 1 mM-oATP and 
increasing concentrations of ATP in 50 mM-TEA, 10 mM-magnesium acetate, pH 8.0 
at 25°C. At time intervals aliquots were removed and assayed for ATPase activity as 
described in section 2.4.1(a). The concentrations of ATP present were 0 mM (o), 1 
mM (■) and 5 mM (A).
B . Protection against oATP inactivation by inclusion of ATP
GroEL (-5 .3  pM per subunit) was incubated in the presence of 1 mM oATP and 
varying concentrations of ATP in a buffer of 50 mM-TEA, 10 mM-magnesium acetate, 
pH 8.0 at 25°C. After 6  hours incubation samples were withdrawn and assayed for 
ATPase activity as described in section 2.4.1(a).
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4.2 .5  Stoichiometry of incorporation of oATP into GroEL
In order to measure the incorporation of oATP into GroEL, the protein was 
inactivated by [2', 5', 8  - 3H] oATP. Results of a number of independent experiments 
are presented in Figure 4.4, where the inactivation process is directly related to the 
increasing incorporation of [2', 5', 8  - 3H] oATP. When the enzyme is completely 
inactivated this corresponds to the incorporation of approximately 1.30 moles of oATP 
per active site. Therefore although additional reactions appear to occur at other sites 
complete inactivation of the GroEL ATPase activity is due to the incorporation of about 
1 oATP per subunit.
4 .2 .6  Stoichiometry of incorporation of oATP into substrate protected 
GroEL
Incorporation of oATP into GroEL in the presence of ATP (section 2.11.7) was 
reduced compared to incorporation in the absence of substrate (table 4.3). Substrate- 
protected GroEL retained 65% of its ATPase activity corresponding to the incorporation 
of around 0.6 moles of oATP per GroEL monomer. This is directly comparable to the 
incorporation of approximately 1.6 moles of oATP in inactivated GroEL in the absence 
of ATP (table 4.3). This suggests that the amino acid residue(s) recognised by oATP 
are no longer available for modification in the presence of substrate. Thus by the criteria 
of protection by substrate and stoichiometry of modification it appears that oATP acts 
as an affinity label of the GroEL ATPase site.
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Fig. 4.4 Stoichiometry of inactivation of GroEL ATPase activity by 
oATP
GroEL (~ 3.5 (iM per subunit) was incubated in the presence of 0.6 mM-[2', 5', 8 - 
3H] oATP in 50 mM-TEA, 10 mM-magnesium acetate, pH 8.0. At time intervals 
aliquots were removed and the reaction quenched by a 10 fold excess of sodium 
borohydride for 30 minutes (section 2.11.6). Samples were then assayed for ATPase 
activity (section 2.4.1(a)) before measuring incorporated radioactivity (section 2.11.7).
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Table 4.3
Stoichiometry of inactivation of GroEL ATPase activity by oATP
Incubation Activity (%) oATP/monomer
GroEL* 100 0 .0
GroEL*/ 1 mM-oATP 5 1.57 ± 0.64
GroEL*/ 1 mM-oATP / 5 mM-ATP 65 0.62 ± 0.22
* GroEL concentration was 5 |iM per subunit
4 .3  Identification of the oATP modified peptide
The evidence provided in the previous sections (section 4.2) suggested that 
oATP is indeed an affinity label acting at the GroEL ATPase active site, and that 
inactivation is due to the incorporation of around 1 oATP per GroEL subunit. In order 
to identify the site of modification a differential peptide mapping approach was 
employed. This technique allows identification of regions of the protein which are 
modified by a particular site directed reagent but are protected in the presence of 
substrate. Adenine containing ligands absorb strongly at 260 nm and therefore it was 
not necessary to use radiolabelled oATP in order to detect the oATP modified peptide.
4.4  Peptide mapping
4.4.1 Limited proteolysis of GroEL
In order to determine the susceptibility of GroEL to proteolysis, GroEL was 
digested in the presence of 2% w/w chymotrypsin, trypsin or thermolysin under the
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conditions described in section 2.12. Complete proteolysis was observed after 24 hours 
digestion with all three proteases as analysed by SDS-PAGE and confirmed by reverse 
phase chromatography using a Waters pBondapak C l8  column.
The time course of proteolysis of GroEL in the presence of 2% w/w 
thermolysin, as analysed by SDS-PAGE, is shown in Figure 4.5. Thermolysin was 
selected for peptide mapping of oATP modified GroEL.
4.4 .2  Proteolysis of oATP modified GroEL
GroEL (~50 pM per subunit) was inactivated in the presence of 1 mM-oATP 
for 6  hours by which time less than 5% of the ATPase activity remained. A parallel 
experiment was performed in the presence of 5 mM-ATP (section 2.13.2). Both 
reaction mixtures were quenched by a 1 0  fold excess of sodium borohydride and 
subjected to gel filtration on Sephadex G-25 to remove excess oATP. The protein was 
then transferred to acid-washed round bottomed flasks and digested for 24 hours in the 
presence of 3% w/w thermolysin at 37°C in 0.5% ammonium bicarbonate, with 
continuous stirring. After 24 hours samples were removed and immediately frozen with 
dry-ice in ethanol before lyophilization. Samples were stored at -20°C until required for 
peptide fractionation.
4.4 .3  Differential peptide mapping of oATP modified-GroEL
oATP modified-GroEL in the presence and absence of ATP was prepared and 
proteolysed as described above. Freeze-dried samples were resuspended in deionised 
distilled water and fractionated by reverse phase HPLC using a Waters fiBondapak C18 
column. Peptides were eluted using a linear acetonitrile gradient (section 2.13.4) and 
monitored at both 214 nm (to detect peptide bonds) and at 260 nm (in order to detect 
adenine-containing peptides). When monitored at 214 nm the complex peptide profiles
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were sufficiently similar to make identification of any modified peptide very difficult 
(Fig. 4.6). The presence of an additional peptide species seemed to elute after 
approximately 32 minutes in the modified sample (Fig. 4.6A). The traces monitored at 
260 nm , however, showed one region which was substantially protected by ATP (Fig. 
4.7). This peptide, clearly eluting after approximately 32 minutes (25% CH3CN), was 
present in the modified and inactivated GroEL (Fig. 4.7 A) but absent in the protected 
sample (Fig. 4.7B). Other differences in regions of the peptide profiles were much less 
pronounced. The difference in profiles observed at approximately 32 minutes were 
highly reproducible between separate experiments.
4.4 .4  Isolation and purification of the modified peptide
The material eluting at approximately 32 minutes was collected and re- 
chromatographed by reverse phase HPLC under the same conditions described 
previously (section 2.13.4). The elution profile, monitored at 214 nm, showed a major 
component emerging at the same point in the gradient, but which contained a 
pronounced shoulder (Fig. 4.8 A).
In an attempt to purify this material further aliquots of the sample were loaded 
onto a Pierce microbore (1 x 100 mm) C8 column and eluted with a shallow acetonitrile 
gradient, similar to what was used previously. Again, the peak eluting was not 
symmetrical and, as before - whether monitored at 260 nm or 214 nm (Fig. 4.8B) - 
showed evidence of a shoulder, indicating that more than one peptide species was 
present. This material was, however, collected for amino acid sequence analysis.
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Fig. 4.5 SDS-PAGE analysis of thermolysin limited proteolysis of
GroEL
GroEL (~3.5 (J.M per subunit) was proteolysed in the presence of 2% w/w thermolysin 
under the conditions described in section 2.12. At time intervals aliquots, containing 
approximately 5 |ig of GroEL, were removed and the reaction stopped by the addition 
of 2 mM EDTA for 5 minutes. Samples were then analysed on a 15% SDS-PAGE gel 
(section 2.3) and stained for protein using Coomassie blue as described in section 
2.3.1.
Lane 1: markers; BSA, ovalbumin, GAPDH, carbonic anhydrase, trypsinogen, trypsin 
inhibitor, oc-lactalbumin.
Lanes 2-10: GroEL treated with thermolysin for 1, 20, 40, 60, 90, 120, 180, 360 and
1440 minutes respectively.
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Fig. 4.6 Reverse phase HPLC profiles, monitored at 214 nm, of 
thermolysin digested oATP modified GroEL in the absence (A) and 
presence (B) of ATP
Experimental details are given in section 2.13. Identical quantities of protein were 
injected (~5 nmoles). The diagonal line in each trace represents the acetonitrile gradient 
and detection was carried out at 214 nm to detect peptide bonds. AU represents 
absorbance units.
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Fig. 4.7 Reverse phase HPLC profiles, monitored at 260 nm, of 
thermolysin digested oATP modified-GroEL in the absence (A) and 
presence (B) of ATP
Experimental details are given in section 2.13. Identical quantities of protein were 
injected (~5 nmoles). The diagonal line in each trace represents the acetonitrile gradient 
and detection was carried out at 260 nm to detect adenine-containing peptides. AU 
represents absorbance units.
93
A
bs
or
ba
nc
e 
(2
60
nm
) 
A
bs
or
ba
nc
e 
(2
60
nm
)
40
A.U. 0.006
20
4535 40302515 205 100
Time (mins)
40
A.U. 0.006
- 2 0
4540
Time (mins)
94
% 
c
h
3c
n 
% 
c
h
3c
n
Fig. 4.8 Reverse phase HPLC profiles, monitored at 214 nm, of the 
modified GroEL peptide
A. Re-chromatography on pBondapak C18 column
The modified peptide eluting after approximately 32 minutes (Fig. 4.7A) was collected 
and re-chromatographed under the conditions described previously (section 2.13.4) and 
detection monitored by absorbance at 214 nm.
B Chromatography on a microbore C8  column
The re-chromatographed peptide from Fig. 4.8A was collected and further fractionated 
on a Pierce microbore C8 column. Elution was carried out with a shallow acetonitrile 
gradient (section 2.13.4) and detection monitored by absorbance at 214 nm.
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4 .4 .5  Amino acid sequencing of the modified material
The material eluting after approximately 24 minutes from the C8 reverse phase 
HPLC column (Fig. 4.8B) was collected and subjected to Edman degradation (Table 
4.4).
The data from the amino acid sequencing indicated that two peptides were 
present in the modified material. When compared with the published amino acid 
sequence of GroEL (Hemmingsen et al., 1988) the peptides correspond to residues 
453-462 and 514-518 of the deduced sequence, namely
453 IVLNCGEEPS 
5 i4 ITTEC
The residue observed in cycle 5 of the Edman degradation was tentatively 
identified as tyrosine, however in the GroEL sequence the amino acid observed in each 
peptide at the relevant position was cysteine. The reason for this may be twofold. 
Cysteine residues are notoriously difficult to detect during amino acid sequencing (B. 
Dunbar, personal communication) and if one or the other cysteine residues were 
modified by oATP then the residue would be wrongly identified during Edman 
degradation.
4.5 Mass spectroscopy analysis of the modified material
The amino acid sequencing data suggested that the only plausible site(s) of 
reaction with the aldehyde groups of oATP were with the cysteine side chains present 
in the two peptides. In order to ascertain if one or the other (or both) peptides were 
interacting with oATP, the modified sample was analysed by mass spectroscopy. The 
material that was sequenced was subjected to electrospray mass spectroscopy as
9 7 ;
Table 4.4
Automated Edman degradation of the oATP modified material
Cycle number Residue Yield (pmol)
1 Ala, Val, He, Leu 3.7, 11, 28, 15
2 Thr, Val 7.9, 13
3 Thr, Leu 6.2, 10
4 Asn, Glu 9.7, 9.0
5 Tyr 3 .5
6 Gly 6 .0
7 Glu 5 .5
8 Glu 6 .0
9 Pro 4 .5
10 Ser 2 .0
9 8
described in section 2.13.6. The material was analysed in both in the positive and 
negative ionisation mode, in view of the possibility of the peptide containing at least 
one and possibly three phosphate groups.
The spectrum obtained in the positive ion mode showed a major component 
with a strong doubly charged ion at m/z of 812.6 which corresponds to a molecular 
weight of 1623.2. Ions at m/z 823.5 and 831.6 corresponding to the sodium and 
potassium adducts were also observed (Fig. 4.9A).
The spectrum obtained in the negative ion mode was identical (Fig.4.9B). The 
species present was a strong doubly charged ion at m/z of 810.6 which again gives a 
molecular weight of 1623.2. Although other minor peaks were present in both spectra, 
nothing else of significance was observed.
The molecular mass of 1623 does not represent any of the two peptides with a 
covalently linked oATP. This molecular mass does however correspond to the mass of 
the two peptides linked by a disulphide bridge between the cysteine residues.
4 .6  Sulphydryl titres of GroEL with 5, 5'-dithiobis(2-nitrobenzoate)
The amino acid sequence of GroEL contains three cysteine residues 
(Hemmingsen et al., 1988). From the amino acid sequences of the modified peptides 
the only plausible sites of reaction of oATP with the isolated peptides are with the side 
chains of the cysteine residues {i.e. Cys-457 and / or Cys -518), which would 
presumably yield hemithioacetal derivatives. These derivatives appear to be stable under 
conditions used for HPLC and digestion, but are apparently unstable under conditions 
used for mass spectroscopy analysis and, possibly, Edman degradation.
9 9
Fig. 4.9 Electrospray mass spectroscopy of the oATP modified-peptide
A Electrospray in the positive ion mode
The oATP modified-peptide was collected and further purified by C8  reverse phase 
chromatography (Fig. 4.8B). The peptide collected was freeze dried and diluted 1:1 
with acetonitrile / water before injecting onto mass spectrometer as described in section 
2.13.6. The spectrum acquired was in the positive ion mode.
B Electrospray in the negative ion mode
The oATP modified-peptide was collected as described above and analysed in the 
negative ion mode.
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In order to demonstrate an involvement of cysteine side chains in the reaction between 
GroEL and oATP, GroEL was treated with the thiol specific reagent 5, 5'-dithiobis(2- 
nitrobenzoate) (DTNB) before and after inactivation with oATP. This assay measures 
the release of nitrothiobenzoate (NTB) upon reaction of a thiol with DTNB (Fig. 4.10), 
by the increase in absorbance at 412 nm. Liberation of NTB was calculated using a 
molar absorption coefficient of 13 600 M ^cnr1 (Ellman, 1959). Titratable thiol groups 
were measured according to section 2.15.
GroEL contains no cysteine residues linked by a disulphide bridge, since all 
three thiol groups can react with DTNB (Table 4.5). However, the three thiol groups 
present are free for reaction with DTNB only in the presence of 0.1% SDS suggesting 
that in the native protein all the cysteine residues are buried within the GroEL structure. 
When GroEL was reacted with 1 mM-oATP for 6.5 hours, under which conditions > 
95% of the ATPase activity was lost, the thiol content was reduced to approximately 1 
per chain. ATP protection results in an increased availability of the thiol groups to 
interact with DTNB. This suggests that GroEL interacts with oATP leading to a loss in 
thiol groups which is consistent with the results of the sequencing work above.
Table 4.5:- Sulphydryl titration of GroEL
Incubation Remaining - SH Modification
Activity (%) Native GroEL + 0.1% SDSl
GroEL 100 0 .0 3 .10
GroEL / ATP 100 0 .0 3 .20
GroEL / oATP 3 0 .0 1.05
GroEL / oATP / ATP 33 0 .0 1.94
The results are the average of 3 experiments
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Fig. 4.10 Reaction of thiol with DTNB
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4.7 Studies on proteinase K-treated GroEL
Treatment of GroEL with proteinase K leads to the removal of a portion of the 
C-terminal part of the polypeptide chain, including the highly conserved G/M rich last 
13 residues (Langer et al., 1992b; Martin et al., 1993). The truncated form of GroEL 
retains approximately only 20% of its uncoupled ATPase activity but maintains its 
characteristic tetradecameric structure and is able to mediate protein folding with 
[rhodanese as a substrate. This truncated form of GroEL was also used in order to study 
the binding of oATP.
4 .7 .1  Stoichiometry of oATP incorporation into proteinase K-treated 
GroEL
GroEL digested in the presence of 2% w/w thermolysin for 60 minutes in 50 
mM-TEA, 10 mM-magnesium acetate, pH 8.0 at 25°C (section 2.14.1) was N- 
lerminally intact as shown by amino acid sequencing of a Western blot of the 
proteolysis (Table 4.6). This is consistent with the work of Langer et al. (1992b) who 
proposed that the proteolysis was from the C-terminus, with the last 16 residues being 
proteolysed (Martin et al., 1993). The last 16 residues in the GroEL amino acid 
sequence does not contain any of the 3 cysteine residues known to be present. The 
extent of incorporation of oATP into proteinase K clipped GroEL (section 2.14.5) was 
essentially the same as that observed in a parallel experiment with native GroEL (Table
4.7). Incorporation of oATP into proteinase K clipped GroEL was in the order of 2.2 
moles of oATP per subunit in inactivated GroEL, with less incorporation observed in 
ATP protected clipped GroEL. Approximately 1.1 moles of oATP were incorporated 
into the protected sample. In addition the remaining ATPase activity was protected in 
the presence of substrate. The ATPase activity in the clipped GroEL is expressed as a 
percentage of activity remaining over the ATPase activity after treatment with proteinase 
3C. Thus substrate protection could still be demonstrated in the proteolysed form of
1 0 4
GroEL, indicating that ATP binding is unaffected by the absence of these C-terminal 
residues.
Table 4.6
Automated Edman degradation of proteinase K treated-GroEL
Cycle number Residue Yield (pmol)
1 Ala 14
2 Ala 15
3 Lys 15
4 Asp 21
5 Val 13
6 Lys 14
7 Phe 19
8 Gly 9
9 Asn 9 .5
10 Asp 10
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Table 4.7
Stoichiometry of modification of oATP into proteinase K treated-GroEL
Incubation Activity (%) oATP / monomer
Native GroEL / oATP 3 1.76
Native GroEL / oATP / ATP 70 0 .60
Clipped GroEL / oATP 13 2 .20
Clipped GroEL / oATP / ATP 38 1.1
106
4 .7 .2  Stabilisation effects of ATP against proteolysis with proteinase K
The presence of 5 mM-ATP stabilised the GroEL structure towards proteolysis 
by proteinase K compared to in the absence of ATP (Fig. 4.11 A). Although the C- 
terminal residues were still clipped off, the remainder of the protein was substantially 
more resistant to further proteolysis. This is likely to be due to an ATP induced 
conformational change in the GroEL structure which conveys resistance to proteolysis. 
Interestingly the loss of ATPase activity of GroEL was also protected by the inclusion 
of ATP (Fig. 4.1 IB). There was a dramatic loss of ATPase activity upon proteolysis 
without the prior inclusion of ATP but in its presence, despite an initial dip in activity, 
approximately 70% of the initial rate of ATP hydrolysis was retained. It appears 
therefore as though ATP can still bind to GroEL in the absence of the 16 C-terminal 
residues and be hydrolysed at a rate similar to the native protein when ATP induces a 
conformational alteration in the structure of GroEL which protects against more 
extensive proteinase K digestion.
4 .7 .3  Effect of oATP against proteolysis with proteinase K
The presence of 1 mM-oATP conveyed no protection at all against proteolysis 
by proteinase K. The stock solution of oATP available did not allow the use of higher 
concentrations for direct comparison with the protection against proteolysis afforded by 
5 mM-ATP, above. Proteolysis appeared to proceed more rapidly in the presence of 
oATP than in its absence (Fig. 4.12). It is not quite clear why this should occur. One 
possible explanation is that the subtle structural differences between oATP and ATP 
may be sufficient to cause slightly different conformational changes in the GroEL 
structure on interacting with the ATP binding site, thus exposing different regions of 
the protein towards the protease. The ATPase activity of GroEL in the presence of 
oATP was not measured in view of the inhibitory effects of the analogue. Different
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Fig. 4.11 Proteinase K limited proteolysis of GroEL
A. SDS-PAGE analysis of proteinase K digested GroEL
GroEL (~2 jiM per subunit) ± 5mM-ATP was proteolysed in the presence of 2% w/w 
proteinase K under the conditions described in section 2.14.1. At time intervals 
aliquots, containing approximately 3 (ig of GroEL, were removed and the reaction 
stopped by the addition of 2 mM-PMSF. Samples were then analysed on a 15% SDS- 
PAGE gel (section 2.3) and stained for protein using Coomassie blue as described in 
section 2.3.1.
Lane 1: markers (Sigma HMW kit); myosin, (3-galactosidase, phosphorylase b, BSA, 
ovalbumin, carbonic anhydrase.
Lanes 2-9: GroEL treated with proteinase K in the absence of ATP for 5, 30, 60, 90, 
120,180, 240 and 300 minutes respectively.
Lanes 10-17: GroEL treated with proteinase K in the presence of 5 mM-ATP for 5, 30, 
60, 90, 120,180,240 and 300 minutes respectively.
B Effect of limited proteolysis on the ATPase activity of GroEL
GroEL in the absence (O) and presence (■) of 5 mM-ATP was proteolysed in the 
presence of 2% w/w proteinase K as described above. At time intervals the proteolysis 
was stopped by the addition of PMSF and aliquots containing ~ 10 |ig GroEL were 
assayed for ATPase activity (section 2.4.1(a)).
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Fig. 4.12 SDS-PAGE analysis of proteinase K treated-GroEL in the 
presence of oATP
GroEL (~2 |iM per subunit) ± ImM-oATP was proteolysed in the presence of 2% w/w 
proteinase K under the conditions described in section 2.14.1. At time intervals 
aliquots, containing approximately 3 jig of GroEL, were removed and the reaction 
stopped by the addition of 2 mM-PMSF. Samples were then analysed on a 15% SDS- 
PAGE gel (section 2.3) and stained for protein using Coomassie blue as described in 
section 2.3.1.
Lane 1: markers; BSA, ovalbumin, GAPDH, carbonic anhydrase, trypsinogen, trypsin 
inhibitor, a-lactalbumin.
Lanes 2-9: GroEL treated with proteinase K in the absence of oATP for 5, 30, 60, 90, 
120, 180, 240 and 300 minutes respectively.
Lanes 10-17: GroEL treated with proteinase K in the presence of 1 mM-oATP for 5, 
30, 60, 90, 120, 180, 240 and 300 minutes respectively.
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batches of proteinase K were used between the experiments in Figure 4.11 and Figure 
4.12 which accounts for the slight differences in rates of proteolysis in the controls.
4.8 Potential active site reagents
In addition to oATP, GroEL was treated with a number of other potential 
affinity reagents and group specific reagents in order to try to identify the residues 
involved in ATP binding and hydrolysis. These are discussed below.
4 .8 .1  5'-FluorosuIphonylbenzoyladenosine
5f-Fluorosulphonylbenzoyladenosine (5'-FSBA) is a synthetic adenosine 
analogue which has been used as a potential affinity label for a number of adenine 
binding proteins (Colman et al., 1977). This reagent has a sulphonyl fluoride moiety 
which can act as an electrophilic agent in covalent modifications of several classes of 
amino acids including tyrosine, lysine, serine, histidine and cysteine. This broad range 
of specificity gives a reasonable chance of reaction within any particular nucleotide site.
Treatment of GroEL with lmM-5'-FSBA under conditions described in section
2.11.2 showed no inhibition of the GroEL ATPase activity even after prolonged 
incubation for up to 24 hours. This reagent was therefore not suitable for further 
studies on the GroEL ATP binding site.
4 .8 .2  4-(iodoacetamido)salicyIic acid
Salicylate often competes with ATP so 4-(iodoacetamido)salicylic acid may be 
considered as a 'pseudo-affinity label', whereby the salicylate moiety directs the reagent 
towards the ATP binding site. 4-(iodoacetamido)salicylic acid is reactive towards thiol 
groups and has the advantage of being able to introduce fluorescent groups into
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proteins (Price, 1979). There was no noticable loss in GroEL ATPase activity with this 
reagent (section 2.11.1) in incubations of up to 5 hours, at both 4°C and 25°C.
4 .8 .3  Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate has been extensively used to modify lysine residues, 
which are often found in nucleotide binding sites and especially in phosphate binding 
loops. Generally, pyridoxal 5'-phosphate inhibits enzymes by the formation of a Schiff 
base with a reactive lysine. This type of linkage can be readily hydrolysed but 
irreversible inactivation can be achieved by reduction with sodium borohydride
GroEL (~3.5 per subunit) was incubated in 50 mM-TEA, 10 mM- 
magnesium acetate pH 7.0 with ImM pyridoxal 5'-phosphate at 25°C followed by 
fixing with a 10 fold molar excess with sodium borohydride. The reaction was carried 
out in the dark and at time intervals samples were assayed for ATPase activity. After 
incubation for up to 3 hours only a small decrease in ATPase activity of 10-15% was 
observed. No further studies were carried out with this reagent.
4 .8 .4  Methyl acetimidate
Treatment of GroEL with the lysine specific reagent methyl acetimidate under 
conditions described in section 4.8.3 showed no inhibition of the ATPase activity with 
concentrations up to 2 mM even on prolonged exposure.
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4 .9  Discussion
In order to fully understand the mechanism of action of GroEL several 
investigators have studied the role of ATP binding and hydrolysis and their relationship 
to GroEL-mediated protein folding. The binding and hydrolysis of ATP is a highly co­
operative process which is enhanced by the presence of the co-chaperonin GroES 
(Gray and Fersht, 1991; Bochkareva et al., 1992) and is dependent on the presence of 
both Mg2+ and K+ for optimum activity (Viitanen et al., 1990). Recent evidence has 
indicated that the GroEL double-toroid behaves in an asymmetric manner with respect 
to ATP hydrolysis in the presence of GroES (Todd et al., 1993) and that it is the 
binding and hydrolysis of the nucleotide (in conjunction with GroES) which drives the 
'chaperone machinery' to release polypeptides in a folded or folding-competent state. 
Despite our (partial) understanding of the chaperoning mechanism, nothing at all is 
known about the location of the ATP binding site within the GroEL protein. Although 
the amino acid sequence of GroEL has been elucidated and the quaternary structure 
solved from electron microscopy the arrangement of the polypeptide chain within the 
tertiary structure of the protein is unknown. Neither does the published amino acid 
sequence of the GroEL protein (Hemmingsen et al., 1988) contain the consensus 
sequence -G-(X)4 -G-K-T/S- often found in the phosphate-binding loop of many ATP
i
and GTP binding proteins (Walker et al., 1982; Saraste et al., 1990). The aim of the 
work described in this chapter was, therefore, to locate and identify the important 
region(s) of the polypeptide chain involved in the binding of ATP.
The periodate-oxidised ATP analogue oATP differs from ATP only in minimal 
ribose modification and has been used extensively to specifically react with nucleotide 
binding sites in proteins. This analogue also appeared to react with the ATP binding site 
of GroEL and showed properties relevant to an affinity label. The ATPase activity of 
GroEL was found to be approximately 0.1 sec‘l per subunit, in close agreement with 
other reported values (Viitanen et al., 1990; Todd et al., 1993). As shown in figure
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4.2A, the inclusion of oATP with GroEL led to a decrease in activity in a pseudo-first 
order fashion, which was concentration dependent with respect to oATP. Using 1 mM- 
oATP the half life of inactivation was approximately 22 minutes with essentially all 
ATPase activity lost after 2 hours incubation. The demonstration of saturation kinetics 
provided evidence that oATP forms a dissociable complex with GroEL prior to 
inactivation. The apparent determined from Fig. 4.2B was 2.1 mM which is 
comparable to other reported K: values for oATP inactivation which vary from 6.7 |iM 
for the inactivation of rabbit skeletal muscle phosphorylase kinase (King and Carlson, 
1981) to 10 mM for the coupling factor-latent ATPase from Mycobacterium phlei 
(Kumar et al., 1979). In the absence of oATP there was no loss of activity over time 
and inclusion of ATP led to substantial protection against inactivation (Fig. 4.3). Up to 
70% of the ATPase activity could be retained by the inclusion of 5 mM-ATP. This 
indicates that inactivation is likely to be due to interactions at or near the ATPase active 
site. In preliminary experiments it was found that the addition of freshly thawed oATP 
solution to GroEL resulted in a lag period of approximately 2 hours before any 
substantial inactivation occurred. This lag could be eliminated by preincubation of the 
oATP at 25°C for 2 hours before addition. However preincubation of GroEL at 25°C 
before the addition of freshly thawed oATP did not abolish the lag. The reason for this 
discrepancy is not clear.
Further evidence for the inactivation being at or near the ATPase active site 
came from the measurement of the stoichiometry of modification. The complete 
inactivation of GroEL was due to the incorporation of approximately 1.3 moles of 
oATP per GroEL subunit. This is in line with the proposal that the GroEL tetradecamer 
has 14 ATP binding sites (Bochkareva et al., 1992). Inclusion of ATP led to ai
reduction in the incorporation of oATP binding to approximately 0.6 moles per GroEL 
subunit (Table 4.3). Thus the inactivation of the ATPase activity of GroEL is due to the 
incorporation of about 1 oATP per GroEL subunit, which can be protected by ATP, 
although additional reactions appear to occur at other sites. Interestingly, similar levels
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of incorporation of oATP into proteinase K treated GroEL (in the presence and absence 
of ATP) were also observed (Table 4.7). This protein is N-terminally intact but has lost 
its C-terminus last 16 residues through proteolysis (Martin et al., 1993). The results 
presented here, however, would suggest that the truncated GroEL can bind ATP in a 
similar fashion to the full-length protein and may explain why it has similar functional 
properties both in vitro, to refold |rhodanese in a GroES and ATP dependent manner, 
(Langer et al., 1992b), and can also substitute for full-length GroEL in vivo 
(McLennan et al., 1993).
Attempts to locate the site of reaction by a differential peptide-mapping approach 
proved to be more difficult than anticipated. A modified adenine-containing peptide was 
located by absorbance at 260 nm; this could be protected by inclusion of ATP (Fig.
4.7). This modified peptide, isolated after reverse-phase chromatography of a complete 
thermolytic digest of GroEL, was not homogeneous and contained more than 1 peptide 
sequence. Attempts to separate the peptide species were unsuccessful. The usual site of 
modification of oATP has been proposed to be with a lysine residue either to form a 
Schiff base, which can be stabilised by reduction with sodium borohydride to form an 
irreversible imine linkage, or a dihydroxymorpholino derivative (Easterbrook-Smith et 
al., 1976; Colman, 1983; Berknov et al., 1990; Rabinkov and Amontov, 1990). 
Neither of the 2 peptides isolated, corresponding to residues 453-462 (IVLNCGEEPS) 
and 514-518 (l l'i EC) in the GroEL sequence, contained a lysine residue or an arginine 
residue which is also a potential reactive site. From the sequences of the peptides the 
only plausible site(s) of reaction are with one or the other cysteine residues present in 
each peptide. This residue was not identified correctly in either case during peptide 
sequencing (although cysteines are very difficult to detect during Edman degradation), 
unlike the other amino acid residues. Indeed the sulphydryl group of cysteine has been 
proposed to be a potential site of reaction for oATP whereby the product of the reaction 
is a hemithioacetal (King and Carlson, 1981). On at least one occasion this has been
1 i
directly demonstrated. The inhibition of avian myeloblastosis virus reverse transcriptase
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by oATP is believed to be due to the reactivity of the oATP dialdehyde groups towards 
essential sulphydryl residues of the protein (Srivastava et al., 1983). Interestingly these 
authors observed that sodium borohydride treatment reversed the inhibition of oATP. 
This was not observed upon oATP inactivation of the GroEL ATPase activity. The 
inactivation of the ATPase activity did not appear to be affected whether or not the 
protein was treated with sodium borohydride, as inactivation curves were virtually 
identical (data not shown). Direct evidence for the involvement of cysteine side-chains 
came from the sulphydryl titration experiments using DTNB. Inactivation of GroEL by 
oATP led to the blocking of 2 of the 3 thiol groups present in GroEL which were then 
unable to react with DTNB (Table 4.5). Substrate protection of GroEL resulted in an 
increased availability of thiol groups for reaction with the sulphydryl-specific reagent, 
consistent with protection against complete inactivation of the ATPase activity. The 
decrease in the number of available thiol groups observed upon oATP treatment was 
not observed upon inclusion of ATP alone, as has been observed previously (Mendoza 
and Horowitz, 1992), suggesting that this is a property specific to the ATP analogue. 
Thus from the evidence from the modified peptide sequence(s) and sulphydryl 
modification it would appear that at least one, and possibly both, of the cysteine 
residues, Cys 457 and Cys 518, identified in these studies are present in the region of 
the GroEL ATP binding site.
From the available data, however, it is not possible to predict with any certainty 
which of the isolated cysteine residues are involved in this function. The reaction of the 
aldehyde group(s) of oATP at either Cys 457 or Cys 518 (or a cross-link of the oATP 
with the 2 cysteine residues) to yield hemithioacetal derivatives (Fig. 4. 13) is 
apparently stable under the conditions used for digestion, HPLC and DTNB treatment 
but is apparently unstable for mass spectroscopy analysis and, possibly, Edman
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Fig. 4.13 Proposed reaction of oATP with active site cysteine
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degradation. Under these conditions it would appear that the adenine moiety is lost and 
that the presence of the 2  cysteine containing peptides could lead to the formation of a 
disulphide bridge. There was no evidence for the presence of additional peptides in the 
correct Mr range for an oATP modified peptide during mass spectroscopy analysis 
(Fig. 4.9). Interestingly, however, although considerable kinetic evidence exists to 
suggest that oATP can act as an affinity label for a number of ATP binding proteins, 
attempts to isolate and identify oATP modified peptides or amino acids have generally 
proved unsuccessful. In several cases proposed morpholine-like derivatives appear to 
be unstable during attempts at identification (King and Carlson, 1981; King and 
Colman, 1983; Berkinov et al., 1990). Thus it is feasible that oATP has limited use for 
the identification of amino acids which form complexes other than reducible Schiff 
bases with oATP. Clearly a more detailed investigation of the chemistry of the reaction 
and the stability of the derivatives is required to clarify this situation.
The cysteine residues of GroEL are not conserved so presumably Cys 457 and 
Cys 518 are not essential for the ATPase catalytic function of the protein; however they 
are nucleophilic groups which can react with oATP. The indication that Cys 457 and / 
or Cys 518 may form part of the ATP binding site is consistent with a number of 
observations. GroEL that has been covalently modified by either of the sulphydryl- 
specific reagents N-ethylmaleimide or 2-(4'-(iodoacetamido)anilino) naphthalene-6 - 
sulphonic acid is unable to support the GroES and ATP dependent mediated refolding 
of Jrhodanese;, despite being able to form a binary complex with the unfolded 
polypeptide (Mendoza and Horowitz, 1992). This may indicate that the ATP-mediated 
release of the polypeptide from GroEL is affected by the blocking of important cysteine 
residues present at the ATP binding site. Recently, Bochkareva et al. (1994) have 
demonstrated that the ATPase activity of GroEL can be completely inhibited by another 
sulphydryl-specific reagent 2 , 2 '-dipyridyl disulphide and have shown that the 
nonhydrolysable ATP analogue 35S-ATP-y-S can specifically form cross-links to Cys 
137 in GroEL. Analysis of the stability of single and double mutants in which cysteine
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residues are replaced by serine has shown that Cys 518 (identified in these studies) is in 
close proximity to Cys 137 (Bochkareva et al. unpublished results). Using a different 
affinity labelling approach Martin et al. (1993b) have identified a conserved residue, 
Tyr 477, which can form cross-links to 8 N3-ATP. These authors have assigned this 
tyrosine residue to be located in a 40-kD ATP binding domain located in the C-terminal 
region of the chaperone protein. This proposed ATP binding domain contains both Cys 
457 and Cys 518 identified in these studies but does not contain the residue Cys 137 
putatively identified by Bochkareva et al. (1994) to be responsible for binding the y -  
phosphate group of ATP (although this bond may have been hydrolysed in the work of 
Martin et al. (1993b)). Until the three dimensional structure of the protein is solved one 
can only speculate on the location of the ATP binding site. Alignments of the amino 
acid sequences of members of the chaperonin 60 family (including the eukaryotic 
cytosol TRiC class) show 2 regions of especially high homology (Lewis et al., 1992). 
A conserved feature of these proteins is ATP binding and hydrolysis, so comparisons 
of sequences should help to identify regions involved in this function. The first block 
of homology between amino acids 80-100 show a highly conserved motif centred 
around -GDGTT(T/S)-. Lewis et al. (1992) have identified this region as a possible (J- 
phosphate ATP binding domain closely related to that found in cAMP dependent 
protein kinase. This region is, however, outwith the putative 40-kD ATP binding 
domain identified by Martin et al. (1993b), who themselves have proposed a region 
spanning residues 164-172 and 241-251 of the GroEL sequence to be responsible for 
binding of triphosphate groups. Sequence alignments of these regions of GroEL show 
close homology to other known chaperonin 60 proteins and contain a conserved 
potential active site lysine residue located at position 167 in GroEL (Fig. 4.14). Site- 
directed mutagenesis of this residue may provide important clues regarding its location 
relative to the ATP binding site. These sequences, however, are unrelated to members 
of the TRiC sub-class of chaperonins. The second block of homology identified by 
Lewis et al. (1992), present in both the classical chaperonin 60s and the TRiC class, is
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164 * 172
GroEL (E. coli) AMDKVGKEGVIT
RuBP (T. aestivum) 
Hsp60 (S. cerevisiae) 
Hsp60 (H . sapien)
A IDKVGPDGVLS 
AMEKVGKEGVIT 
AMEK V GKEG VIT
241 251
GroEL (E. coli) KAGKPILIIAE
RuBP (T. aestivum) QLRCPLFIVAE
Hsp60 (S. cerevisiae) QSRRPLLIIAE
Hsp60 (H. sapien) QSRRPILIIAE
Fig. 4.14 Sequence alignments of proposed ATP triphosphate binding 
regions in chaperonin 60 proteins.
These putative ATP binding regions of GroEL were proposed by Martin et al. (1993b). 
The numbering is according to the E. coli protein. Boldfaces are residues conserved 
in all four sequences. * indicates a highly conserved Lysine residue which may be 
present in an ATP phosphate binding loop. These alignments are taken from the 
sequences reported by Lewis et al. (1992) and Tsugeki et al. (1992).
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between residues 400-500, where there are no significant insertions or deletions, which 
contain a conserved -V(A/P)GGG- motif. This region may also play an important role 
in binding parts of the ATP molecule. The definitive answer to this question will come 
from X-ray crystallography studies and site-directed mutagenesis of potential active site 
amino acids.
In conclusion, a region of the GroEL protein has been identified which may be 
responsible for ATP binding. This region is located towards the C-terminus of the 
protein and is dependent on the presence of Cys 417 and / or Cys 518. It should be 
noted that the reactive functional groups of oATP are in the ribose moiety of the adenine 
nucleotide, whereas Bochkareva et al. (1994) and Martin et al. (1993b), using ATP 
analogues with different reactive groups, identified ATP binding regions in the GroEL 
molecule towards the N and C-terminus, respectively. These results, taken together 
with the conserved amino acid regions, indicate that the tertiary structure of each 
subunit must be as such to bring these regions of the polypeptide chain into close 
proximity so as to create an ATP binding site. One possible arrangement is that amino 
acid residues towards the N-terminal half of GroEL are involved in the binding of 
phosphate groups of ATP, as has been observed for a number of ATP binding proteins 
(Walker et al., 1982; Saraste et al., 1990), whilst the amino acids near the C-terminus 
are involved in the binding of the sugar moiety, and the purine ring. A similar type of 
structural arrangement exists in several ATP binding proteins including sugar kinases, 
actin and Hsp70 proteins (Bork et al., 1992). It remains a task for future work to fully 
characterise the amino acids involved in the ATP binding site of GroEL.
As an additional point of interest, the reported specific absorption coefficient 
values of GroEL at 280 nm (for a 1 mg/ml solution) show large discrepancies, varying 
between 0.21 - 0.416. Hayer-Hartl and Hard (1993) proposed that this could be 
accounted for by the presence of variable amounts of contaminating polypeptides 
between preparations, although the existence of mutant GroEL polypeptides was not
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ruled out. There is obviously a need to determine correctly the concentrations of GroEL 
solutions in order to study stoichiometry of interactions and understand the mechanism 
of action of the chaperone protein. The value used in these experiments was the one 
quoted by Price et al. (1991) of 0.285. This would seem to be a good estimate for the 
GroEL preparations used here since the estimation of thiol groups present in GroEL by 
DTNB, using this specific absorption coefficient, was in agreement with the number 
(i.e. 3) in the published amino acid sequence (Hemmingsen et al., 1988). Thus DTNB 
titration may also prove to be a useful tool to help determine the validity of specific 
absorption coefficients of GroEL preparations.
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Chapter 5 The unfolding and attempted refolding of GroEL
5 .1  Introduction
GroEL, in conjunction with ATP and its co-chaperonin GroES, is known to be 
able to assist in the refolding and assembly of a number of chemically denatured 
polypeptides. The mechanism of assembly of GroEL, and GroEL homologues, 
themselves also pose interesting problems. It has been proposed that these proteins may 
undergo a process of ’self-chaperoning’ in order to attain native structure (Cheng et al., 
1990; Lissin et al.t 1990). In order to examine some aspects of these processes, the 
unfolding of GroEL in the presence of guanidinium chloride (GdnHCl) was studied 
monitoring changes in ATPase activity and in secondary, tertiary and quaternary 
structure. In order to initiate the refolding process the denaturant was removed by 
dialysis which is a widely used technique for studying protein refolding in vitro.
5 .2  Unfolding of GroEL by GdnHCl
Unfolding of GroEL was studied in the buffer used by Lissin et al. (1990), 
namely 50 mM-potassium phosphate, 20 mM-potassium acetate, 5 mM-magnesium 
acetate, 0.1 mM-dithiothreitol, pH 7.5. Solutions of GroEL were incubated in the 
presence of GdnHCl for 15 minutes at 20°C before readings were taken; there were no 
further significant changes upon incubation for a further 45 minutes.
5 .2 .1  Changes in secondary structure
The changes in GroEL secondary structure brought about by GdnHCl was 
monitored by circular dichroism in the far-uv region (190-250 nm). This region of the 
spectrum is dominated by the contributions of the peptide bonds and as such is useful 
to monitor changes in secondary structure in the course of structural transitions.
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The CD spectra of GroEL in the absence of the denaturing agent and in the 
presence of selected concentrations of GdnHCl are shown in Figure 5.1 A. In the 
absence of GdnHCl, the secondary structure content, derived from the spectrum over 
the range 240 -190 nm, corresponds to 44 ± 1% a-helix, 29 ± p-sheet, 27 ± 2% 
remainder. These values were calculated using the method of Provencher and Glockner 
(1981) which uses a linear combination of the CD spectra of reference proteins with 
known secondary structure for a direct analysis of a given protein. The a-helix content 
is somewhat lower from the value reported by Lissin et al. (1990) (57%) who used the 
same method of secondary structure estimation. At least part of this discrepancy may 
arise from the difficulties in determining accurate concentrations of solutions of GroEL 
(Price etal., 1991).
The incubation of GroEL with increasing concentrations of GdnHCl causes a 
marked loss in secondary structure (Fig 5.1 A) whereby a random coil type structure is 
adopted in the presence of upwards of 2.0 M-GdnHCl. The changes in ellipticity at 225 
nm on addition of the denaturant show that there is a sharp transitional change in the 
region from 1.0 - 1.5 M GdnHCl, with a midpoint in the region of 1.35 M GdnHCl 
(Fig. 5. IB). In preliminary experiments at 2°C it was observed that the mid-point of 
transition was lowered to 1.25 M GdnHCl, supporting the observation of Lissin et al. 
(1990) that the chaperone protein is rather less stable at lower temperatures.
5 .2 .2  Changes in tertiary structure
The tertiary structural changes of GroEL in the presence of the denaturing agent 
was measured by fluorescence. The fluorescence of proteins originates from the 
aromatic amino acids, phenylalanine, tyrosine and tryptophan. Fluorescence emission 
is observed when an excited electron returns from the first excited state to the ground 
state whereby, due to energy loss, the emission is shifted to a longer wavelength
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Fig. 5.1A Changes in the far-uv CD spectrum of GroEL in the presence 
of GdnHCl
Spectra were obtained in a buffer of 50 mM-potassium phosphate, 20mM-potassium 
acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, pH 7.5 at 20°C. Unfolding 
of GroEL (50 |ig /  ml) in the presence of varying concentrations of GdnHCl was 
carried out as described in section 2.8.2. Spectra refer to GdnHCl concentrations of 0, 
0.5, 1.3, 1.5, 2.0 and 6.0 M, respectively. Spectra were recorded in a pathlength of 1 
mm (section 2.9.1) by Sharon Kelly in the laboratory of Dr. Nicholas Price at Stirling 
University.
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Fig. 5.IB Changes in eliipticity at 225 nm in the far-uv CD spectra of 
GroEL in the presence of GdnHCl
The changes of eliipticity at 225 nm of the CD spectra of GroEL in varying 
concentrations of GdnHCl (Fig. 5.1 A) are shown relative to that of GroEL in the
absence of GdnHCl.
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compared to the absorption of the chromophore. The contribution of phenylalanine is 
generally very small compared to tyrosine and especially tryptophan, which is the 
dominant amino acid. This technique permits monitoring of the environment in which 
these amino acids exist. The aromatic amino acid content of GroEL is disputed. The 
published amino acid sequence of GroEL, derived from its cDNA sequence, contains 7 
tyrosine residues and no tryptophan residues (Hemmingsen et al.y 1988). Price et al. 
(1991) have proposed that 1 tryptophan residue is present per GroEL subunit with 7 
tyrosine residues, although this may result from contaminating protein(s) (Hayer-Hartl 
and Hard, 1993).
The fluorescence emission spectra of GroEL in varying concentrations of 
GdnHCl were determined with exitation at both 290 nm (Fig. 5.2A) and 280 nm (Fig. 
5.2B). In each case it is clear that major changes occur in the spectrum over the range 
1.0 M - 1.5 M GdnHCl . There is a shift in wavelength maximum as the protein 
unfolds. This is easier to appreciate in figure 5.2A where tryptophan fluorescence is 
selectively excited, than in figure 5.2B where both tyrosine and tryptophan contribute 
to the emission. In the absence of GdnHCl, the wavelength of maximum emission is 
335 nm; this is shifted to 355 nm, the value characteristic of solvent exposed 
tryptophan, in 6 M GdnHCl. The unfolding of GroEL over the narrow range (1.0 -1.5 
M) of GdnHCl is demonstrated in figure 5.2C which shows the changes in intensity of 
fluorescence at 315 nm for excitation at both 280 nm and 290 nm.
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Fig. 5.2 Changes in the fluorescence of GroEL in the presence of 
GdnHCl
Spectra were obtained in a buffer of 50 mM-potassium phosphate, 20mM-potassium 
acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, pH 7.5 at 20°C. Unfolding 
of GroEL (50 |xg /  ml) in the presence of varying concentrations of GdnHCl was 
carried out as described in section 2.8.2. Spectra A, B, C, D and E refer to GdnHCl 
concentrations of 0, 1.0, 1.3, 1.5 and 6.0 M, respectively. Fig. 5.2A and 5.2B refer 
to excitation at 290 nm and 280 nm, respectively.
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Fig. 5.2C Changes in fluorescence at 315 nm of GroEL in the presence 
of GdnHCl
Relative changes in fluorescence at 315 nm of GroEL in the presence of GdnHCl when 
excited at 280 nm (A) and 290 nm (A). See figure legend 5.2 A/B for experimental
details.
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5. 2 . 3  Changes in quaternary structure
Changes in the quaternary structure of GroEL were measured by light scattering 
as described in section 2.9.3. Molecular weight ratios of GroEL in the presence of 
GdnHCl, Mi, to that in the absence of GdnHCl, MOJ were determined by the equation 
(Parr and Hammes, 1975)
M . (n o)2 @n / 3co)2 (c o) (I i,90)
Mo (ni)2@n/9ci)2(ci)Ob,90)
where n is the refractive index, 3 n / 3c is the refractive index increment, c is the protein 
concentration, and I90 is the light scattering intensity at 90°.
The changes in GroEL molecular weight at different GdnHCl concentrations 
was measured by changes in intensity of light scattering at 360 nm. This data shows 
that a marked loss in quaternary structure took place, again over the range 1.0 -1.5 M 
GdnHCl (Fig. 5.3).
5 .2 .4  Changes in GroEL ATPase activity
The ATPase activity of GroEL in the presence of GdnHCl was measured by a 
coupled quench assay of the type described by Johnson and Price (1988), in view of 
the likely effects of the denaturing agent on the coupling enzymes (section 2.4.1(b)). 
The validity of this method was confirmed by control experiments. The GroEL ATPase 
activity was lost in the presence of GdnHCl; essentially all activity was lost by 0.75 M 
GdnHCl (Fig. 5.4).
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Fig. 5.3 Changes in Mr of GroEL in the presence of GdnHCl
Data were obtained in a buffer of 50 mM-potassium phosphate, 20mM-potassium 
acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, pH 7.5 at 20°C. Unfolding 
of GroEL (50 jig / ml) in the presence of varying concentrations of GdnHCl was 
carried out as described in section 2.8.2. The changes in Mr were determined by light 
scattering as described in sections 5.2.3 and 2.9.3. The experimental points represent 
the means of 4 determinations.
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Fig. 5.4 Changes in the ATPase activity of GroEL in the presence of 
GdnHCl
GroEL was unfolded in varying concentrations of GdnHCl at 20°C in a buffer of 50 
mM-potassium phosphate, 20mM-potassium acetate, 5 mM-magnesium acetate, 0.1 
mM-dithiothreitol, pH 7.5 as described in section 2.8.2. After treatment with GdnHCl, 
the ATPase activity of GroEL was measured as described in section 2.4.1 (b).
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5. 2 . 5  Comparison of the various techniques
The various techniques used for monitoring the structural changes during the 
unfolding of GroEL are compared in figure 5.5, where the data are normalised to show 
the changes as a percentage of the maximum change observed. The various 
measurements from CD, fluorescence and light scattering all show major changes 
occuring between 1.0 and 1.5 M GdnHCl. The changes in secondary, tertiary and 
quaternary structure run in parallel with a large loss of structure over a narrow range of 
GdnHCl. The steepness of changes in this region and the lack of any discernible 
plateau suggest that the unfolding of the tetradecamer is a highly cooperative process. 
The ATPase activity is lost at lower concentrations (0.75 M), where there is little 
evidence for any significant overall structural changes, suggesting to a greater lability of 
the catalytic site. An alternative explanation may b e , however, that the denaturant binds 
to important charged side chains at the active site to cause inhibition of the ATPase 
activity.
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Fig. 5.5 Changes in the ATPase activity and structural param eters of 
GroEL in the presence of GdnHCl
The data are normalised to show the difference between GroEL in the absence and 
presence of 6 M GdnHCl as 100%. (0) changes in ATPase activity, (O) changes in 
eliipticity at 225 nm, ( • )  changes in Mr from light scattering, (A) changes in 
fluorescence at 315 nm (excited at 290 nm). The concentration of GroEL was 50 (ig / 
ml for structural measurements and 40 |ig / ml for activity measurements. The buffer 
was 50 mM-potassium phosphate, 20mM-potassium acetate, 5 mM-magnesium acetate, 
0.1 mM-dithiothreitol, pH 7.5 at 20°C.
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5.3  Refolding of GdnHCl denatured GroEL
The refolding of denatured proteins can be initiated by the removal of the 
structure perturbing agent, whether by dilution, dialysis or by a pH-jump. Attempted 
refolding of GroEL which had been denatured in GdnHCl (above) was undertaken by 
the dialysis technique. Denatured GroEL was dialysed against 50 mM-potassium 
phosphate, 20mM-potassium acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, 
pH 7.5 (section 2.8.3) and changes in structural parameters and ATPase activity were 
measured as described in the previous section.
5 .3 .1  Refolding of GroEL after denaturation in low concentrations of 
GdnHCl
When the initial concentration of GdnHCl was 1.0 M or below there was 
essentially complete restoration of secondary, tertiary and quaternary structure of 
GroEL as judged by CD, fluorescence and light scattering, respectively. In addition the 
ATPase activity of the protein, which was lost by 0.75 M GdnHCl, was restored (Fig. 
5.6). However when the initial concentration of GdnHCl was raised progressively 
above 1.0 M, there was a decreasing extent of regain of ATPase activity (Fig. 5.6).
5 .3 .2  Refolding of GroEL after denaturation in higher concentrations of 
GdnHCl
The renaturation of GroEL after incubation with concentrations of GdnHCl 
above 1.0 M will be discussed in this section.
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5. 3 . 3  Secondary structure changes
Irrespective of the initial concentration of GdnHCl, the regain of secondary 
structure as revealed by CD was almost complete. GroEL which was initially denatured 
in 6.0 M GdnHCl and had been completely unfolded in a random coil type structure 
regained approximately 90% of its secondary structure upon dialysis, as judged by 
eliipticity at 225 nm (Fig. 5.7). It was also found in preliminary experiments that when 
dialysis was performed at 2°C instead of 20°C the regain of secondary structure was 
less efficient (57% of the eliipticity at 225 nm was restored).
5.3 .4  Tertiary structure changes
The loss in the ability of GroEL to regain its ATPase activity at concentrations 
above 1.0 M GdnHCl (Fig. 5.6) correlated with a progressive loss of ability of GroEL 
to regain correct tertiary structure as monitored by the wavelength of maximum 
emission when excited at 290 nm (Fig. 5.8A). When the initial concentration of 
GdnHCl was 6.0 M (corresponding to complete unfolding of the protein ) the 
wavelength of maximum emission after dialysis was 345 nm. This corresponds to an 
intermediate state between the native protein (A, maximum emission 335 nm) and the 
fully unfolded state (A, maximum emission 355 nm). The fluorescence emission spectra 
when excited at 280 nm (Fig. 5.8B) also provides evidence for the attainment of an 
intermediate state when the denaturant was removed.
5.3 .5  Quaternary structure changes
The measurements of quaternary structure by light scattering revealed that under
i
the conditions employed the native quaternary structure was not regained, since in most 
experiments the intensity of light scattering was only some 40 - 50% of a control 
sample which had been incubated in the absence of GdnHCl and subsequently
1 3 8
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Fig. 5.6 Reactivation of GroEL after incubation in GdnHCl
GroEL (50 |!g / ml) was incubated with the stated concentrations of GdnHCl for 15 
minutes at 20°C (section 2.8.1); the denaturing agent was then removed by dialysis as 
described in section 2.8.3. The degree of reactivation is expressed as a regain of 
ATPase activity (section 2.4.1 (a)), relative to a control sample incubated in the absence 
of denaturant.
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Fig. 5.7 Changes in the far-uv CD spectra of GroEL after removal of 
GdnHCl by dialysis
Spectra were obtained in a buffer of 50 mM-potassium phosphate, 20mM-potassium 
acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, pH 7.5 at 20°C. Unfolding 
of GroEL (50 |ig / ml) in the presence of GdnHCl was carried out as described in 
section 2.8.2. GdnHCl was then removed by dialysis (section 2.8.3). The initial 
concentrations of GdnHCl were 0, 0.5, 1.3, 1.5, 2.0 and 6.0 M, respectively. Spectra 
were recorded in a pathlength of 1 mm (section 2.9.1) by Sharon Kelly in the 
laboratory of Dr. Nicholas Price at Stirling University.
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Fig. 5.8 Changes in the fluorescence of GroEL after removal of 
GdnHCl by dialysis
Spectra were obtained in a buffer of 50 mM-potassium phosphate, 20mM-potassium 
acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, pH 7.5 at 20°C. Unfolding 
of GroEL (50 |ig /  ml) in the presence of GdnHCl was carried out as described in 
section 2.8.2. GdnHCl was then removed by dialysis (section 2.8.3). Spectra A and E 
refer to GdnHCl concentrations of 0 and 6.0 M, respectively; spectrum F refers to the 
sample incubated in 6.0 M GdnHCl and then dialysed to remove the denaturing agent. 
Fig. 5.8A and 5.8B refer to excitation at 290 nm and 280 nm, respectively.
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dialysed. It should be noted that on occasion the solutions became slightly turbid under 
these conditions (i.e. where the initial concentration of denaturant was greater than 1.0 
M and then was removed by dialysis) suggesting that aggregate formation had 
occurred.
5 .4  Characterisation of the 'intermediate' state of GroEL
GroEL was observed to regain secondary structure efficiently after unfolding, 
but the correct tertiary and quaternary structure and enzyme activity was not regained. 
In order to characterise this 'intermediate' state of GroEL further, and in particular to 
determine whether it possessed any properties of a 'molten-globule' folding 
intermediate (Ptitsyn et al. ,1990; Christensen and Pain, 1991), ANS binding and 
susceptibility to proteolysis were studied.
5 .4 .1  8-anilino-l-naphthalenesuIphonate (ANS) binding
The 'molten globule' is an early folding state characterised by having most if 
not all of the secondary structure of the native protein in conjunction with a relatively 
compact, but unordered, flexible tertiary structure internalising a molten hydrophobic 
core (Ptitsyn et al. ,1990; Christensen and Pain, 1991). The fluorescence of the apolar 
probe ANS is dependent on the hydrophobicity of the environment and enhanced 
binding of the probe is suggestive of a 'molten globule’ type structure.
The binding of ANS to native, unfolded and 'refolded' GroEL was measured 
by fluorescence as described in section 2.9.5. The fluorescence of ANS (20 pM) in the 
presence of 50 pg /  ml GroEL was enhanced approximately 2.2 fold, compared to free 
ANS. This small enhancement declined further when GdnHCl was included over the 
range between 0 and 6.0 M (Fig. 5.9). The enhancement of only 1.3 fold (over free
1 4 4
ANS) at 6.0 M GdnHCl is consistent with the general observation that ANS does not 
bind to any great extent to either the native or fully unfolded states of proteins (Ptitsyn 
et al. ,1990; Christensen and Pain, 1991). The product obtained after dialysis of 6.0 M 
GdnHCl showed a small 2.1 fold enhancement fluorescence, compared with free ANS, 
suggesting that it does not posses a major characteristic of the 'molten-globule' state 
(i.e. enhanced binding of ANS). A 10 fold enhancement in ANS binding is typical for 
molten globules (Semisotnov et al., 1987).
5 .4 .2  Susceptibility to thermolytic proteolysis
In order to study the compactness of the structure of the GroEL 'intermediate' 
state obtained by dialysis, limited proteolysis was carried out in the presence of 
thermolysin (section 2.9.6). Thermolysin was selected because (a), it is readily 
inactivated by treatment with EDTA, therefore preventing artefactual proteolysis during 
preparation for SDS-PAGE and (b), the preference for large hydrophobic side chains 
which occur only rarely at the surface of native proteins usually is an effective means 
for discriminating between native and non-native structures (Girg et al., 1981).
Native GroEL was observed to be resistant to proteolysis with treatment with 2 
- 100% (w / w) thermolysin as judged by SDS-PAGE (Fig. 5.10). By contrast, the 
product obtained after dialysis was very susceptible to proteolysis. After 10 minutes 
incubation with 2% (w /  w) thermolysin only a small amount of material corresponding 
to an apparent Mr of 54 000 was observed (Fig. 5.10, lane 9). The intensity of this 
band corresponds to 28% of that observed for the intact polypeptide chain (Mr 57 000) 
in the absence of thermolysin (Fig. 5.10, lane 10) as judged by laser densitometric 
analysis. No distinct bands greater than 14 000 Mr were observed with larger amounts 
of protease. This data indicates that the dialysed sample has a more 'open' structure 
than the native protein.
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Fig. 5.9 ANS fluorescence of GdnHCl denatured-GroEL
Unfolding of GroEL (50 jig / ml) in the presence of various concentrations of GdnHCl 
was carried out as described in section 2.8.2, in a buffer of 50 mM-potassium 
phosphate, 20mM-potassium acetate, 5 mM-magnesium acetate, 0.1 mM-dithiothreitol, 
pH 7.5 at 20°C. The fluorescence of ANS (20 (iM) in the presence of GroEL was 
measured (section 2.9.5) and expressed in relative terms over the fluorescence of free 
ANS. (*) denotes the enhanced fluorescence of GroEL in 6.0 M GdnHCl which was 
then removed by dialysis.
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Fig. 5.10 Susceptibility of GroEL to proteolysis by thermolysin
GroEL (50 |ig / ml) was incubated with thermolysin for 10 minutes at 20°C in 50 mM- 
potassium phosphate, 20mM-potassium acetate, 5 mM-magnesium acetate, 0.1 mM- 
dithiothreitol, pH 7.5. The reaction was stopped by the addition of 2 mM EDTA and 
samples analysed on 15% SDS-PAGE gels (section 2.3). Lanes 1, 2 - 8 and 9 - 1 5  
contain Mr markers (section 2.10), native GroEL and GroEL which has been denatured 
and dialysed, respectively. The concentrations of thermolysin (fig / ml) added were: 
lanes 2 and 9, 0; lanes 3 and 10, 1; lanes 4 and 11, 2; lanes 5 and 12, 5; lanes 6 and 13, 
10; lanes 7 and 14, 20; lanes 8 and 15, 50. The band at Mr 33 000 in lanes 7, 8, 14 and 
15 correspond to thermolysin.
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5.5  'Self-chaperoning' of GroEL in the presence of (Mg-ATP)
The proposal by Lissin et al. (1990) that urea dissociated-GroEL 14-mers can 
reassemble in the presence of (Mg-ATP) by virtue of a 'self-chaperoning' mechanism 
was examined with GdnHCl treated GroEL. GroEL (2.4 pM per protomer) was 
denatured in the presence of 6M GdnHCl as before (section 2.8.2) for 15 minutes at 
20°C, then the denaturant removed by dialysis (section 2.8.3). The ATPase activity of 
this sample was less than 10% of the activity of a control in the absence of GdnHCl (as 
was previously observed in section 5.3.1). Incubation of the dialysed sample with 1 
mM ATP for 20 minutes, showed a regain of ATPase activity of some 38% . Addition 
of native GroEL (0.6 pM per subunit) and 1 mM ATP to the dialysed sample for 20 
minutes showed a slightly higher regain of ATPase activity of the order of 50% when 
compared to the control. These results are consistent with those of Lissin et al. (1990) 
and are suggestive of a regain of some tertiary and presumably quaternary structure of 
the dialysed protein. No structural studies were undertaken in conjunction with these 
experiments.
5 .6  Discussion
The results reported here show that the denaturing agent guanidinium chloride 
(GdnHCl) causes major structural alterations in GroEL when the concentration is raised 
above about 1.0 M. The changes in secondary, tertiary and quaternary structure, as 
judged by circular dichroism, fluorescence and light scattering, respectively, run in 
parallel (Fig. 5.5). The steep loss of structure, without any discernible plateau, over a 
relatively narrow range of GdnHCl concentrations (1.0-1.5 M) points to a markedly 
cooperative unfolding of the tetradecamer. A similar cooperative behaviour has been 
reported for the unfolding of the GroEL homologue symbionin (a chaperonin present inI
the aphid endosymbiont), although this protein is more labile to disassembly than native 
GroEL in the presence of urea (Morioka and Ishikawa, 1993). This greater lability to
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denaturation may reflect subtle differences in the oligomeric arrangements between the 
2 proteins (symbionin also has phosphotransferase activity as well as ATPase activity). 
By way of contrast, the unfolding of the hexameric glutamate dehydrogenase occurs in 
two distinct stages via a trimeric intermediate as the GdnHCl concentration is increased 
(West and Price, 1988), indicating that complete unfolding in a cooperative fashion is 
not universal and presumably is dependent on the strength of intersubunit interactions. 
The ATPase activity of GroEL was lost at lower concentrations of GdnHCl (0.75 M) 
before any significant structural changes had occurred. It is likely that the more 
pronounced loss of ATPase activity is due to the greater sensitivity of the active site 
towards structural pertubations as has been observed for other proteins (Tsou, 1986; 
West and Price, 1988; West and Price, 1989; West and Price, 1990; Kelly and Price, 
1991). An alternative explanation is that the denaturant itself is binding to important 
charged amino acid side-chains at the active site and one cannot rule out this possibility. 
It should be noted that because the unfolding process cannot be considered a reversible 
process (under these conditions), the changes in the various properties studied do not 
represent the attainment of a true equilibrium between the native and unfolded states of 
the protein. The protein should be regarded as reaching a metastable state, especially in 
the ’transition region' between 1.0-1.5 M-GdnHCl, which is observed to be stable over 
a period of 1 hour.
Attempts to refold the protein by removal of the denaturant by the dialysis 
technique proved to be largely unsuccessful. At concentrations at or below where the 
major structural alterations occurred (i.e. 1.0 M) there was essentially complete regain 
of secondary, tertiary and quaternary structure and in addition the ATPase activity was 
restored (Fig 5.6). When the initial concentration of GdnHCl was above the level
i
where the major structural alterations occurred, GroEL was unable to regain a native­
like conformation. In this respect the behaviour of GroEL is analogous to glutamate 
dehydrogenase (West and Price, 1988), aspartate aminotransferase (West and Price, 
1989; West and Price, 1990), citrate synthase (West et al.y 1990) and fumarase (Kelly
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and Price, 1991). Whilst the secondary structure of GroEL can be regained with high 
efficiency upon refolding from the completely denatured state (Fig. 5.7), the tertiary 
arrangement of the GroEL polypeptide upon dialysis is intermediate between that of the 
native and fully unfolded state (Fig. 5.8). The results obtained with the smallest 
amounts of thermolysin suggest that a folded structure involving most (54 kD out of 57 
kD) of the polypeptide chain had been formed. However, this product still has a 
relatively open structure compared to native GroEL, since it is degraded by larger 
amounts of proteinase (Fig. 5.10). Not surprisingly, therefore, neither the ATPase 
activity nor the correct quaternary structure could be regained. The inability of GroEL 
to refold into its correct oligomeric conformation under the conditions used in this work 
is, at least in part, likely to reflect the size and complexity of the protein. A lack of 
proper coordination between the processes of polypeptide folding and domain pairing 
and thus oligomerisation may lead to the formation of a folding intermediate which is 
unable to attain its final native structure and may lead to aggregation of the protein (as 
was observed on occasion during these experiments). This type of behaviour has been 
observed for a number of multidomain and multisubunit proteins upon attempted 
refolding (see Price, 1992).
The inability of GroEL to reassemble correctly after denaturation poses 
interesting questions concerning the assembly of the protein in vivo. Lissin et al. 
(1990) have shown that the refolding of GroEL in vitro after denaturation in 4 M-urea 
requires the presence of Mg-ATP (and is enhanced by GroES) and have postulated the 
idea of ’self-chaperoning'. In this proposal GroEL monomers are capable of Mg-ATP 
dependent self-assembly and reformation of the native tetradecamer which in turn can 
stimulate the oligomerisation of the remainder of GroEL monomers in an ATPase 
dependent manner. This process occurs in a highly cooperative fashion. The results 
presented in this chapter also showed that a regain in the ATPase activity of GroEL 
could only be achieved by the presence of Mg-ATP (and was slightly enhanced by the 
addition of native GroEL), although no structural studies were undertaken with these
1 5 0
proteins. In a study of mif 4 mutants in yeast, Cheng et al. (1990) concluded that the 
assembly of the mitochondrial chaperonin Hsp60 in vivo is dependent on a pre-existant 
functional tetradecameric complex. Another GroEL homologue, symbionin, is required 
for its own assembly in vitro in an ATP-dependent process, analogous to GroEL 
(Morioka and Ishikawa, 1993). Thus these results, plus those described in this chapter, 
show that GroEL, and its homologues are unable to refold spontaneously . In the case 
of GroEL, and symbionin, refolding is dependent on the presence of Mg-ATP and is 
stimulated by native GroEL (and also GroES). Such requirements resemble the GroE 
mediated refolding of many polypeptides (section 1.5.6.4), thus GroEL not only 
chaperones the (re)folding of other proteins but also appears to chaperone its own 
assembly in vitro. As a point of interest it has been shown that a chemically synthesised 
version of the co-chaperonin GroES is able to assemble into its active oligomeric form 
in the absence of any co-factors (Mascagni et al., 1991). Thus this protein differs from 
other oligomeric proteins such as rubisco in that it is able to spontaneously assemble in 
the absence of (other) chaperones.
The GroEL protein was observed to be less stable at lower temperatures, 
consistent with Lissin et al. (1990). GroEL monomers undergo cold denaturation at 
temperatures lower than 5°C and are unable to oligomerise into the native 
tetradecameric structure even in the presence of Mg-ATP (Lissin et al., 1990; Lissin 
and Hemmingsen, 1993). The lack of stability at low temperatures would indicate that 
hydrophobic interactions play an important role in the stabilisation of the oligomer, 
since such interactions are less stable with decreasing temperatures. Recent structure- 
function studies of GroEL have indicated that the N-terminus of the polypeptide plays a 
crucial role in the assembly of the tetradecamer. Mutations in either Ala2 (Horovitz et 
al., 1993a) or Lys3 (Horovitz et al., 1993b) weaken intersubunit interactions and thus 
destabilise the oligomeric structure. A charge reversal of Lys3 to Glu completely 
prevents the oligomerisation of GroEL in vivo (Horovitz et al., 1993b). The lysine 
residue at position 3 in the GroEL amino acid sequence is absolutely conserved
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between the chaperonins and may therefore be critical for intersubunit stabilisation. The 
stability of the native GroEL tetradecamer is therefore likely to involve multiple 
intersubunit interactions involving both charged and hydrophobic interactions. 
Interestingly, although the N-terminal of GroEL is crucial for its correct assembly the 
conserved glycine and methionine-rich motif found at the C-terminus appears "to be 
dispensable. Removal of these 16 C-terminal residues do not affect the ability of GroEL 
to function either in vitro or in vivo (Langer et al., 1992b; McLennan et al., 1993). In 
order to completely understand the role of GroEL, the structural basis of its own 
assembly requires to be fully elucidated. It remains to be directly demonstrated that 
GroEL is able to 'self-chaperone' in vivo and / or whether additional, as yet 
unidentified, chaperone-like proteins exist which may (also) assist in the assembly of 
the GroEL tetradecamer.
To summarise the results of this chapter, GroEL monomers, in the absence of 
ATP, are able to spontaneously regain secondary structure but not higher order 
structure or ATPase activity. The product obtained upon removal of denaturant is more 
sensitive to proteolysis by thermolysin, unlike the native protein, but does not show 
enhanced binding of ANS, a characteristic property of the 'molten-globule' state of 
proteins. Regain of native-like properties, as judged by regain of ATPase activity, 
requires the presence of ATP and is enhanced by native GroEL. It remains a task for 
future work to characterise this 'folded intermediate' state of GroEL in more detail and 
to further explore the role played by GroES and ATP in the later steps involved in the 
acquisition of the correct tertiary and quaternary structures of the GroEL protein.
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Chapter 6 General discussion and future prospects
6 .1  Introduction
The aims of the work presented in this thesis was to study structure-function 
relationships of the GroEL protein with regards to (1) the location of the functionally 
important ATP binding site and (2) the nature of the GroEL (self-)assembly process. 
The preceding chapters have described in detail the progress made in fulfilling these 
original objectives and are summarised below.
6 .2  The ATP binding site of GroEL
The binding and hydrolysis of ATP by GroEL is the critical step for the release 
of 'polypeptide substrates' from the chaperone protein, yet when this work was 
initiated nothing at all was known about the location of or the important amino acid 
residues present at the ATP binding site. Using an affinity labelling approach, residues 
towards the C-terminus of GroEL were identified as being present at or near the ATP 
binding site of GroEL (Chapter 4). In particular two residues Cys457 and / or Cys518 
were proposed to be the site of reaction for the reactive aldehyde group(s) of the ATP 
analogue 2' 3' dialdehyde ATP (oATP) (published in Thomson et al., 1993). This 
proposal is consistent with other affinity labelling approaches undertaken and since 
published (Martin et al., 1993a; Bochkareva et al., 1994 discussed in detail in section 
4.9). Although individual reactive groups have now been identified which are 
presumably present in the location of the ATP binding site, it is unknown whether they 
are absolutely essential for the ATPase activity of GroEL. The 3 cysteine residues 
present in GroEL are not conserved, possibly indicating a non-essential role. Essential, 
and conserved, amino acid side chains such as those of lysine and arginine, often found 
in the phosphate binding regions of nucleotide binding sites have not been identified to 
date. In the studies undertaken in this work, lysine specific reagents such as pyridoxal 
5'-phosphate and methylacetimidate were ineffective in inhibiting the GroEL ATPase 
activity, under the conditions employed. Identification of these catalytically important
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residues are likely to come, if not from chemical modification then, from X-ray 
crystallography studies. To date GroEL crystals which diffract to a low resolution have 
been obtained (Spangfort et al., 1993; Svensson et al., 1994). These crystals diffract 
only to a maximum of 7 A (Spangfort et al., 1993) and it will take a higher resolution 
diffraction before the three dimensional structure of GroEL and thus the molecular 
mechanism of its function is solved.
It will also be of great interest to know whether the limited sequence 
conservation between the chaperonins and their weakly related homologues in the 
eukaryotic cytosol (the heterologous TRiC class) reflects the maintenance of ATPase 
activity (Lewis et al., 1992) or whether the ATP binding pockets of these two classes 
of protein are similar but non identical. The latter possibility would be consistent with 
the putative ATP triphosphate binding regions of GroEL identified by Martin et al. 
(1993b) which shows homology to other members of the 'classical' chaperonin class of 
proteins but not to members of the TRiC class. It is known that at least two classes of 
purine nucleotide triphosphate binding folds exist. Those proteins with the Walker et al. 
(1982) type A motif (e.g. adenylate kinase, elongation factor Tu, myosin) have a 
common nucleotide binding fold (Saraste et al., 1990; Milner-White et al., 1991) which 
is distinct from other ATP binding proteins (e.g. Hsp70s, actin, hexokinase) (Bork et 
al., 1992). We must wait for crystallography studies to determine the nature of the ATP 
binding fold(s) within the chaperonin and TRiC classes.
6 .3  GroEL assembly
The question of how GroEL itself assembles into it characteristic tetradecameric 
structure is also one which has not been fully resolved. The results reported in chapter 
5 (published in Price et al., 1993) indicate that the GroEL protein is unable to 
reassemble into its native structure following denaturation in guanidinium chloride. 
Unfolding of the protein appears to be a highly cooperative process, although the amino
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acids present at the ATPase active site appear to be more sensitive to small structural 
alterations. Although the polypeptide can spontaneously regain secondary structure 
upon removal of denaturant, regain of functional chaperonin properties requires the 
presence of Mg-ATP and is enhanced by native GroEL. These results are consistent 
with the proposal that GroEL and its homologues can 'self-chaperone' in vitro (Lissin 
et al., 1990; Morioka and Ishikawa, 1993). It still remains for the folding pathway of 
the GroEL protein to be characterised in more detail and to determine whether GroEL 
can self-assemble in vivo. The in vivo assembly of the GroEL homologue in yeast 
mitochondria, Hsp60, is dependent on the presence of a pre-existing functional Hsp60 
complex (Cheng et al., 1990). This protein is nuclear encoded and then transported into 
the mitochondrial matrix. It is therefore likely that chaperones of the Hsp70 class are 
involved at some stage in the translocation of the polypeptide into the matrix and its 
subsequent assembly into native structure, although, as yet, this has not been 
demonstrated. A sequential folding pathway involving the E. coli Hsp70 homologue 
DnaK and GroEL has also been proposed for the assembly of some prokaryotic 
cytosolic proteins (Langer et al., 1992a), therefore it is feasible that DnaK and its co- 
chaperones may also play an important role in the assembly of the GroEL chaperonin in 
vivo. Thus whilst GroEL (and its homologues) may indeed undergo a process of 'self- 
chaperoning' in vivo, one cannot rule out the involvement of additional (possibly as yet 
unidentified) factors in the attainment of native structure. It should also be noted that of 
the experimental criteria used to indicate that both symbionin and GroEL undergo 'self- 
chaperoning' into their native oligomeric form in vitro (i.e. as judged by molecular 
mass, regain of ATPase activity and electron microscopic appearance) no reconstitution 
studies using reassembled chaperonins and other model protein systems have beeni;
undertaken. It remains to be demonstrated, for example, whether reassembled GroEL 
can also assist in the reassembly of denatured rubisco in a manner analogous to native
. i
GroEL. This point needs to be clarified in order to confirm that the correct native-like 
three dimensional structure of GroEL has been obtained.
155
6.4 Unanswered questions in the field of chaperone proteins
The implication that chaperone proteins play important roles in general denovo 
protein folding is one that has come about only relatively recently. Although research in 
this field is progressing rapidly the stuctural basis and mechanism of chaperone 
function is not fully understood. Some of the oustanding questions in this field will be 
outlined below.
The structural basis of chaperonin recognition of polypeptide substrates in not 
yet fully understood. The available evidence would suggest that GroEL recognises 
hydrophobic regions present in early folding intermediates of several (unrelated) 
polypeptides which also contain some elements of secondary structure (discussed in 
section 1.5.6.6). Whether or not these early folding intermediates contain some sort of 
target or consensus sequence which may be recognised by GroEL has yet to be firmly 
elucidated , as has the nature of the GroEL polypeptide binding ’pocket' itself. Martin 
et al. (1993a) proposed a reaction mechanism of the GroEL-GroES cycle whereby the 
polypeptide substrate bound within the central cavity, presumably at multiple sites 
within the channel to allow a cooperative release, and was released in a folding 
competent state by the concerted actions of ATP and GroES. These authors proposed 
that the unfolded polypeptide initially bound to the available free GroEL ring opposite 
to the ring with bound GroES. Electron microscopic analysis of the Thermus 
thermophilus holo-chaperonin (i.e. a homologue of the GroEL-GroES complex) has 
recently shown that the unfolded substrate polypeptide 3-isopropylmalate 
dehydrogenase does indeed bind to the opposite end of chaperonin-60 to where 
chaperonin-10 is bound (Isii et al., 1994). This is likely, therefore, to be a common 
mechanism between all polypeptides which undergo GroE mediated folding in vivo. 
This raises some more interesting questions about the role of the GroE proteins during 
chaperonin-mediated folding, which at present are unresolved. For example, during 
multiple cycles of polypeptide binding and release do (some) folding polypeptides
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shuttle between the two rings of GroEL or do they interact only with the same ring they 
initially bind to and, therefore, does GroES (also) shuttle between both ends of the 
GroEL cylinder to coordinate the release of the polypeptide substrate ?. Surprisingly 
GroES has also been shown to be able to bind to but not hydrolyse ATP (Martin et al., 
1993b). An additional role of GroES has therefore been proposed to donate ATP to 
GroEL and thus increase the cooperativity of ATP binding which presumably would 
increase the efficiency of GroE-mediated folding. This interesting proposal remains to 
be confirmed although it should be relatively simple to demonstrate any transfer of 
adenine nucleotides between the chaperonins.
One of the other outstanding questions is does a sequential chaperone folding 
pathway, involving Hsp70s and Hsp60s, also exist for the folding of polypeptides 
within the cytosol, as has been demonstrated using purified E. coli chaperone proteins 
in vitro (Langer et al., 1992a). This pathway (which exists in mitochondria, and is 
described in section 1.6) would potentially minimise the chances of aggregation or 
misfolding of many, and especially larger, polypeptides but it remains to be confirmed 
in vivo and demonstrated in cell-free translation systems in vitro. It seems likely that 
such a folding pathway does exist in the cytosol, at least for some polypeptides, in 
view of the differential binding capabilities of the two classes of chaperone proteins. 
Whether such a folding pathway exists in the eukaryotic cytosol remains unclear to 
date, in view of the relative novelty of the eukaryotic cytosolic chaperonin-like proteins 
(the TRiC class).
6 .5  Evolution of the chaperonin family
Studies on the E. coli GroE proteins has given a remarkable insight into how 
many, but not all, polypeptides require their assistance to attain native structure both in 
vitro and in vivo. The remarkable structural and functional conservation between
.i
GroEL and GroES and their analogues in mitochondria and chloroplasts has given an
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indication of the importance of these proteins within the cell and indeed these proteins 
are essential for normal cellular function. These proteins probably evolved from a 
common eubacterial origin. No homologues have, however, been identified in the 
eukaryotic cytosol to date. Their closest relations appear to be the weakly related 
members of the TRiC sub-family of chaperonins which have been found to be present 
in the cytosol of all eukaryotic cells examined to date (see Frydman et al., 1992; Gao et 
al., 1992; Lewis etal., 1992; Yaffe et al., 1992). Like the 'classical' chaperonins these 
proteins have a double-ring structure which has ATPase activity, unlike them, 
however, the stacked ring structure exists as hetero-oligomeric complex arranged with 
an eight or nine fold symmetry. The heteromeric nature of the TRiC complex consists 
of up to ten different subunits several of which, but not all, are related to the ubiquitous 
eukaryotic protein TCP1 (Frydman et al., 1992; Kubota eta l., 1994). The diversity of 
subunits present in the complex may give it a greater spectrum of potential polypeptide 
substrates (compared to 'classical' chaperonins) and reflect the evolution of more 
complex functions required to deal with the folding and assembly more highly evolved 
polypeptides present in the eukaryotic cytosol. The TRiC complex has already been 
shown to facilitate the (ATP assisted) folding of tubulin, actin and firefly luciferase in 
vitro (Frydman et al., 1992; Gao etal.t 1992; Yaffe et al., 1992). It is likely that other 
polypeptides functionally interact with the TRiC complex and that it will have a general 
role in polypeptide folding within the eukaryotic cytosol, possibly equivalent to the 
'classical' chaperonins. The common structural and functional similarities of the 
chaperonins and the TRiC sub-family of chaperonins suggests that they either arose 
from a common ancestor or evolved convergently to carry out chaperoning functions in 
their respective compartments. Studies on the TRiC complex are still in its infancy and 
a lot is unknown about its function. No chaperonin-10 like co-factor (if it exists) has 
been identified for TRiC and it still remains to be directly demonstrated that the complex
, i
assists polypeptide folding in vivo. The bacterial GroE system may provide important 
clues about its mechanism of action.
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6 .6  Future prospects
It seems likely that the list of potential chaperone proteins will grow longer as 
further interest and research in this field is generated. Indeed a putative chaperonin 60 
protein has recently been identified, after heat shock, in the nucleus of a fish cell line 
(Sanders et al., 1994) whilst bacteriophage T4 encodes a protein which, despite 
absence of sequence similarity, can substitute for GroES in the GroEL dependent 
refolding of rubisco in vitro and in vivo and assist bacterial growth at non-permissive 
temperatures (van der Vies et al., 1994). These and other findings, including the recent 
proposals that both protein disulphide isomerase and peptidyl prolyl cis-trans 
isomerase have chaperone activities (discussed in sections 1.4.1 and 1.4.2), may 
indicate the need for the definition and / or the categorisation of chaperone proteins to 
be altered. The danger is that some proteins will be proposed as chaperones by virtue of 
simply providing an interactive surface which may have the ability to act as a 
'biochemical sponge1 and so prevent aggregation of a given polypeptide in the in vitro 
situation but will not have this function in vivo. These situations must be clarified in 
more detail.
The GroE chaperone system is now relatively well characterised and it remains 
for eukaryotic chaperonins (in particular the TRiC class) to be further explored. Some 
of the outstanding questions regarding chaperonin mediated protein folding have been 
outlined above, and will no doubt be source of future research in order to gain further 
insights into the mechanism of how these remarkable components assist in the 
acquisition of correct protein structure within the cell. In a practical sense it is likely that 
co-expression of these proteins will provide to be of great use to maximise expression 
of recombinant proteins both in bacteria and in transgenic plants. For medical interest it 
may be of importance to identify dysfunctional chaperone proteins which may 
(possibly) affect protein folding and thus have implications which may lead to disease.
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Providing the answers to such questions will, no doubt, prove to be of great 
significance
1 6 0
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